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 Abbreviations 
 
αSMA alpha smooth muscle actin 
µl microliter 
A/V arteriovenous 
AAV adeno associated viruses 
ADAM17 ADAM metallopeptidase domain 17 
Alk5, TGFBR1 transforming growth factor, beta receptor 1 
Amot angiomotin 
Angpt2 angiopoietin 2 
angiogenesis vessels sprouting from preexisting vessels 
Apj receptor apelin receptor 
BCE bovine capillary endothelial cells 
bHLH basic helix loop helix 
cDNA complementary DNA 
Col IV collagen IV; a marker for blood vessels 
Connexin 40 see GJA5 
Cldn5 claudin 5 
Connexin-37 see GJA4 
COUP-TFII see Nr2f2 
csf-1 colony stimulating factor 1 
DAPT N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycine-1,1-
dimethylethyl ester 
Dkk1 dickkopf1 
ddH2O double distilled water 
Dll4 delta-like 4 
DNA deoxyribonucleic acid 
dNTP deoxy nucleotide-triphosphate 
DRVP deep retinal vascular plexus 
E2F E2F transcription factor 
ECM extracellular matrix 
ECs vascular endothelial cells 
efficacy the quality of being successful in producing an intended result; 
effectiveness 
eGFP enhanced green fluorescent protein 
EphB4 EPH receptor B4 
ER endoplasmatic reticulum 
EVR exudative vitreoretinopathy 
FEVR familial exudative vitreoretinopathy 
Fovea A depression in the center of the macula of the retina where only 
cones are present and blood vessels are lacking. 
Fz-4 frizzled 4 protein 
FZD4 frizzled 4 gene 
gDNA genomic deoxyribonucleic acid 
GFAP glial fibrillary acidic protein 
GFP green fluorescent protein 
GJA4 gap junction protein, alpha 4 
GJA5 gap junction protein, alpha 5 
GPR91/SUCNR1 succinate receptor 1 
GSK3 glycogen synthase kinase 3 
HEK293T cells human embryonic kidney 293T cells 
Hes1 hairy and enhancer of split 1 
Hey1 hairy/enhancer-of-split related with YRPW motif 1 
HMEC human microvascular endothelial cells 
HMEC-1 human microvascular endothelial cells 
hs Homo sapiens 
HUVEC human umbilical vascular endothelial cells 
IB4 Isolectin B4; a marker for blood vessels 
IBA1 induction of brown adipocytes 1 
IHC immunohistochemistry 
IRVP intermediate retinal vascular plexus 
ISH in situ hybridisation 
Jag1 jagged 1 
kb kilobases 
KO Ndphy/- mice 
LD50 
 
the amount of a toxic agent (as a poison, virus, or radiation) that is 
sufficient to kill 50 percent of a population of animals within a 
certain time 
Lfng lunatic fringe 
LiCl lithium chloride 
LIF leukemia inhibitory factor 
LRP5 low density lipoprotein receptor-related protein 5 gene 
LRP-5 low density lipoprotein receptor-related protein 5 protein 
MAE mouse aortic endothelial cells 
MAOA monoamine Oxidase A 
MAOB monoamine Oxidase B 
MAPK mitogen activated protein kinase 
MB megabases 
MgCl2 magnesium chloride 
mm Mus musculus 
Monc-1 a immortalized neural crest stem cell line 
morpholino nonionic antisense oligonucleotide analogs with a stable 
morpholine moiety replacing the pentose ring 
MT1-MMP membrane anchored metalloproteinase MT1 
N1ICD notch1 intracellular domain 
NaCl sodium chloride 
ND Norrie disease 
NDP Norrie Disease Pseudoglioma gene 
ng nanogramm 
NGF nerve growth factor 
Nr2e1 nuclear receptor subfamily 2, group E, member 1 
Nr2f2 nuclear receptor subfamily 2, group F, member 2 
Nrp1 neuropilin 1 
Nrp2 neuropilin 2 
OMIM Online Mendelian Inheritance in Man; a database of human genes 
and genetic disorders 
PCR polymerase chain reaction 
PDGFA platelet derived growth factor A 
PDGFB platelet derived growth factor B 
PDGFRα platelet derived growth factor receptor alpha 
PFA paraformaldehyde 
pTopflash Wnt reporter luciferase construct 
PU.1 spleen focus forming virus proviral integration oncogene spi1 
QRT-PCR quantitative real time polymerase chain reaction 
RhoA ras homolog gene family, member A 
RMCs retinal myeloid cells 
RNA ribonucleic acid 
SDS sodiumdodecylsulfate 
sFlt-1 soluble VEGFR1 
SMA smooth muscle actin 
Smad5 SMAD family member 5 
SMCs smooth muscle cells 
SRF serum response factor 
SRVP superficial retinal vascular plexus 
sVEGFR1 soluble VEGFR1 
synteny conservation of gene order 
Syx syntaxin, mammalian RhoA ortholog 
TGFβ transforming growth factor β 
TrkA tyrosine receptor kinase A 
TSPAN12 tetraspanin 12 gene 
Tspan-12 tetraspanin12 protein 
Unc5b unc-5 homolog B 
UPR unfolded protein response 
vasculogenesis de novo formation of blood vessels 
VEGF or VEGF-A vascular endothelial growth factor 
VEGF/VPF vascular endothelial growth factor / vascular permeability factor 
VEGF-A vascular endothelial growth factor A 
VEGFR1 VEGF receptor 1 
VEGFR2 VEGF receptor 2 
VEGFR3 VEGF receptor 3 
WT wildtype mice 
 
 
  
Summary 
Norrie disease is an X-linked recessive disorder that presents with congenital blindness, progressive 
deafness and rarely with mental retardation. It is caused by mutations in the Norrie Disease 
Pseudoglioma (NDP) gene, which may also lead to milder diseases like exudative vitreoretinopathy, 
retinopathy of prematurity or Coats’ disease. In the eye, mutations in NDP lead to a delayed and 
incomplete development of the superficial retinal vascular plexus (SRVP) and they prevent the 
development of the two deep retinal vascular plexuses. This is accompanied with persisting hyaloid 
vessels around the vitreous. It has been shown that Norrin, the protein product of NDP, binds the co-
receptor complex consisting of Fz-4, LRP-5 and Tspan-12 which leads to the downstream activation 
of canonical Wnt signaling.  
Despite the phenotypic and molecular knowledge about Norrin, the intrinsic function of Norrin 
during retinal blood vessel development remains a mystery. This thesis aimed to gain more insight 
about the role of Norrin during retinal blood vessel development from Ndphy/- mice. This work 
suggests that Norrin-Wnt signaling and Notch signaling may not be directly linked. Further, 
endomucin was identified as a marker for central thorn-like aligned filopodia in Ndphy/- mice and 
extensive mural cell coverage of the SRVP from Ndphy/- retinas was found after P9. Arterial/vein 
crossing within the SRVP of Ndphy/- retinas was described for the first time. This indicates that MAPK 
signaling might be altered in Ndphy/- retinas since knockout mice with altered MAPK signaling also 
display vessel crossing. Norrin was further identified to be a mitogen for cells of the SRVP which is in 
concert with in vitro data from micro vascular endothelial cells. Finally, equal numbers of hyaloid 
vascular associated macrophages was found between P7 and P12 in Ndphy/- mice, suggesting that 
hyaloid vessels fail to regress despite the presence of a constant number of macrophages. In sum, it 
was shown that the loss of Norrin signaling might primarily affect MAPK signaling rather than Notch 
signaling. 
 
 
 
  
Zusammenfassung 
Die Norrie Krankheit, zu deren Hauptanzeichen kongenitale Blindheit, progressiver Höhrverlust und 
in einigen Fällen mentale Retardierung zählen, wird X chromosomal vererbt. Verursacht wird die 
Norrie Krankheit durch Mutationen im Norrie Disease Pseudoglioma (NDP) Gen. Einige Mutationen 
im NDP Gen können auch zu milderen Phänotypen wie etwa zu Exudativen Vitreoretinopathien, 
Frühgeborenen Retinopathie oder Morbus Coats führen. Alle bisher bekannten Mutationen im NDP 
Gen führen im Auge zur unvollständigen Entwicklung des oberflächigen retinalen Blutgefässnetzes 
und ein fehlendes Auswachsen der beiden tiefen retinalen Blutgefässnetzwerke. Weiter verhindern 
Mutationen im NDP Gen die Rückbildung der hyaloiden Blutgefässe des Vitreus. Bisher wurde 
gezeigt dass Norrin, das vom NDP Gen codierte Proteinprodukt, an einen Rezeptorkomplex 
bestehend aus Fz-4, LRP-5 und Tspan-12 bindet und schliesslich die kanonische Wnt-Signalkaskade 
aktiviert.  
Obwohl man schon länger über ein molekulares und phänotypisches Basiswissen bezüglich Norrin 
verfügt, blieb die intrinsische Funktion dieses Proteins grösstenteils verborgen. Diese Doktorarbeit 
hatte zum Ziel, durch systematisches Studium von Norrin-Gendefekt-Mäusen, mehr Wissen über die 
Funktion von Norrin zu gewinnen. Die Auswertung der generierten Daten lassen folgende Aussagen 
zu: Die Norrin-Wnt- und Notch-Signalkaskaden sind nicht direkt gekoppelt. Endomucin ist ein 
molekularer Marker für zentrale dornartig angeordnete Filopodien des oberflächigen retinalen 
Blutgefässnetzwerks von Norrin-Gendefekt-Mäusen. Die oberflächigen retinalen Blutgefässe von 
Norrin-Gendefekt-Mäusen sind spätestens neun Tage nach der Geburt übermässig mit Mauerzellen 
bedeckt. Das Kreuzen von Arterien und Venen bei Norrin-Gendefekt-Mäusen weist auf reduzierte 
Aktivität der MAPK-Signalkaskade in retinalen Endothelzellen hin. Norrin ist ein Mitogen für 
Endothelzellen der oberflächlichen retinalen Blutgefässe von Mäusen. Schliesslich wurden konstante 
Anzahlen von Makrophagen, welche an die hyaloiden Gefässe des Vitreus angelagert sind, zwischen 
7 und 12 Tagen nach der Geburt bei Norrin-Gendefekt-Mäusen gefunden. Dies zeigt, dass die 
fehlende Regression der hyaloiden Blutgefässe bei Norrin-Gendefekt-Mäusen nicht durch eine 
verminderte Anzahl and Makrophagen verursacht wird. Zusammenfassend wurde gezeigt, dass der 
Verlust von Norrin, nicht primär zu verändertem Notch Signaling führt, sondern eher verändertes 
MAPK Signaling verursacht. 
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1. Introduction  
The human eye is a powerful sensory organ that allows catching the moving scene at a glance. When 
healthy, we are most of the time unaware of the benefit of having functional eyes. Sometimes, e.g. 
when entering a tunnel by car or being dazzled by the sun, we lose the ability to see for a tick and 
realize the power of vision. Developmental defects, degenerative diseases or eye injuries can lead to 
permanent or temporal impaired vision or blindness. Norrie disease is one example of a familial 
developmental disease, caused by mutations in the Norrie Disease Pseudoglioma gene (NDP) (Berger 
et al., 1992). Its gene product, Norrin, binds to a receptor complex consisting of Frizzled4 (Fz-4), Low 
Density Lipoprotein Receptor-related Protein 5 (LRP-5) (Xu et al., 2004) and the auxiliary membrane 
protein Tetraspanin12 (Tspan-12) (Junge et al., 2009) and triggers canonical Wnt signaling. A few 
other eye diseases similar to Norrie disease do exist. These diseases are associated with mutations in 
NDP, FZD4, LRP5 or TSPAN12 and feature retinal vascular defects. Aberrant signaling of another 
pathway, the Notch signaling pathway, also causes retinal vascular defects. This thesis aimed to 
investigate the interplay of Norrin and Notch signaling during blood vessel development in the 
mouse eye. The activity of both signaling cascades is likely to be altered in developing retinal blood 
vessels from Norrin deficient mice. Therefore the introduction starts to give a general overview 
about the eye and its most important structures (e.g. the retina) with later focus on the retinal 
vascular development and the Norrin-Wnt and Notch signaling cascades. 
1.1 The eye 
The eye, in the interplay with the brain, is the sensory organ that allows humans to perceive color, 
shape, and motion and to differentiate between light intensities that may vary about ten orders of 
magnitude. The structures of the eye develop from all three blastodermic layers. The anterior, non-
neuronal, part of the eye develops from the mesoderm, which gives rise to the cornea, sclera and 
the uveal tunics (iris, ciliary body and choroid). The surface ectoderm gives rise to the lens. The 
posterior part of the eye descends from the neuroectoderm that gives rise to the diencephalon 
which in turn forms two optic buds that finally become the retina and its associated pigment cell 
layer (Figure 1). 
 
 
Figure 1: Schematic representation of a mid-sagittal section of the human eye and retina. Anterior structures 
include the cornea, pupil, lens, iris and the sclera. Posterior structures are the choroid, retina and the optic 
nerve (adapted from www.webvision.med.utah.edu/imageswv/Sagschem.jpeg). 
Light enters trough the cornea, the transparent sector of the otherwise white appearing sclera. The 
sclera is made of a tough fibrous tissue that shapes the eye and confers stability to the eye globe. 
The light then passes the pupil, the opening of the iris. The iris is a usually blue, green or brown skin 
also containing a sphincter muscle that regulates the diameter of the pupil according to perceived 
light intensity. The light then passes the lens and vitreous before it impinges clearly focused on the 
retina, where phototransduction, the first step of photo perception, occurs. 
1.2 The retina 
The retina is located adjacent to the choroid, which is an extensively vascularized tissue that 
nourishes the retina (Figure 1). The retina itself is organized in three neuronal or nuclear (ONL, INL, 
GCL) and two synaptic or plexiform (OPL, IPL) layers (Figure 2). The outer nuclear layer (ONL) consists 
of photoreceptors, which are the light sensing cells. The human retina consists of two different types 
of photoreceptors: the rods and the cones. The rods absorb dim light and are the major cells 
involved in scotopic vision. The cones, which are more abundant at the center of the retina, are 
excited by bright light (photopic vision) and are, in contrast to rods, color sensitive. The 
photoreceptors project to synapses of bipolar cells (BC) at the outer plexiform layer (OPL). In 
addition to bipolar cells, the OPL consists also of horizontal and amacrine cell somas (HC, AC). 
Horizontal and amacrine cells modulate the transduced neuronal signal. The bipolar and amacrine 
cells project at the inner plexiform layer (IPL) to ganglion cells (GC). The somas of the ganglion cells 
are located at the ganglion cell layer (GCL). The axons of the ganglion cells leave the retina as the 
optic nerve and project to brain areas involved in visual processing. 
 
Figure 2: Light micrograph of a vertical section through the human retina (A) with schematic representation 
of the major retinal layers with their respective cell types (B). Five major layers are observed in retinal 
sections. The most apical layer is the retinal pigment epithelium (RPE). Adjacent to the RPE is the 
photoreceptor layer that consists anatomically of the outer segments (OS), inner segments (IS) and the 
outer nuclear layer (ONL). The synapses of the photoreceptors (rods and cones) connect to synapses of 
bipolar cells (BC) at the outer plexiform layer (OPL). The cell somas of the bipolar cells are located at the 
inner nuclear layer (INL). Additionally, the INL hosts the somas of the horizontal (HC) and amacrine cells 
(AC), which are involved in signal implementation. The bipolar and amacrine cells connect to the ganglion 
cells (GC) in the inner plexiform layer. The somas of the ganglion cells are located at the ganglion cell layer 
(GCL) which represents the innermost layer of the retina. Mueller cells (MC) are glial cells spanning through 
the entire retina. Adapted from www.anatomy.unimelb.edu.au/researchlabs/rees/images/retina.jpg 
The retina has the highest oxygen demand of all human tissues and hence depends on a well-
developed blood supply (Yu et al., 2001). The developing retina is nourished by three vascular 
systems: the hyaloid, retinal and choroid vascular systems. This thesis focuses on the development 
of the retinal vascular system as well as hyaloid vascular regression, which are both severely altered 
in Norrin knockout (Ndphy/-) mice. The following sections describe the characteristic clinical features 
of Norrie disease and the normal development of human and mouse retinal vasculature. 
1.3 Norrie disease and Norrin 
Norrie disease (ND, OMIM #310600) is a severe X-linked recessive form of congenital blindness. The 
locus underlying the disease was first mapped to Xp11.3 and later, by positional cloning, narrowed 
down to the Norrie Disease Pseudoglioma (NDP) gene that encodes for the Norrin protein (Berger et 
al., 1992; Chen et al., 1992; Chen et al., 1993; Sims et al., 1992). The severity of the phenotype 
caused by mutations in Norrin varies even within a family and includes essentially congenital 
blindness and progressive hearing loss and sometimes mental retardation. Norrie Disease patients 
with large gene deletions in Xp11.4 (including NDP) often develop additional clinical features, 
including hypogonadism, epilepsy, microcephaly, immunodeficiency and growth disturbancies 
(Berger1998).  
Cardinal ocular signs of Norrie disease include leukokoria, pseudoglioma and phthysis bulbi (Chynn 
et al., 1996)(Bergen et al., 1994) (Figure 3). Leukokoria is a condition characterized by a reflective 
white mass within the eye that gives the appearance of white pupils (Figure 3A). Pseudoglioma is an 
inflammatory condition of the eye resembling a glioma of the retina and is marked by a 
circumscribed suppurative inflammation of the vitreous body (Figure 3B). Phthisis bulbi is the 
progressive atrophy and degeneration of the eye and occurs mainly in older patients (Figure 3C). 
  
Figure 3: Clinical signs of Norrie Disease. A) Leukokoria B) Pseudoglioma of the enucleated eye from the 
patient depicted in A. C) Phthisis bulbi of a 77 year old patient (Chynn et al., 1996; Bergen et al., 1994) 
The NDP gene comprises three exons (Figure 4). Only exons 2 and 3 are partially translated into 
Norrin. More than 110 distinct NDP point mutations have been identified in Norrie disease patients 
(appendix 1). In addition, several mutations in NDP have been identified in patients with familial 
exudative vitreoretinopathy (FEVR), Coats’ disease (CD) and/or retinopathy of prematurity (ROP) 
(Berger and Ropers, 2001). These Norrin-related diseases are described in the Masterthesis from 
Jurian Zuercher, Walter Haenseler or Lea Sollfrank and in the PhD Thesis from Nikolaus Schaefer and 
in Berger et al., 2010 (Berger et al., 2010). A table that summarizes the most prominent features of 
these syndromes is available in appendix 2. The mouse homologue of NDP, Ndph, has been cloned 
and mapped. RNA in situ hybridization studies of Ndph revealed transcription in the inner nuclear 
layer and ganglion cell layer of the retina, Purkinje cells of the cerebellum and in the olfactory bulb 
of two-week-old mice (Berger et al., 1996). Ye et al. used a knock-in mouse, which carries the coding 
sequence of human placental alkaline phosphatase inserted at the Ndph locus (NdphAP) and found 
that Ndph is expressed in Müller glia in the retina and Bergman glia in the cerebellum and more 
widespread by astrocytes in the fore- and midbrain. In the cochlea of the inner ear, NdphAP 
expression was limited to the stria vascularis and a capillary plexus between the organ of Corti and 
the spiral ganglion (Ye et al., 2011). Due to the lack of functional Norrin antibodies, no Norrin 
localization studies based on immunohistochemistry have been published yet. Norrin also confines 
neuroprotective functions. Loss of retinal ganglion cells has been reported in Norrin-deficient mice 
(Ohlmann et al., 2005) and vitreal injection of recombinant Norrin protected optic nerve axons and 
perikarya of surviving retinal ganglion cells after N-methyl-D-aspartate (NMDA) injection in these 
mice (Seitz et al., 2010). This effect of Norrin could be abolished by additional injection of 
recombinant Dkk-1 protein, indicating that neuroprotection is mediated by canonical Wnt signaling. 
Norrin/NMDA treatment led to increased expression of LIF, FGF-2, BDNF, PSIP1 and CNTF in treated 
eyes. Norrin is also expressed in the luminal and glandular epithelia during the estrus cycle and in 
the antimesometrial decidual reaction zone at day 7 of gestation in albino rats. This suggests that 
Norrin regulates decidual and the placental angiogenesis of the luminal and glandular epithelial and 
decidual cells in rat (Kaloglu et al., 2011). Furthermore, Ndph-/- mice are infertile due to defects in 
vascularization and decidualization during pregnancy from E7 onwards, which results in embryonic 
loss (Luhmann et al., 2005b). 
 
Figure 4: Schematic representation of the NDP locus on the short arm of the X chromosome. Transcription 
involves all three exons. Translation involves only partially exons 2 and 3 (red) which encode for the Norrin 
protein. 
The human Norrin protein consists of 133 amino acids and shows high homology to other species 
including its cow and mouse orthologue (Figure 5A). The first 24 amino acids are predicted to be a 
signal peptide, suggesting that Norrin is a secreted protein (Figure 5A+B). Norrin is rich in cysteins 
and predicted to form a cystine-knot structure reminiscent of mucins, slit, von Willebrand factor and 
transforming growth factor beta (TGFβ) (Figure 5B+C) (Meindl et al., 1992; Meitinger et al., 1993). 
This structural relatedness to the TGFβ-family suggests that Norrin might have similar functions and 
that it is involved in differentiation and cell fate. Norrin is believed to form disulphide-bonded 
oligomers that are associated with the extracellular matrix (Perez-Vilar et al., 1997).  
 
Figure 5: Bioinformatic analysis of the Norrin protein. A) Multiple alignment of human, cow and mouse 
amino acid sequences of Norrin showing strong conservation among species (CLUSTAL W v1.82). Different 
colors highlight specific domains: orange frame = amino acids encoded by exon 2; red = signal peptide;  
green = intramolecular disulfide bridge forming cysteins;  magenta = intramolecular disulfide bridge forming 
cysteins; blue = cysteine putatively involved in dimerisation or oligomerisation B) Schematic drawing of the 
putative tertiary structure of Norrin representing a cystine-knot (adapted from Meitinger et al., 1993). Color 
setting is equal to the one used in A. C) 3D model of Norrin as a monomere. An α-helix is shown instead of 
the v-loop in B (from Meitinger et al., 1993). 
Xu et al., 2004 have shown in cell culture assays that Norrin binds to Fz-4 (frizzled-4) and its co-
receptor LRP-5 (Low-density lipoprotein receptor-related protein 5) and activates the canonical Wnt 
pathway (Xu et al., 2004). The same group has shown that Fz-4 is the only Norrin receptor among 
the existing ten mammalian frizzled receptors (Smallwood et al., 2007). Another protein, Tspan-12 
(tetraspanin 12), has recently been reported to be an auxiliary membrane protein during Norrin-Wnt 
signaling (Junge et al., 2009) (Figure 6). Tspan-12 belongs to the family of tetraspanins which are 
thought to be organized in specialized microdomains that act as signaling platforms in the plasma 
membrane (Boucheix et al., 2001; Hemler2005). Junge et al. 2009, showed, using Wnt-reporter 
luciferase assays and deconvolution microscopic resolved co-stainings, that Tspan-12 significantly 
regulates Norrin/β-catenin but not Wnt/β-catenin signaling by modulating Fz-4 multimerisation 
(Figure 6). Interestingly, TSPAN12 expression is restricted to the vasculature in the retina, but Norrin, 
Fz-4 and LRP-5 show broader expression profiles within the retina (Figueroa et al., 2000; Hartzer et 
al., 1999; Junge et al., 2009; Wang et al., 2001; Xia et al., 2010). Soon after, mutations in TSPAN12 
were described in FEVR patients with autosomal dominant inheritance (Nikopoulos et al., 2010; 
Poulter et al., 2010). 
 
Figure 6: The auxiliary transmembrane protein Tspan12 mediates Norrin-Wnt-signaling. In canonical Wnt-
signaling (left) about 20 Wnt ligands bind to any of the 10 frizzled receptors which are associated with LRP5 
or LRP6. Binding of canonical Wnt-ligands (e.g. Wnt3A) leads to the accumulation of β-catenin in the nucleus 
and subsequently to the expression of Wnt target genes that regulate various processes in the embryo and 
in adult tissues. In the retina, the non-Wnt ligand Norrin binds Fz-4 and LRP-5 on endothelial cells. Tspan-12 
facilitates clustering of multiple Fz-4/Lrp-5 complexes (right). This complex also initiates downstream β-
catenin signaling, which is required for proper retinal vascularization during development. From Clevers 
2009. (Clevers2009) 
Lack of Norrin, Fzd-4, Lrp-5 or Tspan-12 prevents the formation of the deep and intermediate retinal 
vascular plexuses in mice (Berger et al., 1996; Junge et al., 2009; Richter et al., 1998; Xia et al., 2008; 
Xu et al., 2004). The time course of retinal vascular development in human and mouse is described in 
the following sections. 
1.4 The time course of retinal vascularization in human and mouse 
In humans, the retinal vascularization proceeds completely in utero. It starts at approximately 16 
weeks of gestational age. During these early stages, vascular supply to the eye is mainly provided by 
the hyaloid vessels originating from the optic nerve, passing the primitive vitreous towards the 
anterior segment. The hyaloid vessels regress during retinal vascularization ensuring transparency of 
the vitreous (Mitchell et al., 1998). Hyaloid regression is usually completed before 34 weeks of 
gestation when retinal vascularization is already well advanced. The nasal retina is completely 
vascularized at 36 weeks of gestational age, whereas the temporal vessels reach periphery at ora 
serrata at approximately week 40. Human term infants are thus born with fully developed retinal 
vessels and a regressed hyaloid vasculature. In contrast to human, both, retinal vascularization and 
hyaloid regression occur postnatally in mice (Gyllensten  et al., 1954a; Gyllensten  et al., 1954b). The 
time course of retinal vascularization and hyaloid regression described here applies only to C57BL/6J 
mice, as we use them in our lab, and may slightly vary in other mouse strains. In total, three retinal 
vascular plexuses are formed in the mouse retina (Figure 7). 
  
Figure 7: Schematic representation of vascular development in the early postnatal mouse eye A) Temporal 
cross-sections of the eye showing the hyaloid vessels in red, the retina in orange and the postnatal day (P) in 
black. B) Cross-section of the central retina showing the development of the superficial (lowest), 
intermediate (middle) and deep vascular plexuses (upper). ONL = outer nuclear layer; INL = inner nuclear 
layer; GCL = ganglion cell layer; P = postnatal day. Adapted from Xu et al., 2004. 
The superficial vascular plexus, on top of the ganglion cell layer, develops during the first postnatal 
week by radial outgrowth of vessels, originating from the optic nerve head, reaching the periphery 
at P7-P8. The superficial capillaries start sprouting vertically from P7 onwards to form first the deep 
and later the intermediate vascular plexus. The deep plexus develops between P8 and P12 in the 
outer plexiform layer. The intermediate plexus, later located at the inner plexiform layer, forms 
between P12 and P15. All vascular plexuses remodel (Figure 8) during the whole development, 
starting at P3 and are considered mature by the end of the third postnatal week (P18-21) (Hofmann 
et al., 2007; Stahl et al., 2010). 
 
Figure 8: Retinal blood vessel morphogenesis in the mouse during the first 15 postnatal days (P) 
schematically represented as retinal whole-mounts. A) The development of the superficial retinal vascular 
plexus (SRVP) begins at P0 when sprouts grow from the optic nerve head towards the periphery. At P3, 
more mature vessels, next to the optic nerve head, begin to remodel into an alternating radial pattern of 
arteries and veins interconnected by capillaries. At P7, when the SRVP reaches the retinal front, deep 
sprouts grow downwards and form the deep retinal vascular plexus (DRVP) (not shown). At P15, the SRVP 
and DRVP have matured and the intermediate retinal vascular plexus develops between the two established 
vascular layers (not shown). B) Guiding tip cells followed by dividing stalk cells ensure the proper 
development of the immature SRVP. Older vessels behind the leading edge of the SRVP remodel into 
arteries (A) and veins (V). Note the absence of capillaries at the peri-arterial space (after Hofmann et al., 
2007). 
Our Ndphy/- mice were generated by targeted replacement of the coding sequence of exon 2 by a 
reverse oriented neomycine cassette. This results in the deletion of the first 56 amino acids of 
Norrin, including the signal peptide (Berger et al., 1996) and therefore a loss of function of the 
protein. The ganglion cell layer of Ndphy/- retinas is disorganized. Electroretinography from Ndphy/- 
retinas showed a reduced b-wave, indicating a severe involvement of the inner retina, while the a-
waves were indistinguishable at low intensities and only became conspicuous with brighter flashes 
(Ruether et al., 1997). Later it was shown that photoreceptors are degenerated in older Ndphy/- mice 
(Lenzner et al., 2002). More importantly, the development of the superficial retinal vascular plexus 
(SRVP) is delayed and incomplete and the deep and intermediate retinal vascular plexuses (DRVP, 
IRVP) do not develop in Ndphy/- mice (Figure 9). The hyaloid vessel regression is also delayed and 
incomplete in Ndphy/- retinas (Luhmann et al., 2005a). Our group suggested a biphasic disease 
progression in Ndphy/- mice: In the early phase, the lack of Norrin causes a sprouting angiogenesis 
defect of retinal endothelial cells which leads to the delayed outgrowth of the superficial vessels and 
prevents the formation of the deep capillary networks in the retina. In the later phase, the lack of 
the deep vascular plexuses leads to inner retinal hypoxia, which in turn leads to HIF1 mediated 
upregulation of VEGF-A. The high VEGF-A levels may also contribute to vessel leakiness (Luhmann et 
al., 2005a; Schafer et al., 2009). Hearing loss in Ndphy/- mice starts at 3-4 months with the loss of 
high frequencies and it progresses to a loss of all frequencies till 15 month of age. The hearing loss is 
caused by enlarged vessels of the stria vascularis that decrease progressively in their numbers finally 
resulting in the loss of outer hair cells and in the loss of spiral ganglion neurons (Rehm et al., 2002). 
 
Figure 9: Ndphy/- mice do not develop the deep and intermediate retinal vascular plexuses (DRVP, IRVP). 
Sections of wildtype (WT, left) and Ndphy/- (KO, right) retinal whole-mounts from mice at postnatal day 7 
(P7) are shown. Retinas were stained against collagen IV which labels the basement membrane that 
underlies the retinal blood vessels (red). Top row: The basement membrane of the superficial retinal 
vascular plexus (SRVP) from wildtype retinas (left) appears denser and more organized compared to Ndphy/- 
mice (right). The diameter of the basement membrane sleeves seems to be enlarged in Ndphy/- retinas. 
Bottom row: z-stacks of the respective sections from above are shown. Deep sprouts grow downwards to 
form the DRVP at P7 in wildtype (left) but not in Ndphy/- retinas (right). Pictures were taken by Nikolaus 
Schaefer. 
Similarly, knockout mice for Fzd4, Lrp5, Tspan12 and Angpt2 also fail to develop the DRVP and IRVP. 
An overview about the respective phenotypes of these knockout mice is given below (Table 1). 
 
 
 
 
 
Table 1: Overview about knockout mice that lack the DRVP and IRVP 
 Ndph-/y FZD4-/- LRP5-/- TSPAN12-/- Angpt2-/- 
Chromosome Xp11.4 11q14-q21 11q13.4 7q31 8p33 
OMIM #310600 #133780 #601813 #613310 *601922 
Locus name EVR2 EVR1 EVR4 EVR5 - 
Knockout complete* endothelial* complete* complete* complete* 
complete knockout 
embryonic lethal 
no*/** Yes no no no*/** 
Natural dead of mice n.a. n.a. n.a. n.a. 2 weeks** 
Vascular plexuses 
present 
superficial**/****** superficial* superficial* superficial* superficial* 
Expression Müller cells*****  Müller cells within the INL 
at p42**** 
 hyaloid vessels and outer boarder of 
INL plus smooth muscle cells of large 
arteries*/** 
Microaneurisms 
extending from NFL 
present** n.a. n.a. present* n.a. 
MECA-32/Plvap 
staining 
present***/***** present**/*** present*** present* n.a. 
Slc38a5 downregulated at p7***  downregulated at p21 
**** 
 n.a. 
Delayed hyaloid vessel 
regression 
present** present* present** present* present* 
Focal hemorrhage n.a. present* n.a. present* n.a. 
Retinal glial cell 
activation 
present** n.a. n.a. present* n.a. 
Ischemia-induced 
retinal 
neovascularisation 
yes******* yes *** n.a. n.a. no* 
Vessel enlargement in 
the stria vascularis of 
the inner ear 
present**** present* n.a. present* n.a. 
ERG diminished oscillatory potentials and reduced b-
wave; confirmed retinal hypoxia** 
n.a. b-wave amplitude 
reduced**** 
n.a. n.a. 
References *Berger et al., 1996 
**Luhmann et al., 2005 
***Schäfer et al., 2009 
****Rehm et al., 2002 
*****Junge et al., 2009 
******Richter et al., 1998 
*******Luhmann, manuscript in progress 
*Xu et al., 2004 
**Ye et al., 2009 
***Paes et al., 
2011 (a) 
 
*Xia et al., 2008 
**Lobov et al., 2005 
***Junge et al., 2009 
****Xia et al., 2010 
*Junge et al., 2009 * Hackett et al., 2002 
**Gale et al., 2001 
n.a. = not available; (a) no FZD4-/- mice were used in this publication, but mice were treated with anti-Fz-4 antibody; 
 
It is clear that Norrin-mediated Wnt signaling is essential to initiate deep sprouting (Ye et al., 2010) 
according to the phenotypic data gained from knockout mice in Table 1. However, to date it is not 
clear how Angpt2 and Wnt signaling are connected in this regard. The following sections cover 
knowledge about molecular mechanisms in angiogenesis including sprouting angiogenesis and blood 
vessel maturation.  
1.5 The development of the retinal vasculature 
1.5.1 Retinal astrocytes form a scaffold for endothelial cells above the ganglion cell layer  
The retinal vascularization is energy dependent. It has been shown that succinate, a Krebs cycle 
metabolite, activates expression of proangiogenic factors upon binding to its receptor GPR91/Sucnr1 
in retinal ganglion cells (Sapieha et al., 2008). This seems to be an initial step that links tissue energy 
demand and initiation of angiogenesis. Development of the retinal vasculature is preceded by an 
invasion of astrocytes, migrating from the optic nerve head (Watanabe et al., 1988) in a radial 
fashion across the inner surface of the retina to form an astrocytic network above the retinal 
ganglion cells. The astrocyte migration and network formation occurs during the first postnatal days 
(Fruttiger et al., 1996; Ling et al., 1988). The presence of the astrocytic network seems to be 
essential for the development of retinal blood vessels, since the avascular retinas from the possum, 
avascular areas in horse, rabbit, primates and the avascular fovea in humans all lack the astrocytic 
network (Stone et al., 1987). But, in contrast, all vascularized areas in these retinas possess an 
astrocytic network. These observations suggest that the retinal astrocyte network and the retinal 
vasculature are developmentally linked. The retinal astrocytes differentiate from an astrocyte 
precursor lineage at the optic nerve by expression of the Pax2 transcription factor (Chu et al., 2001; 
Mi et al., 1999). The exact mechanism of differentiation is unknown, but, the earliest marker that 
distinguishes retinal astrocytes from all other populations of astrocytes is PDGFRα (platelet derived 
growth factor receptor alpha). PDGFRα is expressed by retinal astrocytes in the optic nerve, several 
days before they start to invade the retina. Plateled derived growth factor A (PDGFA) is secreted by 
retinal ganglion cells, that already cover the developing retina, and serves as a mitogen for retinal 
astrocytes (Fruttiger et al., 2000; Mudhar et al., 1993). Immature retinal astrocytes have a spindle 
shaped (elongated and bipolar) morphology during migration across the retina. They establish a 
mesh-like network as soon as they reach the retina, expressing low levels of GFAP (glial fibrillary 
acidic protein) and high levels of vimentin (Chu et al., 2001). Retinal astrocytes then experience 
hypoxia and start strongly to express VEGF-A (vascular endothelial growth factor A), which has been 
shown to be the key stimulus for retinal angiogenesis (Pierce et al., 1996; Stone et al., 1995; West et 
al., 2005). However, a more recent study questions this dogma by the finding that mice with retinal 
astrocytes that lack the expression of VEGF develop normal retinal vascular plexuses (Scott et al., 
2010). As the vascular network expands, the vascular endothelial cell covered retinal astrocytes 
acquire a more mature state. The mature state of astrocytes is induced by endothelial cell derived 
LIF (leukemia inhibitory factor) which induces GFAP expression and downregulates vimentin and 
VEGF expression, leading to a stellate-like appearance (Chu et al., 2001; Kubota et al., 2009a; West 
et al., 2005). The maturation of astrocytes is suggested to create a negative-feedback loop that limits 
both, astrocyte and blood vessel numbers (West et al., 2005). The key component to regulate the 
number of astrocytes is the orphan receptor Nr2e1 (nuclear receptor subfamily 2, group E, member 
1 or Tlx), which is strongly expressed by immature retinal astrocytes. Nr2e1 expression is 
downregulated in retinal astrocytes as they mature (Miyawaki et al., 2004). In Nr2E1 mutant mice, 
retinal astrocytes fail to acquire the mature stellate morphology and remain highly elongated. They 
proliferate slowly, express high levels of GFAP and retinal vascularization is severely delayed 
(Miyawaki et al., 2004). It is not clear from the literature if the deep and intermediate vascular 
plexus develop in Nr2E1 mutant mice. 
1.5.2 Vascular growth in the retina 
To date, formation of the retinal vasculature in humans is believed to occur by vasculogenesis (de 
novo formation of vasculature) and angiogenesis (branching and growth of the vasculature from 
existing vessels) (McLeod et al., 2006). In mice, only angiogenesis seems to contribute to the 
formation of the retinal vasculature. Endothelial cells are the key proliferating cells during 
angiogenesis. They are among the least proliferating cell types, with about one per 10’000 cells 
entering the cell cycle in the adult stage (Hobson et al., 1984). This quiescence is rapidly inverted 
during angiogenesis by the virtue of acting growth factors. As previously described, retinal blood 
vessels of the superficial plexus grow from the optic nerve head (central) towards the periphery of 
the retina (peripheral). Vessels at the growing periphery of the retinal vasculature are less mature 
than the more central ones. Therefore different stages of vascular differentiation in a peripheral to 
central gradient are observed during the investigation of the superficial retinal plexus 
(Fruttiger2007). Endothelial cells of the leading edge from the growing retinal superficial vascular 
plexus represent a specialized subclass of vascular endothelial cells, designated tip cells. The tip cells 
extend numerous long filopodia (Kurz et al., 1996; Marin-Padilla et al., 1989; Ruhrberg et al., 2002), 
similar to axonal growth cones, and are responsible for the guidance of the growing blood vessels 
according to guidance cues (e.g. VEGF-A) from the environment (e.g. extracellular matrix, ECM) 
(Eichmann et al., 2005). Adjacent stalk cells divide ensuring proliferation of the endothelial cells 
(Figure 8). Delta/Jagged-Notch signaling (Figure 10) plays a crucial role in tip versus stalk cell fate 
(Figure 11). In general, the Delta/Jagged-Notch pathway enables cell-cell communication influencing 
proliferation, differentiation or apoptosis. Delta and Jagged are single pass transmembrane ligands 
for single pass transmembrane Notch receptors. Notch receptors are proteolytically cleaved upon 
binding of an activating ligand leading to the intracellular separation of the Notch intracellular 
domain (NICD) which migrates to the nucleus and activates the transcription of Notch target genes 
(Figure 10) (reviewed in Thurston et al., 2007). 
 
Figure 10: The mechanism of intracellular Delta/Jagged-Notch signaling. The Notch receptor undergoes a 
series of proteolytic cleavages (S2 and S3 cleavage) upon binding of Delta or Jagged ligands. S3 cleavage is 
mediated by the enzyme γ-secretase, which can be inhibited by DAPT. The S3 cleavage leads to the release 
of the Notch intracellular domain (NICD), which translocates to the cell nucleus. Once in the nucleus, the 
NICD interacts with CBF1, Su(H) and CSL family transcription factors helping to convert the co-repressor (Co-
R) complex into an activator complex, inducing the expression of Notch target genes of the Hey and Hes 
families. Modified from Thurston et al., 2007. (Thurston et al., 2007) 
The gene expression of tip cells is distinct from endothelial cells at other positions of the vascular 
plexus. Notch1-ligand Dll4 (delta like 4), PDGFB (platelet derived growth factor B), apelin, VEGFR2 
(VEGF receptor 2), Nrp1 (neuropilin 1), Unc5b (unc-5 homolog B) and membrane anchored 
metalloproteinase MT1 (MT1-MMP) are upregulated in tip cells of the vascular plexus (Claxton et al., 
2004; Gerhardt et al., 2003; Lu et al., 2004; Saint-Geniez et al., 2002; Yana et al., 2007). Jagged1, 
another Notch1-ligand and Lfng (lunatic fringe) are upregulated in stalk cells. In zebrafish tip cells, 
Dll4 is upregulated upon VEGF-A-VEGFR2 signaling which leads to a transient disassembly of the 
Tel/CtBP repressor complex (Roukens et al., 2010). Tip cell-derived Dll4 subsequently activates 
Notch1 signaling in adjacent stalk cells suppressing their ability to sprout. Accordingly, impaired Dll4-
Notch1 signaling leads to excessive non-productive sprouting visible by an elevated number of tip 
cell filopodia (Hellstrom et al., 2007b; Lobov et al., 2007; Thurston et al., 2007). In contrast, Jag1 
levels are high in stalk cells and antagonize the more potent Dll4. As a consequence, Jag1 is hardly 
able to activate Notch1 signaling in adjacent tip cells. This interaction regulates the number of tip 
versus stalk cells in the developing vascular plexus. Further, Notch1 is modified by the 
glucosaminyltransferase Lfng. This amplifies the Dll4-Notch1 signaling in stalk cells but reduces 
Notch1 activity upon binding of Jag1, rendering Jag1 to act as a Dll4 antagonist (Benedito et al., 
2009) (Figure 11a). Notch-regulated ankyrin-repeat protein (Nrarp), a Notch target gene in stalk 
cells, destabilizes N1ICD and induces Lef-1 dependent Wnt signaling which helps stabilizing the stalk 
cell phenotype and prevents EC retraction (Phng et al., 2009). Furthermore, VEGF induces PlexinD1 
expression on tip cells which interacts with retinal ganglion cell derived Sema3E. This Sema3E-
PlexinD1 signaling negatively regulates VEGF-induced Dll4 expression on tip cells and influences 
tip/stalk cell balance, Dll4 distribution and lowers vascular density (Figure 11b) (Kim et al., 2011).  
 
Figure 11: Balanced tip versus stalk cell selection during retinal vascular development in mice. (A) Notch1 
(N1) signaling by Jagged1 (left) and alterations in the Jag1 and Lfng mutant vasculature (right). VEGF-
A/VEGFR2 signaling in tip cells (grey) enhances (+) the expression of Dll4. Fringe modification of Notch1 in 
stalk ECs (green) enhances Notch signaling induced by Dll4-presenting tip cells, reducing VEGFR2 expression 
and maintaining the stalk cell phenotype. Dll4 is antagonized by Jagged1, which promotes angiogenesis and 
increases tip cell numbers by decreasing Notch activation levels in tip cells, while VEGF-A/VEGFR2 signaling 
is enhanced. Adapted from Benedito et al., 2009. (B) Sema3E–Plexin-D1 modulates Dll4–Notch signaling via 
a VEGF-induced negative feedback loop. VEGF induces Plexin-D1 expression leading to Plexin-D1 
accumulation in tip cells. Sema3E–Plexin-D1 signaling then modulates VEGF-induced Dll4 expression in these 
tip cells and, subsequently, Notch activity in stalk cells. Notch activity controls the level of VEGFR2 in stalk 
cells. From Kim et al., 2011. 
Thus, peripheral Dll4-Jag1-Notch1 signaling in tip and adjacent stalk cells tightly regulate the number 
of tip versus stalk cells. Once tip cells have formed, they guide the growing vascular plexus from the 
center to the periphery of the retina. It is important to note that tip and stalk cells are transient 
phenotypes and not stable cell fates (Jakobsson et al., 2009; Jakobsson et al., 2010). These cells 
undergo iterative cycles leading to transitions between tip and stalk cell phenotypes (Eilken et al., 
2010; Phng et al., 2009; Potente et al., 2011). 
1.5.3 Guidance of sprouting angiogenesis and arterial/venous specification 
The distinct identity of endothelial stalk and tip cells allows different responses of these cells to their 
environment, facilitating vascular growth and guidance. Stalk cells mainly contribute to vascular 
growth by extensively proliferating, whereas proliferation is rare in tip cells (Gerhardt et al., 2003). In 
contrast, only tip cells form extensive bundles of filopodia in the direction of vascular growth. These 
filopodia depend on signaling via VEGFR2, that detects environmental gradients of VEGF-A, and 
mediates migration towards higher concentration of VEGF-A. VEGF mRNA expression is high in the 
non-vascularized, peripheral retina, and low in vascularized retinal regions. Despite a protein 
gradient has not yet been shown, there is evidence for its existence. Firstly, excessive injection of 
VEGFA protein floods the endogenous VEGF gradient and slows retinal vascular growth (van Eys et 
al., 2007) and secondly, three mutant mouse strains, that selectively express only one VEGF-A 
isoform (120, 164 or 188), which differ in their ability to bind the ECM, show different vascular 
growth behavior (Davis et al., 1996; Sato et al., 1995; van Eys et al., 2007). The splicing of VEGF-A 
isoforms has been nicely reviewed in Ladomery et al., 2007. In brief, mice possessing only the VEGF-
A120 isoform, which does not bind to the ECM, have a flattened VEGF gradient and a slowed 
vascular growth in the retina. Mice possessing only the ECM associated VEGF-A188 isoform have a 
strict VEGF gradient leading to extensive retinal vascular branching (Figure 12). 
 
Figure 12: Blood vessel branching in the mouse retina is determined by a VEGF-A gradient. Top row: retinal 
whole-mounts from neonatal wildtype (left), VEGF-A120 (middle) and VEGF-A188 (right) expressing mice. 
Proper branching and elongation of blood vessels are determined by a spatial gradient of the different 
VEGF-A isoforms (middle panel). Matrix associated VEGF188 (red) localizes closer to VEGF-A producing 
astrocytes whereas soluble VEGF-A120 diffuses after secretion (green). VEGF-A164 (black) has intermediate 
properties. A proper VEGF-A gradient including all isoforms controls ramification from larger into smaller 
vessels. Vessels in VEGF-A120 (middle) mice are larger and less ramified than in wildtype littermates (left). 
Vessels in VEGF-A188 mice (right) are smaller and more extensively branched compared to wildtype 
littermates (left). From Carmeliet et al., 2005. (Carmeliet et al., 2005) 
Today, the VEGF family of growth factors is the best characterized growth factor family regarding its 
effects on angiogenesis. This family is large, including VEGF-A to VEGF-E isoforms and PlGF 
(Almodovar et al., 2009). Alternative splicing of VEGFA can additionally generate several variants of 
the growth factor, including also the so-called b isoforms that differ in the last six C-terminal amino-
acid residues and have anti-angiogenic properties (Ladomery et al., 2007). The anti-angiogenic VEGF-
A165b isoform has been shown to be downregulated in diabetic retinopathy which facilitates 
neovascular proliferation (Magnussen et al., 2010). Interestingly, the authors could show that 
bevacizumab (Avastin, Roche), a monoclonal antibody against VEGF-A, did interact with VEGF-
A165b, but pegaptanid (Macugen, Pfizer), another VEGF inhibitor, does not. This highlights the 
importance for better understanding of the role of the different members of the VEGF family of 
growth factors to improve the development of novel drugs. The important and central role of VEGF 
in vascular development is indisputable. Interestingly, miR-132 has recently been identified to act as 
an angiogenic switch. miR-132 has been shown to be upregulated by VEGF in HUVECs, initiating 
proliferation, tube formation and angiogenesis of HUVECs. Similarly, anti-miR-132 inhibited 
angiogenesis in wildtype but not in mice defective of p120Ras-GAP. Thus, miR-132 is believed to 
impede p120RasGAP, an inhibitor of cell cycle protein Ras, in ECs (Anand et al., 2010). VEGF-A165 
has also been shown to prevent extrinsic apoptosis by Nrp1-dependent upregulation of PHACTR-1 
which then prevents the expression of apoptosis death receptors DR4, DR5 and FAS. Furthermore, 
PHACTR-1 depletion decreases PP1 (protein phosphatase 1) activity and thereby disrupts fine-tuning 
of actin polymerization and impairs lamellipodia dynamics (Allain et al., 2012; Jarray et al., 2011). 
However, the existence of VEGF alone cannot account for complex patterning of the retinal blood 
vessels and in the meanwhile, many proteins involved in the fine tuning of retinal blood vessel 
growth have been described. A group around Friedlander reported that injection of anti-R-cadherin 
into P2 mice perturbed the formation of the retinal superficial vascular plexus (Dorrell et al., 2002). It 
was suggested that R-cadherin would mediate the interaction between the astrocyte template and 
the growing blood vessels. But, R-cadherin deficient mice do not have retinal vascular defects 
(Fruttiger 2007). 
EphB4 (Eph receptor B4) and ephrinB2, two other well known axon guidance molecules, are of 
importance during retinal vascular patterning. EphB4 is strongly expressed on veins and ephrinB2 on 
arteries. Therefore this ligand/receptor pair has been linked to the demarcation of venous versus 
arterial fate (Adams et al., 1999; Wang et al., 1998). In addition, the same molecules are important 
in endothelial cell proliferation and migration (Kertesz et al., 2006; Kim et al., 2002; Steinle et al., 
2002; Steinle et al., 2003). Arteries express ephrinB2, Connexin-37, Connexin-40, Dll4, and Nrp1. In 
contrast, veins express EphB4, Nrp2, VEGFR3, COUP-TFII and the Apj receptor (Figure 13). However, 
it is not known how these arterial/venous (AV) markers interact and specify arterial and venous 
differentiation of endothelial cells in detail (Rocha et al., 2009). 
 
Figure 13: Artery- and vein-specific markers. Vascular smooth muscle cells on blood vessels (red/blue) as 
well as pericytes (yellow) covering capillaries (grey) are illustrated. Bottom row: Arterial (red) and venous 
(blue) specific markers are depicted. From Rocha et al., 2009. 
It is believed that A/V specification arises already during primitive vascular plexus formation in the 
yolk sac (Wang et al., 1998). Hong et al, 2006 have shown that VEGF-A signaling inhibits arterial fate 
in cells committed to venous differentiation (Hong et al., 2006). The mode of action might be 
depending on VEGF receptor expression. VEGFR2 is expressed on arteries and veins, but VEGFR3 
expression is restricted to veins. Also binding affinities of the respective VEGF isoforms differ. VEGF-
A is able to bind VEGFR1 and VEGFR2, while VEGF-C and D have higher affinities for VEGFR3. VEGF-A 
mediates PKC-γ/ERK (=MAPK) signaling, while VEGF-D induces PI3K/Akt pathways. VEGF-C is able to 
induce both pathways (Jia et al., 2004). PKC-γ/ERK signaling induces arterial fate (Covassin et al., 
2006; Lawson et al., 2003; Takahashi et al., 2001) while PI3K/Akt signaling inhibits PKC-γ/MAPK 
activation in zebrafish and in vitro (Hong et al., 2006). Neuropilins (Nrp1, Nrp2) are modifiers of 
VEGF signaling. Nrp1 forms a receptor complex with VEGFR2, which only interacts with VEGF-A164. 
Endothelial specific deletion of VEGF-A164 co-receptor Nrp1 leads to loss of arterial markers such as 
connexin40 or ephrinB2. Thus, Nrp1 binding isoforms of VEGF preferentially induce arterial markers 
(Mukouyama et al., 2005). Further, deletion of the cytoplasmatic domain of Nrp1 leads to A/V 
crossing in the mouse retinas (Fantin et al., 2011). Deletion of Nrp2 impairs lymphangiogenesis but 
not vascular development. Apart from VEGF signaling, Notch signaling plays a pivotal role during 
arterial specification (Duarte et al., 2004; Gale et al., 2004; Krebs et al., 2000; Krebs et al., 2004; 
Lawson et al., 2001). Notch signaling acts downstream of VEGF signaling (Lawson et al., 2002) which 
induces expression of Dll4 and Notch1 (Liu et al., 2003; Lobov et al., 2007). COUP-TFII is a 
transcription factor exclusively expressed in veins and it is thought to be the initial regulator of 
venous endothelial identity (You et al., 2005). Little is known about the mode of action from COUP-
TFII, but its negative effect on Dll4 and Nrp1 expression is believed to underlie the regulation of 
venous differentiation (Rocha et al., 2009). Norrie patients display venous insufficiency (Rehm et al., 
2002). AV specification in the mouse retina is visible from P3 onwards (Figure 14). These processes, 
that start at P3 in the retina and finally end with mature blood vessels are termed vascular 
remodeling and maturation and summarized in the next chapter. 
1.5.4 Vascular remodeling and maturation 
As mentioned in the section ´Vascular growth in the retina´, vessels at the periphery of the growing 
retinal vasculature are less mature than the more central ones. This implicates that the initially 
established primitive superficial vascular plexus is remodeled ending up as an organized vascular 
tree (Figure 14).  
 
Figure 14: Remodeling of the superficial retinal vascular plexus in mice. A) A primitive but uniform vascular 
plexus has formed at P3. B) The growing vascular plexus already reached a higher hierarchy of organization 
where arteries (a) and veins (v) can be distinguished. C) The remodeled primary plexus has reached the 
periphery of the retina and vessels start to sprout in a perpendicular manner into the deeper neural layers 
of the retina to form the deep plexus (arrowheads). Some veins start to disappear from the plexus (arrow). 
Scale bar = 200 μm. From Fruttiger 2007. 
Differences in vessel diameters and capillary free zones around arteries emerge, allowing 
distinguishing between arteries and veins. Some capillaries are strengthened, while others are 
pruned. The latter is evident in the vicinity of arteries and can occur via migration and re-localization 
of endothelial cells (Hughes et al., 2000) or by endothelial cell apoptosis (Ishida et al., 2003). 
Apoptosis of endothelial cells is mediated by CD2+/CD25+ leukocytes that adhere the capillaries 
through CD18 activating Fas ligand that induces endothelial cell death. Similarly, both, blockade of 
CD18 or Fas ligand with antibodies increases vascular density. In the opposite, depletion of 
macrophages by intraocular injection of clodronate liposomes reduces vascular density (Checchin et 
al., 2006). This shows that immune cells can have diverse and sometimes opposite roles during 
vascular development. A possible mediator that causes capillary pruning could be VEGF-A120. It has 
been shown in vitro that the VEGF concentration in the medium directly influences the diameter of 
newly forming vascular sprouts (Nakatsu et al., 2003) and, more importantly, it has been shown that 
capillary pruning is defective in VEGF-A120 mice and that major retinal blood vessels are of larger 
diameter in these mice (Figure 12). TGFβ signaling is also involved in diameter control of blood 
vessels possibly by activating its downstream target SRF. SRF mediates also SMC recruitment to the 
dorsal aorta (Miano et al., 2004; Niu et al., 2005; Parlakian et al., 2004) and myocardin and Elk-1 
compete for the same docking site in SRF, modulating SMC-specific gene expression (Franco et al., 
2009). However, Elk1/Sap1 double knockout mice do not display retinal vascular defects. But Srf or 
Mrtf-a/b (Mkl-1/2) double knockout mice show delayed and incomplete development of the SRVP 
and lack DRVP and IRVP development (Alfred Nordheim, personal communication). SRF and δEF1 
promote the expression of α-SMA (Nishimura et al., 2006). The systemic deficiency of Norrin, which 
has a similar structure as TGFβ, has also been reported to lead to dilated retinal blood vessels in 
mice (Luhmann et al., 2005a) and hence is another candiadate to be involved in the regulation of 
vessel diameter. However, it is not clear if blood vessels are dilated in Ndphy/- mice. It seems that 
blood vessels, stained with isolectinB4, have about the same diameter, but that the basal 
membranes around the vessels, stained with collagen IV, are enlarged (Figure 9, Schaefer et al., 
2009). The state of maturation of the superficial retinal vascular plexus can be assessed by the 
Oxygen-Induced Retinopathy Model (OIR model) (Connor et al., 2009; Stahl et al., 2010). There, P7 
mice litters are exposed to 80% of oxygen for five days. Subsequently, litters are euthanized at P12. 
The exposure of mice to the elevated oxygen levels leads to vasobliteration during the exposure 
period peaking at P12. The obliteration primarily affects central retinal capillaries around arteries. It 
was suggested that direct oxidative damage to endothelial cells by reactive oxygen species (Gu et al., 
2003) and/or oxygen mediated downregulation of VEGF-A account for this effect (Pierce et al., 
1996). Capillaries in the vicinity of arteries are mostly affected, because areas around arteries 
contain the highest oxygen concentrations (Riva et al., 1986) and the lowest VEGF-A level (Claxton et 
al., 2003). The effects caused by hyperoxia may be exaggerative, but similar to the processes that 
lead to the formation of capillary free zones adjacent to arteries during normal development. Vessel 
coverage by pericytes and vascular smooth muscle cells provides resistance to hyperoxia (Chan-Ling 
et al., 2004). The cell-cell signaling between mural and endothelial cells is reciprocal. Endothelial 
cells recruit mural cells by secreting PDGFB, which acts via PDGFRβ on mural cells (Hellstrom et al., 
1999). Mural cells in turn express angiopoietin1 (Ang1) that acts on Tie2 receptor on endothelial 
cells (Nishishita et al., 2004; Satchell et al., 2001; Suri et al., 1996). Injection of soluble PDGFB causes 
mural cell detachment and potentiates hyperoxia-mediated vaso-obliteration (Benjamin et al., 
1998). Likewise, injection of an anti-PDGFRβ antibody impedes vascular remodeling by inhibiting 
mural cell recruitment (Uemura et al., 2002). TGFβ signaling is also involved in the recruitment of 
smooth muscle cells. Smad5 knockout mouse embryos display enlarged blood vessels ensheathed by 
decreased numbers of smooth muscle cells, suggesting that the Alk1-Smad1/5 pathway is essential 
during this process (Bertolino et al., 2005). Two other remodeling or maturation steps that can be 
observed in the retina are the formation of the blood-brain (BBB) and of the blood-retina barrier 
(BRB). The formation of the BBB is better understood than the formation of the BRB. However, it is 
known that normally developed retinal blood vessels at P10 are impermeable to FITC-dextran. In 
contrast, vessels of Ndphy/- mice are permeable for indocyanine green dye at P14 and at P21 
(Luhmann et al., 2005a) which could be an indication for remodeling defects. Another explanation 
for the permeability of Ndphy/- blood vessels could be the upregulation of Meca-32/Plvap which may 
lead to fenestration of the blood vessels (Schafer et al., 2009). It is likely that both is true. 
Furthermore, our group has shown that claudin-5 mRNA is downregulated in Ndphy/- retinas at P7. 
Claudin-5 as well as two other tight junction proteins, occludin and zonula occludens-1 (ZO-1) are 
expressed by adult retinal blood vessels. Elevated occludin expression levels are linked to tightness 
of endothelial monolayers in cell culture (Kevil et al., 1998; Wong et al., 1997) and protein 
extravasation into the retina correlates with reduced membrane occludin levels in the retinal 
vasculature of diabetic rats (Antonetti et al., 1998; Barber et al., 2000; Barber et al., 2003). Regarding 
the SRVP, this could be mediated by astrocytes that regulate vascular permeability there (Barber et 
al., 2000; Gardner et al., 1997). It has been established recently that Slit2-Robo4 signaling 
counteracts VEGF induced vascular permeability (London et al., 2009). Regarding the deeper 
plexuses, Müller cells are good candidates to induce barrier properties (Tout et al., 1993), possibly 
via secretion of Norrin (Ye et al., 2009) which might promote the maintenance of the BRB via Fz-4 
(Paes et al., 2011).  
1.5.5 Deep retinal vascular plexus development 
The deep vascular plexus of the retina develops by sprouting from the superficial plexus starting at 
P7 in mice (Figure 14C) (Stahl et al., 2010). The sprouts emerge exclusively from veins, venules and 
capillaries in the vicinity of veins (Figure 14C). This sprouting starts at the center of the retina and 
expands towards the periphery. It is preceded by transient VEGF-A mRNA expression in the inner 
nuclear layer (Stone et al., 1995). The vascular sprouts grow along Müller cell processes into the 
retina. They turn sideways when they reach the inner and outer boarder of the inner nuclear layer, 
leading to the formation of the DRVP and IRVP (Figure 7). Müller cells are also suspected to express 
Norrin in the retina (Ye et al., 2009). This could explain the lack of both deeper vascular plexuses in 
Ndphy/- mice. It has been shown that overexpression of Norrin in the vitreous rescues the Ndphy/- 
phenotype (Ohlmann et al., 2005). This suggests that Norrin acts as a general switch to activate 
DRVP formation rather that it acts as a morphogen during DRVP formation (Ye et al., 2010). As 
mentioned earlier, Fz-4, LRP-5, Tspan-12, Angpt2, SRF and Mrtf-a/b are essential for deep plexus 
formation (Caprara et al., 2011; Gale et al., 2002; Hackett et al., 2002; Junge et al., 2009; Luhmann et 
al., 2005a; Xia et al., 2008; Xia et al., 2010; Xu et al., 2004). 
1.5.6 Regression of the hyaloid vasculature 
In mice, hyaloid regression starts when retinal vascular blood vessels start to grow, but it most 
extensively progresses between P9 and P12 when deep sprouting occurs. Mutants that lack deep 
retinal plexus development (Ndphy/-, FZD4-/-, LRP5-/-, TSPAN12-/-, Angpt2-/-) have delayed or 
incomplete hyaloid regression (Hackett et al., 2002; Junge et al., 2009; Lobov et al., 2005; Luhmann 
et al., 2005a; Xu et al., 2004). It has been shown that hyaloid regression can be inhibited by ablating 
macrophages (Diez-Roux et al., 1997; Lang et al., 1993). Macrophages have been shown to induce 
hyaloid regression by Wnt7b expression that acts via Fz-4 and LRP-5 on hyaloid vessels (Lobov et al., 
2005). Wnt7b-independent FZ-4 activation might play a role as well in hyaloid regression, because 
Ndphy/- mice also show persistent hyaloid vessels (Fruttiger 2007). Persistence of hyaloid vessels in 
Angpt2-/- mice implicate that Tie2 receptor signaling might play a role in hyaloid regression (Hackett 
et al., 2002). Macrophages are rare or absent in BMP4+/- mice and hyaloid regression also fails in 
BMP4+/- mice. However, it is not clear if deep retinal vascular plexus development is affected in these 
mice (Chang et al., 2001). 
1.6 The aim of the thesis 
Back in 1992 it was found that mutations in NDP lead to Norrie disease in men. Despite some 
knowledge about the binding receptors of Norrin has been gained, its molecular function remains a 
mystery. 
This thesis addresses the function of Norrin using cell culture assays and the Ndphy/- mouse model. 
The aim was to elucidate if Norrin-Wnt signaling is linked to Notch signaling - either within a single 
cell, across neighboring cells (Figure 15) or not at all.  
 
Figure 15: Possible modes of interaction between Norrin-Wnt and Notch signaling. Binding of Norrin to the 
co-receptor complex consisting of Frizzled4 (Fz-4), low density lipoprotein related receptor 5 (LRP-5) and 
Tetraspanin 12 (Tspan-12) activates canonical Wnt signaling. The activation starts by phosphorylation of 
disheveled (Dvl) which, over several steps, leads to stabilization of β-catenin that migrates to the nucleus 
and activates Wnt-target gene expression (possibly Jagged1) (black). Notch signaling in stalk cells is 
activated by binding of delta like 4 (Dll4) from tip cells. This leads to cleavage of Notch1 with subsequent 
migration of the Notch intracellular domain (NICD) to the nucleus and to the expression of Notch target 
genes (green). Two possible modes of interaction were investigated in this thesis. (1) Is Dvl capable of 
inhibiting Notch signaling by binding and inactivating NICD? (2) Is Jagged1 a Norrin-Wnt target gene that is 
not anymore expressed in Ndphy/- mice? (red).  
Several lines of evidence suggested a role of Norrin as a negative regulator of Notch1 signaling: (a) 
the vascular phenotypes are similar in Norrin knockout mice and mice haploinsufficient for Notch1 
or Dll4, (b) Norrin is a ligand of Fz-4/LRP-5/Tspan-12 and triggers  canonical Wnt signaling, (c) 
Dishevelled (Dvl1), a downstream effector of Wnt, directly interacts with cleaved Notch1, (d) despite 
of high VEGF levels, neovascularization has never been observed in Norrin knockout mice, (e) the 
Notch1/Hes1/Hes2 axis promotes glial cell differentiation, which also fits the Norrin phenotype. 
Thus, we hypothesized that a putative Norrin-Notch signaling interaction could occur in two ways 
(Figure 15): (1) Any of the three mammalian Dvls might be capable of inhibiting Notch signaling by 
binding and inactivating NICD in stalk cells (2) Jagged1 a putative Norrin-Wnt target gene in stalk 
cells could not anymore be expressed in Ndphy/- mice and thus fail to inpede Notch signaling in 
adjacent tip cells.  
To resolve this  issue we conducted the following experiments: 
- Dvl1,2,3 – N1ICD interaction and their influence on Wnt- and Notch signaling were  
investigated by luciferase reporter assays. 
- Differential Notch target gene expression of Hes1, Hes2, Hes5, Hey1 and Hey2 from 
HEK293T cells  that were stably transfected with a wildtype Norrin or an empty construct 
was analyzed by qPCR. 
- Immunohistochemistry on retinal whole-mounts was done to elucidate the expression of  
Notch1 ligands Jag1 and Dll4. 
- Immunohistochemistry on retinal whole-mounts against the arterial marker a-SMA and 
against the venous markers EphB4 and Apj were conducted, since Notch signaling is also 
involved in the regulation of arterial versus venous faith. 
- Ndphy/- mice were crossed with the Notch reporter mice (TNR1 mice) to monitor Notch 
activity within the SRVP during its development. 
- DAPT, a Notch pathway inhibitor, was injected into Ndphy/- and wildtype mice to investigate 
the influence of Notch inhibition on the development of the SRVP. 
Additionally, the following experiments were conducted: 
- An extensive morphometric analysis of the SRVP in which I compared the vascular 
phenotype from Ndphy/- with other knockout mice. 
- The proliferation of the SRVP from Ndphy/- and wildtype mice was compared after BrdU 
injection. 
- The vascular remodeling of the SRVP from Ndphy/- and wildtype mice was compared by co-
staining the plexus with isolectin B4 and collagen IV. 
- Artery and vein crossing of the SRVP from Ndphy/- mice was described and linked to MAPK 
signaling by phenotypic comparison between different mice and by monitoring MAPK 
activity of wildtype and p.C95R Norrin expressing cells using a MAPK specific luciferase 
reporter assay. 
- Immunohistochemistry of the SRVP from Ndphy/- and wildtype mice against endomucin was 
conducted. 
- An additional goal was to describe the Norrie Disease phenotype in Ndphy/- mice in more 
detail and to test whether postnatal administrated sub-lethal doses of LiCl could rescue the 
Norrie phenotype in mouse pups, because LiCl is known to activate Wnt signaling. 
- The number of hyaloid associated macrophages from the SRVP from Ndphy/- and wildtype 
mice was quantified on retinal wholemounts after applying immunohistochemistry against 
Iba1 and co-staining with isolectin B4. 
- Finally, luciferase reporter assays were used to measure the impact of Norrin on TGFβ 
signaling, ER stress and estrogen response. 
  
2. Material and Methods 
2.1 Material 
2.1.1 Cloning constructs for luciferase assays 
Cloning primers are listed as forward followed by reverse primers. Sequencing primers are always 
forward oriented. 
 
Subcloning Kits and competent cells 
TOPO TA cloning Kit Invitrogen, Carlsbad, USA 
pJET1.2 cloning Kit Fermentas, St. Leon-Rot, D 
TOP10 E. coli cells Invitrogen, Carlsbad, USA 
INV110 E. coli cells Invitrogen, Carlsbad, USA 
 
LRP5 sequencing primers 
CCACCGTGCCAACCTGG Microsynth, Balgach, CH 
CTGTGAGGAGGACAATGGC Microsynth, Balgach, CH 
TGCAGG TGG ACG ACATCC Microsynth, Balgach, CH 
GTGTGCCAACTTGGATGGG Microsynth, Balgach, CH 
CTTCACACCCCACGCAACC Microsynth, Balgach, CH 
GCAAGTCCTCGTGTGGAG Microsynth, Balgach, CH 
AGGGCCATCGTCGTCAAC Microsynth, Balgach, CH 
GATGATCGAGCGTGTGGAG Microsynth, Balgach, CH 
TGCTGACCTGTGGAGAGCC Microsynth, Balgach, CH 
GTGTCTATTTTGTGTGCCG Microsynth, Balgach, CH 
CTCCCTGTACAACATGGAC Microsynth, Balgach, CH 
CGCTGGTGGACAAGGTG Microsynth, Balgach, CH 
TGACTGTATGCACAACAACG Microsynth, Balgach, CH 
TGTTTTGACCTCTCTGAGCC Microsynth, Balgach, CH 
 
FZD4 sequencing primers 
GCCAATGGGGATGTTGATCT Microsynth, Balgach, CH 
GCACATGGAGATGCGGATG Microsynth, Balgach, CH 
TGGGAACCAATTCTG ATCAG Microsynth, Balgach, CH 
GTATAAGCCAGCATCATAGC Microsynth, Balgach, CH 
CTTAAGAACACAGGATGTGC Microsynth, Balgach, CH 
GAGTGTCAGAATAACCCACC Microsynth, Balgach, CH 
G ACTGATGGTCAAGATTGGG Microsynth, Balgach, CH 
CAGGCAATCACACACGTTGC Microsynth, Balgach, CH 
 
Sequencing primer for pTopflash and pFopflash 
CTAGCAAAATAGGCTGTCCC Microsynth, Balgach, CH 
 
Sequencing primer for pJH23a and pJH25a 
GGAAGACGCCAAAAACATAAAG Microsynth, Balgach, CH 
 
Cloning Primers hsDl14 
TCTAGAATGGCGGCAGCGTCCCGG Microsynth, Balgach, CH 
TCTAGACTACATTACAGATC CTCTTCTGAGATGAGTTT 
TTGTTC ATATACCTCCGTGGCAATGACAC 
Microsynth, Balgach, CH 
 
Sequencing primers for hsDll4 
CACCAGATGCACTCATCAGC Microsynth, Balgach, CH 
TGCAGCAAGCCAGCAGAGTG Microsynth, Balgach, CH 
AACACAGCACCTTGAGCTGC Microsynth, Balgach, CH 
GACATCCATCGATGCCTGTG Microsynth, Balgach, CH 
CAGAAGGACAACCTGATTCC Microsynth, Balgach, CH 
 
Primers for hsFZD4: 
CTGGGGTTGCTCCTGCAGTTGCTGCTGCTCCTGGGGC 
CGGCGCGGGGCTTCGGGGACGAGGAAGAGCGGC 
Microsynth, Balgach, CH 
AAGCTTATGGCCTGGCGGGGCGCAGGGCCGAGC 
GTCCCGGGGGCGCCCGGGGGCGTCGGTCTCAGT 
CTGGGGTTGCTCCTGCAGTTGC 
Microsynth, Balgach, CH 
AAGCTTTTACAGATCCTCTTCTGAGATGAGTTTTTG 
TTCATATACCACAGTCTCACTGCCTTTTCC 
Microsynth, Balgach, CH 
 
Cloning Primers mmDvl1 
AAGCTTATGGAACAAAAACTCATCTCAGAAGAGGATC 
TGGCGGAGACCAAAATCATCTACC 
Microsynth, Balgach, CH 
AAGCTTCTATTATCACATGATGTCCACAAAGAACT Microsynth, Balgach, CH 
 
Sequencing primers mmDvl1 
ACAATGAGACAGGCACAGAG Microsynth, Balgach, CH 
TCAACATGGAGAGGCACCAC Microsynth, Balgach, CH 
ACTGGCTGTACACACACGTG Microsynth, Balgach, CH 
AGTGAAGGGAGCAAGAGCAG Microsynth, Balgach, CH 
GCAATGACGACGCTGTACGG Microsynth, Balgach, CH 
 
Cloning primers mmDvl2 
AAGCTTAAGCTTATGGCGGGCAGCAGCG Microsynth, Balgach, CH 
AAGCTTTCATTACTACAGATCCTCTTCTGAGATGAGTT
TTTGTTCCATAACATCCACAAAAAACTC 
Microsynth, Balgach, CH 
 
Sequencing primers mmDvl2 
GGTTGTCTCCTGGCTTGTG Microsynth, Balgach, CH 
GTACCAGCCTAGGAGACTC Microsynth, Balgach, CH 
CAACGACGATGCTGTACGAG Microsynth, Balgach, CH 
AAGATCACCATCCCAAACGC Microsynth, Balgach, CH 
ACGAGCTTTCTTCGTACACC Microsynth, Balgach, CH 
GGTAGTTATGATGCCTCCAC Microsynth, Balgach, CH 
GCTGGATGGGCTCATTTCG Microsynth, Balgach, CH 
CCACGCTCGTTACTTTGGC Microsynth, Balgach, CH 
CTCACAGCCACCACTGAGG Microsynth, Balgach, CH 
CGAAATGAGCCCATCCAGC Microsynth, Balgach, CH 
GGAGACATGCTTTTGCAGG Microsynth, Balgach, CH 
 
Cloning primers mmDvl3 
AAGCTTAAGCTTATGGGCGAGACCAAGATC Microsynth, Balgach, CH 
AAGCTTCTATTATCACAGATCCTCTTCTGAGATGAGTT
TTTGTTCCATCACATCCACAAAGAACTC 
Microsynth, Balgach, CH 
 
Sequencing primers mmDvl3 
CGCACAGGAGGCATTGGG Microsynth, Balgach, CH 
CTTTCAGCAGCATCACAGAC Microsynth, Balgach, CH 
CGGCTGCTTCACATTACCC Microsynth, Balgach, CH 
AGTATGCTAGCAACCTGCTG Microsynth, Balgach, CH 
GAGAAGGACCCAAAAGCTGG Microsynth, Balgach, CH 
CCGATGCTGATGATGACC Microsynth, Balgach, CH 
 
Cloning primers hsTSPAN12 
AAGCTTAAGCTTATGGCCAGAGAAGATTCCGTG Microsynth, Balgach, CH 
AAGCTTAAGCTTTCACTATTAGGTGCTATCCAGGCCCA
GCAGCGGGTTCGGAATCGGTTTGCCTAACTCCTCCATC
TCAAAGTG 
Microsynth, Balgach, CH 
 
Sequencing Primers hsTSPAN12 
TTTAACTGCAGAAACGAGGG Microsynth, Balgach, CH 
GGTGGCTTACTCATGCTTGG Microsynth, Balgach, CH 
TCCTGGCCATGATTCTCACC Microsynth, Balgach, CH 
ATGACCGGATGAACCACAGG Microsynth, Balgach, CH 
CCACAATATCCTAACATCCC Microsynth, Balgach, CH 
CAGATTTCTTTTCACCGTTCCAC Microsynth, Balgach, CH 
 
Constructs 
clone purpose cloned purchased donation 
pTopflash Wnt-activity luciferase reporter  a  
pFopflash Wnt-activity luciferase reporter  a  
pWnt3A Wnt-reporter assay; pos. control   c 
pNDP_wt_myc Wnt/Notch-activity measurement x   
pNDP_P.C95R_myc Wnt/Notch-activity measurement x   
pNDP_wt Wnt/Notch-activity measurement x   
pNDP_P.C95R Wnt/Notch-activity measurement x   
pDvl1 Wnt-activity assay; pos. control x   
pDvl2 Wnt-activity assay; pos. control x   
pDvl3 Wnt-activity assay; pos. control x   
pJH23a Notch-reporter luciferase construct   d 
pJH25a Notch-reporter luciferase construct   d 
pN1ICD Notch reporter assay; pos. control   e 
pDll4 Notch reporter assay; pos. control x   
pE2F Cell cycle reporter assay  b  
pERSE ER stress reporter assay  b  
pSRF MAPK reporter assay  b  
pSMAD TGFβ reporter assay  b  
pERE Estrogen response reporter assay  b  
a) the constructs were purchased from Addgene. b) the constructs were purchased from SABioseciences, now a Qiagen 
Company. c) the pWnt3A construct was a donation from Konrad Basler from the University of Zurich, Switzerland. d) the 
constructs were a donation from Diane Hayward from the John Hopkins University, USA. e) the construct was a donation 
from Raphael Kopan from the Washington University, USA. 
 
HeBS 2x solution 
32.7 g Sodium chloride (Fluka, Buchs, CH), 23.8 g N-2-hydroxyethylpiperazine-N’-2-2-ethanesolfonic 
acid (HEPES) (Fluka, Buchs, CH) and 0.4 g Disodiumhydrogenphosphate (Fluka, Buchs, CH) were 
dissolved in 1.8 liters of water. pH was adjusted to 7.05 using a 5N Sodiumhydroxyde solution. 
ddH2O was added to a final volume of 2 liters. Sterile 50 ml aliquots were made and stored at -20°C. 
2.5 M Calciumchloride solution 
A 
183.8 g Calcium chloride dihydrate (Fluka, Buchs, CH) were dissolved in 500 ml ddH2O under stirring. 
Sterile 10 ml aliquots were made and stored at -20°C. 
Sequencing reagents 
Sequencing buffer Applied Biosystems, Foster City, USA 
BigDye Applied Biosystems, Foster City, USA 
Primer Microsynth, Balgach, CH 
ddH2O  
Sephadex G-50 Sigma-Aldrich, Buchs, CH 
2.1.2 TaqMan analysis of Notch target genes in HEK293T cells 
 
RNA isolation and cDNA synthesis 
Qiashredder Kit Qiagen, Hilden, DE 
RNeasy Kit Qiagen, Hilden, DE 
RNA Nano Chips Agilent, Waldbronn, DE 
Superscript III Reverse Transcriptase Kit Invitrogen, Carlsbad, USA 
 
TaqMan Sonden 
 Assay ID   
HEY1 Hs01114113_m1 human ABI, Foster City, USA 
HEY2 Hs01012058_m1 human ABI, Foster City, USA 
HES1 Hs00172878_m1 human ABI, Foster City, USA 
HES2 Hs00219505_m1 human ABI, Foster City, USA 
HES5 Hs01387464_g1 human ABI, Foster City, USA 
 
TaqMan internal controls 
S18 RNA  human/mouse ABI, Foster City, USA 
GAPD  human/mouse ABI, Foster City, USA 
 
TaqMan PCR Kit 
TaqMan 2x Universal PCR Master Mix ABI, Foster City, USA 
 
2.1.3 Analysis of Notch activity in Ndphy/- mice 
 
Norrie mice genotyping primers 
CTA TCG CCT TCT TGA CGA GTT Microsynth, Balgach, CH; SL105 
GGC CTG GGT GGA GAG GCT TTT T Microsynth, Balgach, CH, SL106 
GTA TTG CAT CCA TAT TTC TTG G Microsynth, Balgach, CH; SL107 
CTC TCC ATC CCC TGA CAA GGA Microsynth, Balgach, CH; SL108 
TTC AGC CCT ACA GCC ACA TGA Microsynth, Balgach, CH; SL120 
ATG TGG GTT CCT GTC CCA CTG Microsynth, Balgach, CH; SL121 
 
Notch reporter mice genotyping primers 
AAG TTC ATC TGC ACC ACC G Microsynth, Balgach, CH 
TCC TTG AAG AAG ATG GTG CG Microsynth, Balgach, CH 
CTA GGC CAC AGA ATT GAA AGA TCT Microsynth, Balgach, CH 
GTA GGT GGA AAT TCT AGC ATC ATC C Microsynth, Balgach, CH 
 
Proteinase K mix for digestion of tail biopsies 
390 µl ddH2O  
50 µl Tris*HCl pH 7.5, c=1 mol/l Merck, Darmstadt, DE 
5 µl EDTA pH 8.0, c=0.5 mol/l Merck, Darmstadt, DE 
10 µl SDS 10% Merck, Darmstadt, DE 
20 µl NaCl c=5 mol/l Merck, Darmstadt, DE 
25 µl Proteinase K, βi=10 mg/l Roche, Basel, CH 
 
PBS 1x 
1 Tablette PBS Invitrogen, Carlsbad, USA 
1000 ml ddH2O  
 
PBST 1x 
9998 ml PBS Invitrogen, Carlsbad, USA 
2 ml  Tween 20 Carl Roth GMBH, Karlsruhe, Germany 
 
PFA 4% 
4 g Paraformaldehyd (PFA, P6148) Sigma-Aldrich, Steinheim, DE 
100 ml ddH2O  
Preheat water to 70°C, add PFA and heat in water bath at 67°C till it dissolves; filter PFA solution into 12 ml Falcon tubes and store them at  
-20°C. Use the aliquots within a month. 
 
Mouse body weight 
Sartorius Balance CP2202S Sartorius, Göttingen, DE 
 
Primary antibodies used for retinal wholemount staining 
Name Company Product number Source Fixation 4% PFA Dilution used 
Jagged1 Santa Cruz SC8303 Rabbit 3 hours 1:200 
Dll4 R&D Systems AF1389 Goat 1 hour 1:200 
Collagen IV AbD serotec 2150-1470 Rabbit 1-24 hours 1:300 
IsolectinB4-FITC Sigma L2895 Griffonia 
simplicif
olia 
1-24 hours 1:500 
IsolectinB4-
AlexaFluor568 
Invitrogen I21412 Griffonia 
simplicif
olia 
1-24 hours 1:500 
SMA-Cy3 Sigma C6198 mouse 24 hours 1:500 
GFP Abcam AB290 Rabbit 24 hours 1:500 
PDGFRα R&D AF1062 Goat 3 hours 1:200 
Iba1 Abcam AB5076 Goat 24 hours 1:200 
Endomucin R&D AF4666 Goat 24 hours 1:200 
 
Secondary antibodies used for retinal wholemount staining 
Name Company Product number Dilution used 
anti-goat-Cy3 Sigma C2821 1:500 
anti-rabbit-Cy3 Dianova 111-165-003 1:500 
anti-rat-FITC Invitrogen A11006 1:500 
DyLight 488 Streptavidin Vector Laboratories SA-5488 1:500 
Anti-goat-AlexaFluor568 Invitrogen A11057 1:500 
Anti-rabbit-AlexaFluor568 Invitrogen A11011 1:500 
 
Antibodies that did not work on retinal wholemounts 
Name Company Product number 
Jagged1 Santa Cruz SC6011 
Nrp1 Calbiochem PC343 
EphrinB2 Santa Cruz SC1010 
Cleaved Notch1 Cell Signaling Technology 2421 
Norrin Santa Cruz SC49311 
ADAM10 Calbiochem PC528 
Hey1 Chemicon AB5714 
Desmin Abcam AB8592 
Integrinβ1 Millipore MAN1997 
Phalloidin-TRITC Sigma P1951 
Ki67 Abcam Ab883-500 
Girdin IBL-Hamburg JP18979 
Girdin-phosphate IBL-Hamburg JP28067 
EphB4 R&D Systems AF446 
Desmin Abcam AB8592 
APJ Abcam AB66218 
 
DAPT injection 
DAPT Sigma-Aldrich, Steinheim, DE 
Peanut oil Sigma-Aldrich, Steinheim, DE 
Ethanol (100%) Merck, Darmstadt, DE 
Precision syringe Merck, Darmstadt, DE 
30G1/2” needle Merck, Darmstadt, DE 
2 ml screw top vial with septum Sigma-Aldrich, Steinheim, DE 
 
BrdU injection 
BrdU Sigma-Aldrich, Steinheim, DE 
Precision syringe Merck, Darmstadt, DE 
30G1/2” needle Merck, Darmstadt, DE 
2 ml screw top vial with septum Sigma-Aldrich, Steinheim, DE 
Anti BrdU Antibody BD Biosciences, Allschwil, CH,  
 
LiCl injection 
Lithiumchloride (LiCl) Sigma-Aldrich, Steinheim, DE 
PBS Invitrogen, Carlsbad, USA 
Precision syringe Merck, Darmstadt, DE 
30G1/2” needle Merck, Darmstadt, DE 
2 ml screw top vial with septum Sigma-Aldrich, Steinheim, DE 
2.2 Methods 
2.2.1 Cloning and organizing constructs for luciferase reporter assays 
New clones were necessary to conduct pathway reporter assays. Clones were either produced by 
myself, donated from other labs or purchased from commercial suppliers. 
2.2.1.1 Cloning of mmDvl1, mmDvl2, mmDvl3 and hsDll4 
The following PCR and cycling conditions were used to amplify mmDvl1, mmDvl2, mmDvl3 and 
hsDll4 (mm = mus musculus, hs = homo sapiens). 
  
  µl 
Pfu buffer 10x 2.5 
dNTPs (20 mM) 0.25 
Primer Fwd (1µM) 0.25 
Primer Rev (1µM) 0.25 
DNA (EST plasmid, 100 ng/µl) 2 
ddH2O 17.5 
Pfu Polymerase 0.25 
MgSO4 (25 mM) 2 
 
°C min  
95 2  
95 1  
65 0.5 35 x 
72 5  
72 5  
 
 
The cloning strategies and encoded products are described below. 
2.2.1.2 Cloning of the hsDll4 construct 
hsDll4 was amplified from the EST (#IRAMp995K2414Q) from ImaGenes (Berlin, DE). The PCR 
product was subcloned into pJet2.1 (Fermentas, St. Leon-Rot, DE) and correct sequence was 
confirmed by Sanger sequencing on an ABI Prism 3100 DNA sequencer. The pJet1.2_hsDll4 was 
digested using XbaI and subsequently shuttled into pBUDCE4.1 destination vector. A construct 
encoding for the following protein was obtained (green = myc-tag): 
hsDll4 MAAASRSASGWALLLLVALWQQRAAGSGVFQLQLQEFINERGVLASGRPCEPGCRTFFRVCLKHFQ
AVVSPGPCTFGTVSTPVLGTNSFAVRDDSSGGGRNPLQLPFNFTWPGTFSLIIEAWHAPGDDLRPE
ALPPDALISKIAIQGSLAVGQNWLLDEQTSTLTRLRYSYRVICSDNYYGDNCSRLCKKRNDHFGHY
VCQPDGNLSCLPGWTGEYCQQPICLSGCHEQNGYCSKPAECLCRPGWQGRLCNECIPHNGCRHGTC
STPWQCTCDEGWGGLFCDQDLNYCTHHSPCKNGATCSNSGQRSYTCTCRPGYTGVDCELELSECDS
NPCRNGGSCKDQEDGYHCLCPPGYYGLHCEHSTLSCADSPCFNGGSCRERNQGANYACECPPNFTG
SNCEKKVDRCTSNPCANGGQCLNRGPSRMCRCRPGFTGTYCELHVSDCARNPCAHGGTCHDLENGL
MCTCPAGFSGRRCEVRTSIDACASSPCFNRATCYTDLSTDTFVCNCPYGFVGSRCEFPVGLPPSFP
WVAVSLGVGLAVLLVLLGMVAVAVRQLRLRRPDDGSREAMNNLSDFQKDNLIPAAQLKNTNQKKEL
EVDCGLDKSNCGKQQNHTLDYNLAPGPLGRGTMPGKFPHSDKSLGEKAPLRLHSEKPECRISAICS
PRDSMYQSVCLISEERNECVIATEVYEQKLISEEDL 
2.2.1.3 Cloning of the mmDvl1, mmDvl2 and mmDvl3 constructs 
The mouse Dvl1, 2 and 3 were amplified from the EST (#F630221L20), EST (#IRAVp968B01112D) and  
EST (#OCACo5052G078D), all purchased from ImaGenes (Berlin, DE). PCR products were subcloned 
into pJet2.1 (Fermentas, St. Leon-Rot, DE) and correct sequence was confirmed by Sanger 
sequencing on an ABI Prism 3100 DNA sequencer. Amplicons were shuttled into pBUD CE4.1 after 
HindIII digestion. Three constructs encoding the following proteins were obtained (green = myc-tag): 
 
mmDvl1 MEQKLISEEDLAETKIIYHMDEEETPYLVKLPVAPERVTLADFKNVLSNRPVHAYKFFFKSMDQDF
GVVKEEIFDDNAKLPCFNGRVVSWLVLAEGAHSDAGSQGTDSHTDLPPPLERTGGIGDSRPPSFHP
NVASSRDGMDNETGTESMVSHRRERARRRNRDEAARTNGHPRGDRRRDLGLPPDSASTVLSSELES
SSFIDSDEEDNTSRLSSSTEQSTSSRLVRKHKCRRRKQRLRQTDRASSFSSITDSTMSLNIITVTL
NMERHHFLGISIVGQSNDRGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDVNFENMSNDDAVRV
LREIVSQTGPISLTVAKCWDPTPRSYFTIPRADPVRPIDPAAWLSHTAALTGALPRYGTSPCSSAI
TRTSSSSLTSSVPGAPQLEEAPLTVKSDMSAIVRVMQLPDSGLEIRDRMWLKITIANAVIGADVVD
WLYTHVEGFKERREARKYASSMLKHGFLRHTVNKITFSEQCYYVFGDLCSNLASLNLNSGSSGASD
QDTLAPLPHPSVPWPLGQGYPYQYPGPPPCFPPAYQDPGFSCGSGSAGSQQSEGSKSSGSTRSSHR
TPGREERRATGAGGSGSESDHTVPSGSGSTGWWERPVSQLSRGSSPRSQASAVAPGLPPLHPLTKA
YAVVGGPPGGPPVRELAAVPPELTGSRQSFQKAMGNPCEFFVDIM 
mmDvl2 MAGSSAGGGGVGETKVIYHLDEEETPYLVKIPVPAERITLGDFKSVLQRPAGAKYFFKSMDQDFGV
VKEEISDDNARLPCFNGRVVSWLVSSDTPQPEVAPPAHESRTELVPPPPPLPPLPPERTSGIGDSR
PPSFHPNVSSSHENLEPETETESVVSLRRDRPRRRDSSEHGAGGHRPGGPSRLERHLAGYESSSTL
MTSELESTSLGDSDEDDTMSRFSSSTEQSSASRLLKRHRRRRKQRPPRMERTSSFSSVTDSTMSLN
IITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDMNFENMSN
DDAVRVLRDIVHKPGPIVLTVAKCWDPSPQAYFTLPRNEPIQPIDPAAWVSHSAALTGAFPAYPGS
SSMSTITSGSSLPDGCEGRGLSVHMDMASVTKAMAAPESGLEVRDRMWLKITIPNAFLGSDVVDWL
YHHVEGFPERREARKYASGLLKAGLIRHTVNKITFSEQCYYVFGDLSGGCESYLVNLSLNDNDGSS
GASDQDTLAPLPGATPWPLLPTFSYQYPAPHPYSPQPPPYHELSSYTYGGGSASSQHSEGSRSSGS
TRSDGGAGRTGRPEERAPESKSGSGSESELSSRGGSLRRGGEPGGTGDGGPPPSRGSTGAPPNLRA
LPGLHPYGAPSGMALPYNPMMVVMMPPPPPPVSTAVQPPGAPPVRDLGSVPPELTASRQSFHMAMG
NPSEFFVDVMEQKLISEEDL 
mmDvl3 MGETKIIYHLDGQETPYLVKLPLPAERVTLADFKGVLQRPSYKFFFKSMDDDFGVVKEEISDDNAK
LPCFNGRVVSWLVSAEGSHPEPAPFCADNPSELPPSMERTGGIGDSRPPSFHPHASGGSQENLDND
TETDSLVSAQRERPRRRDGPEHAARLNGTTKGERRREPGGYDSSSTLMSSELETTSFFDSDEDDST
SRFSSSTEQSSASRLMRRHKRRRRKQKVSRIERSSSFSSITDSTMSLNIITVTLNMEKYNFLGISI
VGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNEINFENMSNDDAVRVLREIVHKPGPIT
LTVAKCWDPSPRGCFTLPRSEPIRPIDPAAWVSHTAAMTGTFPAYGMSPSLSTITSTSSSITSSIP
DTERLDDFHLSIHSDMAAIVKAMASPESGLEVRDRMWLKITIPNAFIGSDVVDWLYHNVEGFTDRR
EARKYASNLLKAGFIRHTVNKITFSEQCYYIFGDLCGNMANLSLHDHDGSSGASDQDTLAPLPHPG
AAPWPMAFPYQYPPPPHPYNPHPGFPELGYSYGGGSASSQHSEGSRSSGSNRSGSDRRKEKDPKAG
DSKSGGSGSESDHTTRSSLRGPRERAPSERSGPAASEHSHRSHHSLTSSLRSHHTHPSYGPPGVPP
LYGPPMLMMTPPPAAMGPPGAPPGRDLASVPPELTASRQSFRMAMGNPSEFFVDVMEQKLISEEDL 
 
2.2.1.4 Cloning of  the hsTSPAN12 
A human Tspan12 clone (Origene, SC112659) was used as PCR template. The following PCR 
conditions were used for amplification: 
 µl  °C seconds   
Pfu Buffer 10x 5  95 120   
H2O 31  94 60  
40x 
 
dNTPs (20 mM) 0.5  50 30  
Primer F/R (10 mM each) 6  72 150  
MgCl2 4  72 300   
DNA (50 ng/µl) 3  10 eternal   
Pfu Polymerase 0.5      
 
The amplicon was subloned into pJet vector, sequenced, HindIII digested and shuttled into pBUD 
CE4.1 vector. The pBud_hsTSPAN12 clone features a V5 tag and was used for Wnt reporter assay. 
The isolated construct encodes the following protein (green = V5-tag): 
 
hsTSPAN12 MAREDSVKCLRCLLYALNLLFWLMSISVLAVSAWMRDYLNNVLTLTAETRVEEAVILTYFPV
VHPVMIAVCCFLIIVGMLGYCGTVKRNLLLLAWYFGSLLVIFCVELACGVWTYEQELMVPVQ
WSDMVTLKARMTNYGLPRYRWLTHAWNFFQREFKCCGVVYFTDWLEMTEMDWPPDSCCVREF
PGCSKQAHQEDLSDLYQEGCGKKMYSFLRGTKQLQVLRFLGISIGVTQILAMILTITLLWAL
YYDRREPGTDQMMSLKNDNSQHLSCPSVELLKPSLSRIFEHTSMANSFNTHFEMEELGKPIP
NPLLGLDST 
 
2.2.1.5 Clones donated from other labs 
The following clones are donations from people of other labs. 
Clone name Donator Affiliation 
pTopflash Konrad Basler University of Zurich, CH 
pFopflash Konrad Basler University of Zurich, CH 
pWnt3A Konrad Basler University of Zurich, CH 
pJH23A Diane Hayward John Hopkins University, USA 
pJH25a Diane Hayward John Hopkins University, USA 
pN1ICD Raphael Kopan Washington University, USA 
pFZD4 Wei Chen Duke University, USA 
pLRP5 He Xi, Bryan MacDonald Harvard Medical School, USA 
pDkk1 He Xi, Bryan MacDonald Harvard Medical School, USA 
2.2.1.6 Adaption of the FZD4 construct 
The FLAG-tagged human FZD4 construct, obtained from Wei Chen from the Duke University, USA, 
revealed altered N-terminal coding sequence during quality control. Therefore the construct was 
repaired by conducting two subsequent PCRs using up to 88 bp oligonucleotides as primers. In 
addition, the construct was myc tagged and cloned into pBud CE4.1 vector. 
 
First PCR: 
 µl 
Pfu Buffer 2.5 
dNTP (20 mM each) 0.25 
Primer F 0.25 
Primer R 0.25 
DNA (50 ng/ul) 2.5 
ddH2O 17 
Pfu Pol 0.25 
MgSO4 (25 mM) 2 
 
°C min  
95 2  
95 1   
55-65 30 35 x 
72 4   
72 5  
10 eternal  
 
 
Second PCR: 
 µl 
Pfu Buffer 2.5 
dNTPs (20 mM each) 0.25 
Primer F 0.25 
Primer R 0.25 
DNA (50 ng/ul) 3 
ddH2O 16.5 
Pfu Pol 0.25 
MgSO4 (25 mM) 2 
 25 
 
°C min  
95 2  
95 1   
55-65 30 35 x 
72 4   
72 5  
10 eternal  
 
A construct encoding the following protein was isolated (green = myc tag): 
hsFZD4 MAWRGAGPSVPGAPGGVGLSLGLLLQLLLLLGPARGFGDEEERRCDPIRISMCQNLGYNVTKMPNL
VGHELQTDAELQLTTFTPLIQYGCSSQLQFFLCSVYVPMCTEKINIPIGPCGGMCLSVKRRCEPVL
KEFGFAWPESLNCSKFPPQNDHNHMCMEGPGDEEVPLPHKTPIQPGEECHSVGTNSDQYIWVKRSL
NCVLKCGYDAGLYSRSAKEFTDIWMAVWASLCFISTAFTVLTFLIDSSRFSYPERPIIFLSMCYNI
YSIAYIVRLTVGRERISCDFEEAAEPVLIQEGLKNTGCAIIFLLMYFFGMASSIWWVILTLTWFLA
AGLKWGHEAIEMHSSYFHIAAWAIPAVKTIVILIMRLVDADELTGLCYVGNQNLDALTGFVVAPLF
TYLVIGTLFIAAGLVALFKIRSNLQKDGTKTDKLERLMVKIGVFSVLYTVPATCVIACYFYEISNW
ALFRYSADDSNMAVEMLKIFMSLLVGITSGMWIWSAKTLHTWQKCSNRLVNSGKVKREKRGNGWVK
PGKGSETVVEQKLISEEDL 
2.2.1.7 Quality control of Wnt luciferase and Notch luciferase reporter constructs 
To monitor canonical Wnt/β-catenin signaling, two constructs harboring either six wildtype 
(pTopflash) or mutant (pFopflash) TCF/LEF binding sites upstream the firefly luciferase gene were 
obtained from Konrad Basler and George Hausmann from the University of Zurich, Switzerland. 
Sequencing using pRVprimer3 that binds to the backbone vector pTA-Luc (Clonetech) revealed no 
sequence alterations (data not shown). 
To monitor Notch signaling activity, two constructs harboring either four wildtype (pJH23a) or 
mutant (pJH25a) CBF1 binding sites upstream the firefly luciferase gene were obtained from Diana S. 
Hayward from The Johns Hopkins University, USA. The backbone vector is pGL2pro (Promega, 
Madison WI, USA). Reporter sequences are listed below. Inserts that alter the proper recognition site 
are printed in bold letters. 
pJH23a: GAT CTG GTG TAA    CAC GCC GTG GGA AAA AAT TTA TG 
pJH25a: GAT CTG GTG TAA ACAC GGG CTT GGA AAA AAT TTA TG 
2.2.1.8 Commercially purchased pathway luciferase reporter constructs 
The luciferase reporter constructs pE2F, pERSE, pSRF and pSMAD were ordered from SABiosciences 
(Frederick, USA) and obtained as 1:40 mix with pRenilla. E. coli were transformed using the construct 
mix and plated on LB plated containing ampicillin. Single colonies of luciferase reporter constructs 
were isolated and sequenced using the RVprimer3. The respective binding sites of the luciferase 
constructs are given in the table below. All constructs have a pTA-Luc backbone. 
pE2F GTGCCAGNAACATTTCTCTGGCCTAACTGGCCGGTACCTGAGCTCGCTAGCCTCGAGGGATCCTTTCGCGGG
AAATTTCGCGGGAAATTTCGCGGGAAATTTCGCGGGAAATTTCGCGGGAAATTTCGCGGGAAAAAGCTTA
GACACTAGAGGGTATATAATGGA 
pERSE TGAGNCTCGCTAGCCTCGAGGGATCCCCTTCACCAATCGGCGGCCTCCACGACGGCCTTCACCAATCGGCG
GCCTCCACGACGGCCTTCACCAATCGGCGGCCTCCACGACGGCCTTCACCAATCGGCGGCCTCCACGACGG
CCTTCACCAATCGGCGGCCTCCACGACGGAAGCTTAGACACTAGAGGGTATATAATGGA 
pSRF TAACTGGCCGGTACCTGAGCTCGCTAGCCTCGAGGGATCCCAGGATGTCCATATTAGGACACAGGATGTCC
ATATTAGGACACAGGATGTCCATATTAGGACACAGGATGTCCATATTAGGACACAGGATGTCCATATTAG
GACACAGGATGTCCATATTAGGACAAAGCTTAGACACTAGAGGGTATATAATGGA 
pSMAD GGCCTAACTGGCCGGTACCTGAGCTCGCTAGCCAGCCAGACAAAGCCAGACAAAGCCAGACAAAAGCCA
GACAAAGCCAGACAAAAGCCAGACAAAGCCAGACAAAAGCCAGACAAAGCCAGACAAAAGCCAGACAA
AGCCAGACAAAAGCCAGACAAAGCCAGACAAAAGCTTAGACACTAGAGGGTATATAATGGA 
Bold/bold italic letters indicate transcription factor binding sites, underlined letters highlight the TA 
promoter.  
2.2.1.9 Sequencing of clones 
Sequencing conditions were the same for all clones: 
 
 µl 
Buffer5x 1.5 
Primer 1.0 
Plasmid DNA (50 ng/ul) 1.0 
ddH2O 5.7 
BigDye 0.8 
 
°C sec  
96 60  
96 20   
50 10 35 x 
60 3   
10 eternal  
 
 
Sequencing reactions were purified using Sephadex filtration columns and analyzed on an ABI Prism 
3100 Genetic Analyzer. Electropherograms were analyzed using Sequencer software (GeneCodes, 
Ann Arbor, USA).  
2.2.2 Wnt- and Notch-pathway luciferase reporter assays 
Eukaryotic gene expression is regulated by endogenous and environmental stimuli. Initially, an 
extracellular signaling molecule binds its receptor, triggering a series of molecular cascades, which 
activate or deactivate specific transcription factors (TFs) that regulate gene expression. The 
interaction of multiple TFs control the expression of any given gene. The TFs in turn are modulated 
by multiple signal transduction pathways. Many transduction pathways converge at transcription 
factors that bind specific transcriptional response elements (TREs) in promoters of various genes. 
Therefore, reporter constructs that express a reporter gene (e.g. luciferase) controlled by a 
promoter consisting of specific TREs (e.g. TCF/LEF for Wnt signaling, CBF1 for Notch signaling) are 
widely used to monitor respective pathway activity. We delivered these plasmid based reporter 
constructs (pTopflash to monitor Wnt signaling and pJH23a to monitor Notch signaling) by transient 
transfection to the nucleus of HEK293T cells. The readout was done using the commercially available 
Dual GloTM Luciferase Kit (Promega). Statistical analysis was done with SPSS 19. 
2.2.2.1 Calcium phosphate precipitation for transient transfection of HEK293T cells 
4*105 HEK293T cells per well were seeded in a 24-well plate and incubated for 24 hours at 37°C 
under 5% CO2. Subsequently, the cells were transfected using the Ca
2+-precipitation method. 
Therefore a total of 3 µg plasmid DNA mix was added to yield in a total volume of  30 µl ddH2O/DNA 
solution. 3 µl  calcium chloride (c=2.5 mol/l) and 30 µl 2.5x HeBS solution were added. The solution 
was mixed by pipetting up and down and incubated for 20 minutes at ambient temperature. 60 µl 
solution were pipetted dropwise into a well of a 24-well plate. The plate was incubated for 24 to 72 
hours prior to conduction of the luciferase readouts. Three technical replicas were done per 
measurement. Each experiment was repeated twice. 
2.2.2.2 Transient Wnt reporter assay 
Wildtype HEK293T cells were used and treated according to the transfection protocol above to 
measure Wnt activity of transiently expressed wildtype or mutant Norrin. The ratios of transiently 
transfected constructs were as follows: pTopflash : pWnt3A : pFZD4 : pLRP5 : pRL = 1:1:1:1:100 or 
pTopflash : pNDP* : pFZD4 : pLRP5 : pRL = 1:1:1:1:100. pNDP* can be any wildtype or mutant Norrin 
construct. The medium was replaced with 100 µl of fresh medium after 72 hours. The luciferase 
activity was measured using the Dual-GloTM Luciferase Assay System (Promega, Madison, USA). For 
that, 75 µl/well Dual GloTM Luciferase Substrate solution was added. The plates were incubated for 5 
minutes at ambient temperature under light protection. After measuring the Firefly activity using an 
Luminoskan Ascent reader (ThermoLabsystems, Helsinki, Finnland), 50 µl Dual-GloTM Stop and Glo 
Substrate solution were added. Following 10 minutes of incubation at ambient temperature at dark, 
the renilla luciferase activity was measured. Statistical analysis was performed as  described below. 
2.2.2.3 Stable Wnt reporter assay 
HEK293T cells stably expressing wildtype, mutant or no Norrin were used and treated according to 
the transfection protocol above to measure Wnt activity. The ratios of transiently transfected 
constructs were as follows: pTopflash : pFZD4 : pLRP5 : pRL = 1:1:1:100. 25 mM LiCl and 25 mM NaCl 
were used as positive and negative control, respectively. The medium was replaced with 100 µl of 
fresh medium after 48 hours of incubation. The luciferase activity was measured using the Dual-
GloTM Luciferase Assay System (Promega, Madison, USA). Therefore, 75 µl/well Dual GloTM Luciferase 
Substrate solution was added. The plates were incubated for 5 minutes at ambient temperature 
under light protection. After measuring the Firefly activity using a Luminoskan Ascent reader 
(ThermoLabsystems, Helsinki, Finnland), 50 µl Dual-GloTM Stop and Glo Substrate solution were 
added. Following 10 minutes of incubation at ambient temperature at dark, the renilla luciferase 
activity was measured. Statistical analysis was performed as described below. 
2.2.2.4 Conditions to perform the Notch reporter assay 
HEK293T cells stably expressing wildtype or mutant (p.C95R) Norrin were used and treated 
according to the transfection protocol above to measure Notch activity. The ratios of transiently 
transfected constructs were as follows: pJH23a : pN1ICD : pFZD4 : pLRP5 : pRL = 1:1:1:1:20. After 24 
to 72 hours, the medium was replaced with 100 µl of fresh medium. The luciferase activity was 
measured using the Dual-GloTM Luciferase Assay System (Promega, Madison, USA). Therefore, 75 
µl/well Dual GloTM Luciferase Substrate solution was added. The plates were incubated for 5 minutes 
at ambient temperature under light protection. After measuring the Firefly activity using a 
Luminoskan Ascent reader (ThermoLabsystems, Helsinki, Finnland), 50 µl Dual-GloTM Stop and Glo 
Substrate solution were added. Following 10 minutes of incubation at ambient temperature at dark, 
the renilla luciferase activity was measured. Statistical analysis was performed as  described below. 
2.2.2.5 Statistical analysis of reporter assays 
Readouts of reporter assays were only analyzed if the following criteria were met: 
- cells were adherent, looked viable and had a normal morphology before measurement 
- the cell culture medium was red but not orange or yellow before exchange with fresh medium 
- the renilla values of the readout were at least three standard deviations above the average of 
values from empty measured wells 
Readouts that met these criteria were analyzed in SPSS 19 (IBM, New York, USA) using independent 
samples T-test (two-tailed). Average and confidence intervals are displayed in graphs. P-values 
below α=0.05 were considered statistically significant. 
2.2.3 TaqMan analysis of Notch target genes in HEK293T cells 
2.2.3.1 Sample preparation for the quantification of Notch target genes after Norrin 
expression in HEK293T cells 
We assessed the influence of Norrin on the expression of Notch target genes, including Hes1, Hes2, 
Hes5, Hey1 and Hey2 in HEK293T cells. For that, 106 HEK293T cells that stably express wildtype 
(Norrin) or none Norrin (MOCK) were seeded in 75 cm2 T-bottles in 12 ml DMEM medium and 
incubated over night at 37°C, 5% CO2. 2500 ng pFZD4 and 2500 ng pLRP5 were dissolved in 1120 µl 
ddH2O, 125 µl CaCl2 and 1250 µl 2xHeBS buffer and incubated 20 minutes at ambient temperature. 
The transfection mix was transferred onto the cells and regularly distributed by briefly rotating the 
T-bottle. Cells were incubated 72 hours at 37°C, 5% CO2 and harvested. RNA was extracted using 
RNAShredder columns and RNAEasy Kit (both from Qiagen, Hilden, DE) using standard protocols 
provided from Qiagen. Quality control and quantification of extracted RNA was done using RNA 
Nano chip (Agilent, Waldbronn, DE). 2000 ng RNA were used for cDNA synthesis with Superscript III 
reverse transcriptase Kit (Invitrogen, Carlsbad, USA) according to manufacturers´ protocol. 10 ng 
cDNA per reaction were used for target gene analysis and 100 pg per reaction for 18S rRNA or 
GAPDH control analysis. Six technical replicas of four different transfected T-bottles per target and 
control gene were measured in an ABI PRISM® 7900T (Applied Biosystems, Foster City, USA) using 
standard conditions for cycling. All Ct values were between 25-30 since ct values below 35 may 
randomly occur. 
2.2.3.2 Analysis of TaqMan data 
Relative expression was calculated using the cycle threshold method (ΔΔct). First, target gene 
expression was normalized to the endogenous control (18s RNA or GAPDH): Cttarget gene – Ctendogenous 
control. Normalized target gene expression was then normalized to an arbitrary calibrator sample, 
which was the average of all ΔCt from Norrin or non-Norrin expressing cell samples: ΔCtsample – 
Δctcalibrator sample = ΔΔCt. The fold change expression difference was then calculated with the formula: 
2- ΔΔCt. Upper and lower confidence intervals were calculated separately using Student’s t-test at a 
significance level of 95% based on ΔΔCt-values, since confidence intervals cannot be plotted linear 
on the fold change scale. Calculations were done in Excel (Microsoft, Redmont, USA).  
2.2.4 Analysis of Notch activity in Ndphy/- mice 
2.2.4.1 Breeding of Norrin knockout mice (Ndphy/-) 
The coding sequence for the 56 N-terminal amino acids of the murine Ndph gene was replaced by a 
neomycin cassette in the 129/Ola mouse strain (Berger et al., 1996). The obtained Ndphy/-mice were 
backcrossed to the C57BL/6J strain. To avoid genetic drift, male Ndphy/-mice and wildtype female 
C57BL/6J(Fue) mice were bred and their heterozygous female offspring were mated with wildtype 
male C57BL/6J(Fue) mice. All male offspring was used to conduct experiments. 
2.2.4.2 Breeding of Notch Reporter mice (Ndphy/- x Tg(Cp-EGFP)25Gaia/J) 
To detect Notch signaling in vivo, heterozygous female Ndphy/- mice were crossed with homozygous 
Notch reporter mouse (Tg(Cp-EGFP)25Gaia/J, Jackson Laboratory, Main, USA; Hellstrom et al. 2007). 
Experiments were conducted using wildtype or Ndphy/- male offspring harboring the Notch reporter 
cassette. 
2.2.4.3 Health and weight monitoring of mice 
Health was monitored by visual inspection of the mice skin or coat (depending on the age of the 
pups) and hygienic appearance of the animals. Animals with a weight that differed for 3 standard 
deviations from the average of their litter were excluded from experiments. 
2.2.4.4 DNA extraction from mouse tail biopsies 
5 mm mouse tail biopsies were digested 1 h at 55°C at 1200 rpm in 500 µl proteinase K mix (see 
table below). Samples were centrifuged for 5 min at 4°C at 13000 rpm and DNA of the supernatant 
was precipitated using 500 µl 2-propanol. Samples were centrifuged 2 min at 4°C and 13000 rpm. 
The pellet was washed with 200 µl 70% ethanol and dried 10 min at 65°C. DNA was dissolved in 500 
µl ddH2O. 1 µl of extracted DNA was used for genotyping. 
2.2.4.5 Genotyping of Ndphy/- mice 
A multiplex PCR was used to determine the genotype of the mice. Primers SL 107 and SL 108 flank 
exon 2 of the Ndph gene and amplify a 527 bp product from the wild type allele. Primers SL 105 and 
SL 106 bind inside the neomycin cassette of the Ndph knockout allele and yield 3 smaller PCR 
products in combination with primers SL 105 and SL 106: a 133 bp and a 204 bp product (SL 106 with 
SL 108), and an amplicon of 271 bp (SL 105 with SL 107) (Figure 16). 
The Sry gene on the Y chromosome was amplified to identify male mice. For that, the primers SL 120 
and SL 121 were used. If male mouse DNA is provided the amplicon size generated is 406 bp. 
 
 
Figure 16: Ndph genotyping strategy: Amplification of the endogenous wild type locus with two intron 
primers results in a fragment of 527 bp, while three fragments of 133, 204 and 271 bp are amplified from the 
knockout locus (modified after Berger et al., 1996). 
 
Sry genotyping: 
 µl 
ddH2O 16.0 
Buffer B (10x) 2.5 
MgCl2 (25 mM) 3.0 
dNTPs (20 mM) 0.25 
Primer SL188 (10 µM) 1.0 
Primer SL189 (10 µM) 1.0 
Hot Fire Polymerase 0.25 
DNA from mouse tails 
extract 
1 
 
°C min  
95 15  
95 1   
56 1 35 x 
72 2   
72 10  
 
 
Ndph genotyping: 
 µl 
ddH2O 12.75 
Buffer B (10x) 2.5 
MgCl2 (25 mM) 6.0 
dNTPs (20 mM) 0.25 
DTT (100 mM) 1.25 
Primer SL105 (10 µM) 0.25 
Primer SL106 (10 µM) 0.25 
Primer SL107 (10 µM) 0.25 
Primer SL108 (10 µM) 0.25 
Hot Fire Polymerase 0.25 
DNA from mouse tails 1 
 
°C min  
95 15  
95 1   
62 1 35 x 
72 2   
72 10  
 
 
PCR products are analyzed on a 1.5 % agarose gel using 0.5 µg/ml ethidium bromide for staining. 1 
kb DNA ladder (Fermentas, St. Leon-Rot, DE) served as size marker. Interpretation of the amplicons 
are as follows: 
 
Ndph genotyping on an agarose gel: The presence of 
the 133 bp, 204 bp and 271 bands is specific for 
NDPhy/- animals. The presence of 527 bp fragment is 
specific wildtype animals. 
 
Sry genotyping in an agarose gel: The presence of the 
406 bp band is specific for male mice. 
 
2.2.4.6 Genotyping of Notch reporter mice 
In addition to Sry and Ndph genotyping, the presence of the Notch reporter in Ndphy/- x Tg(Cp-
EGFP)25Gaia/J - mice was genotyped using the following PCR conditions. 
 µl 
ddH2O 14.95 
Puffer B 2.5 
MgCl2 (25 mM) 2.0 
dNTPs (20 mM) 0.25 
20 µM primer #637 1.0 
20 µM primer #638 1.0 
20 µM primer #635 1.0 
20 µM primer #636 1.0 
Taq DNA Polymerase 0.3 
DNA (50ng/µl) 1.00 
 
°C min   
95 15  
95 1  
60 1 35x 
72 1  
72 10  
10 hold  
 
 
 
PCR products are analyzed on a 2 % agarose gel using 0.5 µg/ml ethidium bromide for staining. 1 kb 
DNA ladder (Fermentas, St. Leon-Rot, DE) served as size marker. Interpretation of the amplicons are 
as follows: 
 
Notch reporter PCR: The 324 bp band serves as positive control for the PCR reaction. The presence 
of the 174 bp band indicates the presence of the Notch reporter cassette in the animal. The original 
protocol was derived from Jackson Laboratories (Main, USA; www.jax.org). Jackson Laboratories did 
not indicate the nature of the produced amplicons in detail.  
2.2.4.7 BrdU treatment 
BrdU treatment was performed according to a Nature protocol (Pitulescu et al., 2010). 
2.2.4.8 DAPT treatment 
N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycine-1,1-dimethylethyl ester (DAPT) inhibits 
Notch1 signaling by inhibiting Notch1 cleavage enzyme γ-secretase. We used the following protocol 
to inject Ndphy/- and wildtype littermates: 
Day 1 (mice stage P5): 
Health status of animals was evaluated by visual inspection of their skin or coat and by 
weight monitoring. 
5 mg DAPT were dissolved in a 2 ml screw top vial with septum in 100 µl ethanol puriss p.a. 
and subsequently 450 µl peanut oil were added. 
The suspension was vortexed before every injection to ensure optimal emulsion properties 
of the injective. 
50 µl DAPT emulsion were injected subcutaneously at the neck using a 30 G1/2” needle and a 
100 µl syringe. 
Day 2 (mice stage P6): 
The procedure from day 1 was repeated. 
Day 3 (mice stage P7): 
Eyes of euthanized animals were enucleated and retinal whole-mounts were prepared as 
described below. 
2.2.4.9 LiCl treatment 
Lithium chloride dissolved in PBS was injected according to the table below starting P5 for 5 days. 
Conditions for the setup of the injection table were from Smith DF, 1978 and Hofman et al., 2010 
(Hofmann et al., 2010; Smith1978). Abort criterions were lack of gain in body weight, symptoms of 
poisoning or death of mice pups. 
age 
[d] 
weight of 
animal [g] 
LiCl 
(4mg/100 µl 
PBS) [µl] ul PBS 
total volume PBS 
[ml] 
total mass of 
LiCl [mg] 
βi(LiCl) 
[mg/ml] 
c(LiCl) 
(mmol/l) mmol/kg 
%LD 
LiCl 
5 2.5 11.9 38 0.05 0.48 9.5 225 4.5 23.2 
6 3.2 15.3 35 0.05 0.61 12.2 288 4.5 23.2 
7 3.8 18.1 32 0.05 0.72 14.5 342 4.5 23.2 
8 4.3 20.6 29 0.05 0.82 16.5 388 4.5 23.2 
9 4.8 22.7 27 0.05 0.91 18.2 429 4.5 23.2 
10 5.2 24.7 25 0.05 0.99 19.8 466 4.5 23.2 
Eyes were fixed at P12 and analyzed as described below.  
2.2.4.10 Preparation of retinal whole-mounts 
Eyes were dissected in PBS and fixed in 4% paraformaldehyde (PFA) for two hours on ice or over 
night at 4°C. After fixation, retinas were incubated in PBST with 1 to 10% serum together with 
primary antibodies over night at 4°C. Retinas were washed five times using PBST and subsequently 
incubated with secondary antibodies dissolved in PBST. Retinas were washed again five times with 
PBS and mounted using Fluoro Mount (Sigma-Aldrich, Steinheim, DE). Mounted retinas were 
analyzed with Zeiss AxioVison microscope in combination with ApoTome and AxioVs40 V4.6.3.0 or a 
CLSM Leica SP2 inverse microscope (Leica, Wetzlar, DE). 
2.2.5 Quantification of retinal parameters 
Only one eye per mouse was used for retinal quantification. The results of four single measurements 
per retina were arithmetically averaged. At least four retinas from four different male mice were 
used per measurement. Data collection was performed in Excel (Microsoft, Redmont, USA) and 
subsequent statistic analysis was performed in SPSS 18 or 19 (IBM, New York, USA). 
2.2.5.1 Quantification of filopodia per 100 μm vascular front 
Eyes were fixed in 4% PFA at 4°C over night and dissected in PBS. Blood vessels were stained with 
isolectinB4. For quantification, non-overlapping 400x magnified ApoTomeTM microscopy pictures 
were taken from the vascular front (Figure 17). The distance of the vascular front was measured 
using ImageJ (NIH, Maryland, USA) and the number of filopodia were counted using the “counting 
tool” from Photoshop (Adobe, Mountain View, USA). Number of filopodia per 100 µm were 
calculated and compared. 
2.2.5.2 Quantification of branchpoints per field 
Eyes were fixed in 4% PFA at 4°C over night and dissected in PBS. Blood vessels were stained with 
isolectinB4 (IB4). Non-overlapping 200x fluorescence microscopy pictures were used for 
quantification. The “rectangular marquee tool” from Photoshop (Adobe, Mountain View, USA) was 
used to select a 573x573 pixel square and all branchpoints within that square were counted (Figure 
17). 
2.2.5.3 Quantification of the vascular density 
Eyes were fixed in 4% PFA at 4°C over night and dissected in PBS. Blood vessels were stained with 
IB4. Non-overlapping 200x fluorescence microscopy pictures were used for quantification. The 
“rectangular marquee tool” from Photoshop (Adobe, Mountain View, USA) was used to select a 
573x573 pixel square. The vasculature within the square was selected using the Photoshop’s “color 
range tool”. Unspecific stained objects were manually omitted from the selection using the “magic 
wand tool”. The number of selected pixels was read of the “histogram panel”. The vascular density 
was calculated as the ratio of selected pixels divided by 5732 (Figure 17).  
2.2.5.4 Measurements of the vascular length and thickened vascular regions 
To evaluate outcomes of DAPT injections, the vascular radial outgrowth (vascular length) and the 
area of DAPT induced vascular thickening were quantified (Figure 17). For that, four to six 
overlapping fluorescence microscopy pictures (5x magnification) of a single retinal whole-mount, 
stained with isolectinB4, were stitched together using Photoshop’s “Photomerge” function. 
Distances between the retinal outline or the vascular front or boarder of the thickened vascular 
plexus to the optical disc were measured with the “ruler tool” applying the custom scale 468 px = 
1000 µm. The vascular length was calculated by dividing the distance between the optical disc and 
the vascular front by the distance between the optical disc to the retinal border. The thickened area 
was calculated by dividing the distance between the optical disc and the border of the thickened 
vascular region by the distance between the optical disc and the vascular front and subsequently 
subtracting this ratio from 1. 
 
Figure 17: Quantification of retinal parameters. (a) confocal picture of the vascular front stained with 
isolectin B4 to visualize blood vessels (grey) and filopodia (red dots). The yellow line indicates the measured 
distance of the vascular front. Scale bar equals 25 µm. (b) Blood vessels of the central retina are stained 
using isolectin B4 (red). The number of branchpoints (white dots) was counted or the ratio between the red 
and the total number of pixels of the square calculated (= vascular density). Scale bar equals 50 µm. (c) 
Blood vessels of the retina are stained with isolectin B4 (red). Blue lines represent the radial distance from 
the retinal border (=a), vascular front (=b) or the border of the thickened vascular area (=c) to the optical 
disc (center of yellow cross). All measurements were performed on one measurement line (yellow) for each 
leave. Scale bars equal 1000 µm. (Pictures are adapted from the Master Thesis of Martin Fritzsche). 
2.2.5.5 Statistics 
Statistical analysis was performed in SPSS 18 or 19 (IBM, New York, USA) using two-tailed unpaired 
Student’s t-test. Quantitative data from DAPT-injection experiments were processed with univariate 
analysis of variance with two independent variables. Avoiding bias due to unequal sample sizes, the 
estimated marginal means where calculated instead of arithmetically means. P-values below α=0.05 
were considered as statistically significant. 
 
  
3. Results 
During my thesis I became first author of the publication “Alterations of the 5’ Untranslated Region 
of SLC16A12 Lead to Age-Related Cataract”. This publication is thematically not connected to my 
thesis and therefore no additional results are shown or discussed here. The paper is available in 
appendix 5. 
Zuercher J, Neidhardt J, Magyar I, Labs S, Moore AT, Tanner FC, Waseem N, Schorderet DF, Munier 
FL, Bhattacharya S, Berger W, Kloeckener-Gruissem B (2010). Alterations of the 5’untranslated 
leader region of SLC16A12 lead to age-related cataract. Invest Ophthalmol Vis Sci 51:3354-3361 
Own contributions: I cloned the constructs used in the luciferase reporter assay, conducted the 
luciferase reporter assay, did the RNA in silico analysis, designed the figures and wrote and reviewed 
the paper. 
3.1 Norrin stimulates cell proliferation in the superficial retinal vascular 
plexus and is pivotal for the recruitment of mural cells 
The following publication covers the main results from my thesis project. 
Zuercher J, Fritzsche M, Feil S, Mohn L, Berger W (2012) Norrin stimulates cell proliferation in the 
superficial retinal vascular plexus and is pivotal for the recruitment of mural cells. Hum Mol Genet 
(Epub ahead of print) 
Own contributions: I was responsible for animal husbandry, coordinated animal experimentation, 
designed and performed experiments, analyzed and interpreted data, designed the figures, wrote, 
reviewed and submitted the manuscript. 
Norrin stimulates cell proliferation in the superficial
retinal vascular plexus and is pivotal
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Mutations in Norrin, the ligand of a receptor complex consisting of FZD4, LRP5 and TSPAN12, cause severe
developmental blood vessel defects in the retina and progressive loss of the vascular system in the inner ear,
which lead to congenital blindness and progressive hearing loss, respectively. We now examined molecular
pathways involved in developmental retinal angiogenesis in a mouse model for Norrie disease. Comparison
of morphometric parameters of the superficial retinal vascular plexus (SRVP), including the number of filo-
podia, vascular density and number of branch points together with inhibition of Notch signaling by using
DAPT, suggest no direct link between Norrin and Notch signaling during formation of the SRVP. We noticed
extensive vessel crossing within the SRVP, which might be a loss of Wnt- and MAP kinase-characteristic fea-
ture. In addition, endomucin was identified as a marker for central filopodia, which were aligned in a thorn-
like fashion at P9 in Norrin knockout (Ndpy/2) mice. We also observed elevated mural cell coverage in the
SRVP of Ndpy/2 mice and explain it by an altered expression of PDGFb and its receptor (PDGFRb). In vivo
cell proliferation assays revealed a reduced proliferation rate of isolectin B4-positive cells in the SRVP
from Ndpy/2 mice at postnatal day 6 and a decreased mitogenic activity of mutant compared with the wild-
type Norrin. Our results suggest that the delayed outgrowth of the SRVP and decreased angiogenic sprouting
in Ndpy/2 mice are direct effects of the reduced proliferation of endothelial cells from the SRVP.
INTRODUCTION
Mutations in the human NDP (Norrie disease pseudoglioma)
gene, encoding Norrin, cause congenital blindness, progres-
sive deafness and mental retardation, a triad of symptoms
characteristic for Norrie disease (ND) (1–5). Alternatively,
mutations in NDP can exclusively lead to ocular symptoms
in X-linked exudative vireoretinopathy (EVR) (6), Coats’
disease and retinopathy of prematurity (7,8). EVR is also
caused by mutations in Frizzled-4 (FZD4, FZD4), low-density
lipoprotein receptor-related protein 5 (LRP5, LRP5) or
tetraspanin-12 (TSPAN12, TSPAN12) (9–11). Recessive
mutations in LRP5 may also cause osteoporosis pseudoglioma
syndrome (OPPG), which manifests with low bone mass in
addition to the ocular phenotype in patients (OMIM:
#259770). It has been shown in vitro that Norrin is a ligand
for the canonical Wnt signaling receptor complex consisting
of FZD4, LRP5 and TSPAN12 (12,13). Furthermore, the out-
growth of the superficial retinal vascular plexus (SRVP) from
Ndpy/2, Fzd42/2, Lrp52/2 and Tspan122/2 is delayed and
incomplete and all of these knockout mice lack the deep and
intermediate retinal vascular plexuses (12–16). We generated
and examined a Norrin knockout mouse model (Ndpy/2) that
resembles the human Norrie disease phenotype with respect
to blindness and hearing loss (4,14,17). Hyaloid vessels do
not completely regress in Ndpy/2, Fzd42/2, Lrp52/2 and
Tspan122/2 knockout mice (12–14,16). Retinal vascular
hemorrhage and exudation from retinal blood vessels in Ndp
knockout mice (Ndpy/2) are characteristic features. We previ-
ously demonstrated that expression of the plasmalemma
vesicle-associated protein (PLVAP), which mediates vascular
fenestration and promotes vascular leakiness, is highly
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upregulated in Ndpy/2 retinas (18). Upregulation of PLVAP/
MECA32 in retinal endothelial cells (ECs) has also been
shown for Lrp52/2 and Tspan122/2 mice (13). Furthermore,
it was shown that upregulation of PLVAP indicates the loss of
canonical Wnt signaling (19). The delayed outgrowth of the
SRVP and the absence of deep sprouting could be caused
either by defects in sprouting angiogenesis or by reduced pro-
liferation of the SRVP. Sprouting angiogenesis is mediated by
endothelial tip cells that guide the growing SRVP from the
optic nerve head towards the retinal periphery along a vascular
endothelial growth factor (VEGF) gradient (20). Stalk cells
following tip cells divide ensuring proliferation and growth.
Thus, an imbalance of tip and stalk cells could lead to both
observed effects. The proper differentiation of tip and stalk
cells is mediated by a balanced expression and interaction of
Notch1 with its ligands Dll4 and Jagged1 (21–23). Dll4 is
expressed in tip cells and induces Notch signaling in adjacent
stalk cells. In contrast, Jagged1 is expressed in stalk cells im-
peding Notch signaling in adjacent tip cells. Disruption of
Notch signaling has been shown to alter morphometric para-
meters, such as the number of peripheral tip cell filopodia, vas-
cular density and the number of vascular branch points. The
outgrowth of the SRVP along the VEGF gradient involves
MAPK signaling. VEGF, provided by astrocytes or retinal
ganglion cells, binds a receptor complex consisting of VEGF
receptor 2 (VEGFR2) and neuropilin 1 (Nrp1) activating
downstream MAPK signaling. Loss of the cytoplasmatic
Nrp1 domain (Nrp1cytoD/D) or nestin-specific knockout of
VEGF (VEGFNES-CRE) in mice causes artery/vein crossing
(A/V crossing) in the SRVP of these mice. VEGFNES-CRE
mice additionally show aberrant deep sprouting (24,25).
Here, we focused on defects during development of the
SRVP in Ndpy/2 mice. We quantified several vascular and
angiogenic parameters and observed extensive vessel crossing
within the SRVP which might be a MAPK-characteristic
feature. We found reduced cell proliferation in the SRVP at
the vascular front at P6 in Ndpy/2 mice which may explain
the delayed outgrowth of the SRVP. We also detected elevated
mural cell (MC) coverage of the SRVP starting at P9, which is
consistent with previously found upregulation of Tie1, Pdgfb
and Pdgfrb. Finally, we report for the first time endomucin-
positive supernumerary central filopodia of the SRVP in
Ndpy/2 retinas culminating at P9, the time point when the
deep retinal vascular plexus (DRVP) normally would develop.
RESULTS
Vascular development in Norrin knockout mice
The wild-type mouse retina is avascular at birth and outgrowth
of the SRVP progresses from the center towards the periphery
from P1 until P8. Because the outgrowth of the SRVP is in-
complete and delayed in Ndpy/2 mice (14), we hypothesized
that there might be an imbalance between tip cell filopodia
and/or adjacent stalk cell proliferation. We quantified the
number of filopodia as well as the vascular density and
number of branch points in the central plexus at the vascular
front at P5 and P7 (Fig. 1) (Supplementary Material,
Table S1). The number of filopodia was significantly increased
but the vascular density (Fig. 1A, C, E, G, I, K) and the
number of branch points (Fig. 1A, C, E, G, J, L) were signifi-
cantly decreased at P5 and P7 in Ndpy/2 mice. Moreover, filo-
podial protrusions in Ndpy/2 mice are straighter and expand
with a narrower angle than filopodia of wild-type littermates
(Fig. 1O) (Supplementary Material, Table S2). In contrast to
the increased number of filopodia, the vascular front in
general appears to be less ramified with a reduced amount of
long tip cell protrusions (Fig. 1B and F).
Comparison of vascular development in different mouse
models
Available morphometric data from three Norrin-Wnt signaling
knockout mice (Fzd42/2, Lrp52/2 and Tspan122/2), three
Notch signaling knockout mice (Dll4+/2, Jag1iDEC,
Nrarp2/2), Ang2LZ/LZ and Pax6 dependent hypoxia inducible
factor 1 a (HIF1aDPax6) knockout mice were compared
(Table 1). The morphometric comparison of Jag1iDEC with
Ndpy/2 mice was of special interest since Jag1 has been
shown to be a canonical Wnt target gene in hair follicle
cells comprising two LEF/TCF-binding sites within its pro-
moter region (26,27). We compared our morphometric data
from Norrin KO mice with published morphometric data
from Jag1iDEC mice and recognized delayed and incomplete
outgrowth of the SRVP, together with a reduced vascular
density and a decreased number of branch points in
Jag1iDEC and Ndpy/2 mice. In contrast to Ndpy/2 mice, the
number of tip cell filopodia was reduced in Jag1iDEC mice.
Dll4+/2 mice have an increased number of filopodia,
increased number of branchpoints and a denser vascular
SRVP. Hence, the Ndpy/2 phenotype of the SRVP displays
as an intermingled picture, with a peripheral Jag1 gain of
function but central Jag1 loss of function features. We asked
the question whether or not Norrin is a negative regulator of
Notch signaling. To answer this question, we examined the
effect of Notch inhibition in Ndpy/2 mice in order to see if
this may rescue the abnormal vascular development. We quan-
tified and compared morphometric parameters in Norrin
knockout and wild-type mice after inhibition of Notch signal-
ing by injection of the g-secretase inhibitor DAPT (Fig. 2).
Administration of DAPT increased vascular density in wild-
type and Ndpy/2 mice (Fig. 2A–E), while the number of filo-
podia only increased in wild-type but not in Ndpy/2 retinas
(Fig. 2F–J) (Supplementary Material, Table S3).
Retinal EC proliferation in Norrin-deficient mice
To test the hypothesis if Norrin acts as a mitogen for cells in
the SRVP, which would explain the reduced vascular density
as well as the delayed and incomplete radial vascular out-
growth in Ndpy/2 mice, we quantified central EC proliferation
after systemic bromodeoxyuridine (BrdU) injection and found
significantly reduced proliferation rates of isolectin B4
(IB4)-positive ECs from the SRVP in Ndpy/2 mice at P6
(WT: ME+SD 101.71+ 16.54; KO: ME+SD 52.17+
9.62; P-value: 1.8E25) (Fig. 3A and C). The only exceptions
from this observation are local hotspots of proliferation within
bulky unorganized regions at the vascular front (Fig. 3D).
Additionally, we monitored the effect of Norrin on cell
cycle progression in cell culture experiments by using an
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E2F transcription factor-mediated reporter assay (cell prolifer-
ation controlling transcription factor-dependent luciferase re-
porter construct, reviewed in 28). For this, we transiently
transfected pE2F luciferase reporter constructs into
HEK293T cells which ectopically express the same amount
of either human wild-type or a pathogenic variant of Norrin
containing the p.C95R mutation (Supplementary Material,
Fig. S1), which has been associated with the classic picture
of Norrie disease (29). HEK293T cells do not endogenously
express Norrin, but were positive in RT–PCR for transcripts
from FZD4, LRP5 and TSPAN12 (Supplementary Material,
Fig. S1). Similarly to our BrdU data in Ndpy/2 mice, we
found almost 6-fold increased cell cycle progression in cells
that stably express human wild-type Norrin compared with
cells that express the mutant Norrin isoform (Fig. 3F, Supple-
mentary Material, Table S4).
Vascular remodeling in Norrin-deficient mice
Despite the reduced vascular outgrowth of the SRVP, we
occasionally noticed bulky vascular areas at the front of
Ndpy/2 mice, comprising three-dimensional accumulations
of ECs (Fig. 4D). To monitor vascular remodeling across the
plexus, retinal whole-mounts were double stained for IB4
and collagen IV (ColIV). ColIV-positive tubes lacking IB4
staining represent empty basement membrane sleeves at posi-
tions where blood vessels have regressed (30,31). We noticed
that vascular remodeling was elevated in Ndpy/2 mice at per-
ipheral bulky vascular areas of the SRVP, but not in central
areas (Fig. 4C, white dots). Furthermore, we noticed
vessel-crossing in Ndpy/2 retinas. Vessels that morphological-
ly resemble veins [venous character (VC)] cross and grow
below vessels that resemble arteries [arterial character (AC)]
between P7 and P21 (A/V crossing) (Fig. 5, Supplementary
Material, Fig. S3). ACs in Norrin knockout mice also intercon-
nect less to the central plexus compared with the wild-type and
instead grow further into the periphery (Fig. 6D). At P21, dis-
organized twisted and tangled blood vessels form above the
superficial plexus resembling fibrosis (Supplementary Mater-
ial, Fig. S3t and w). We hypothesized that A/V crossing
could be caused by altered astrocyte–EC interaction and
therefore co-stained astrocytes against PDGFRa and blood
Figure 1. Morphometric parameters in Norrin knockout versus wild-type mice. Ndpy/2 mice show decreased vascular density, a decreased number of branch
points but supernumerary filopodia, which are aligned in a more narrow angle compared with wild-type mice at P5 and P7. (A, E, C, G) Representative central
retinal whole-mounts from wild-type (WT) and Ndpy/2 (KO) retinas stained with IB4. (B, D, F, H) Representative peripheral retinal whole-mounts from WT and
Ndpy/2 retinas stained with IB4. Emerging filopodia are visible. Quantification of vascular density (I and K), number of branch points (J and L), number of
filopodia (M and N) and angle of filopodia (O). Average and confidence intervals are shown. P-values below a ¼ 0.05 were considered statistically significant.
Scale bars ¼ 100 mm.
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Table 1. Morphometric data among mutant mice with comparable retinal vascular phenotype
Ndpy/2 Fzd42/2 Lrp52/2 Tspan122/2 Dll4+/2 Jag1iDEC Nrarp2/2 Ang2LZ/LZ HIF1aDPAX6
Pathway affected Canonical
Wnt-
signaling
Canonical
Wnt-
signaling
Canonical Wnt-
signaling
Canonical
Wnt-
signaling
Notch signaling Notch signaling;
tamoxifen-induced
EC-specific deletion
Notch, b-catenin/
Lef1-dependent Wnt
signaling
Tie2 signaling;
LZ ¼ lacZ
Hypoxia
Vascular
outgrowth of
SRVP
Delayed and
incomplete
Delayed and
incomplete
Delayed and
incomplete
Delayed and
incomplete
Delayed Delayed (244%) Delayed but complete Periphery
remains
avascular
Not delayed
nor reduced
Vascular density
of SRVP
Reduced
(234%, P7)
Not available Not available Reduced Increased
(+58%a)
Reduced (232%, P6) Reduced at P5 but not
different in adult
Not available Not available
Number of branch
points of
SRVP
Reduced
(247%, P7)
Not available Not available Not available Increased
(+96%a)
Reduced (265%, P6) Reduced at P5 but not
different in adult
Not available Not available
Number of
filopodia of
SRVP
Increased
(+39%, P7)
Not available Not available Not available Increased
(sprouts
increased
+63%a)
Reduced (227%, P6) Not different at P5 Not available Not available
A/V crossing in
SRVP till P7
Present Present Present Present Absent Absent Present Not deducible
due to
picture
quality
Absent
DRVP Absent Absent Absent Absent Present Present Present Absent Present
Intermediate
retinal vascular
plexi
Absent Absent Absent Absent Present Present Present Absent Absent
References Luhmann et al.
(14), this
work
Xu et al. (12) Xia et al. (16,41)
and Chen
et al. (42)
Junge et al.
(13)
Lobov et al.
(21)
Benedito et al. (22) Phng et al. (43) Gale et al. (44) Caprara et al.
(45)
a% estimated from graph.
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vessels with IB4 (Supplementary Material, Fig. S2). We did
not observe an altered astrocytic network in Ndpy/2 retinas
compared with wild-type and alignment between astrocytes
and ECs was normal.
Mice lacking the Nrp1 cytoplasmatic domain or
VEGFNES-CRE mice also show A/V crossing in the SRVP
(24,25). This suggests that the loss of MAPK signaling
might cause this phenotype. Therefore, we made use of our
stably wild-type or p.C95R Norrin expressing HEK293T cell
lines (Supplementary Material, Fig. S1) to monitor MAPK ac-
tivity. We found a 1.9-fold increase in MAPK signaling in
cells that express wild-type Norrin compared with those that
expressed the mutant, disease-associated variant (Fig. 5I, Sup-
plementary Material, Table S5).
Because of the above-described, strong SRVP phenotype in
Ndpy/2 mice, it was crucial to examine whether the VCs and
ACs exhibit characteristic molecular features of the respective
vessel types. Retinal flatmounts were stained either for endo-
mucin or for smooth muscle actin (SMA) at P7, P9, P12 and
P21. In both, wild-type and Ndpy/2 mice, endomucin stained
veins and venous portions while staining of arteries and arter-
ioles was less intense (Fig. 6, Supplementary Material, Fig. S4)
(32,33). Interestingly, the endomucin staining revealed super-
numerary thorn-like assembled central filopodia around veins
and capillaries of Ndpy/2 retinas (Fig. 6D and E). In contrast,
capillary sprouts were much less abundant and, if present,
much shorter in wild-type mice. Staining for the arterial and
MC marker a-SMA in wild-type mice specifically labeled
arteries at P7, P9 and P12 as well as arteries and large veins
at P21. In Ndpy/2 retinas, arteries, veins and capillaries were
covered with SMA-positive cells at P9, P12 and P21 (Fig. 7,
Supplementary Material, Fig. S5). Thus, MC recruitment to
the SRVP is abnormally increased in Ndpy/2 retinas.
DISCUSSION
Deficiency of Norrin is known to cause Norrie disease, a
severe X-linked recessive human disease characterized by
congenital blindness, progressive hearing loss and, in some
patients, mental retardation. We made use of a mouse model
which mimics the human disease in eye and ear and applied
morphometric analyses, Notch-inhibition by DAPT adminis-
tration, as well as cell proliferation assays to characterize the
angiogenic processes in the retina. We provide evidence that
Norrin is a mitogenic stimulus for cells in the SRVP. Consist-
ently, wild-type Norrin promotes E2F transcription factor-
mediated cell cycle progression in a cell culture assay.
Further, we identified endomucin as a marker for central filo-
podia, which were aligned in a thorn-like fashion at P9 in
Ndpy/2 mice. Finally, we found aberrant vascular SMA-
positive MC coverage of veins and capillaries in the SRVP
Figure 2. Effects of Notch signaling inhibition in wild-type and Norrin knockout mice. Pharmacological administration of DAPT increases vascular density at
the vascular front in wild-type and Ndpy/2 mice. The number of filopodia only increases in wild-type but not in Ndpy/2 mice upon DAPT treatment. (A–D)
Representative retinal whole-mounts stained with IB4 48 h after DAPT injection in P7 wild-type (WT) and Ndpy/2 (KO) animals. (E) Statistical analysis
shows that peripheral vascular density increases in both genotypes upon DAPT treatment. (F–I) Representative retinal whole-mounts of IB4 staining 48 h
after DAPT treatment of P7 wild-type (WT) and Ndpy/2 (KO) animals. Filopodia at the vascular front are visible. (J) Statistical analysis shows that number
of filopodia increases only after DAPT treatment in the WT but not in Ndpy/2 mice. P-values below a ¼ 0.05 were considered statistically significant. Scale
bars ¼ 100 mm.
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in Ndpy/2 mice which indicates abnormally increased MC re-
cruitment of the SRVP from Norrin KO mice.
Norrin and Notch signaling are not directly linked
We examined features of the SRVP in Ndpy/2 mice by quan-
tifying and comparing morphometric parameters (Figs 1 and 2,
Supplementary Material, Tables S1–S3) with published data
from different mouse models with retinal vascular phenotypes
(Table 1). We did not quantify later stages than P7 since the
outgrowth of the superficial plexus in wild-type mice ends
soon after this stage of development.
We noticed that the outgrowth of the SRVP is delayed in all
mouse models (Table 1), but incomplete vascular outgrowth
was only observed in mutants with disrupted canonical Wnt
signaling (Ndpy/2, Fzd42/2 and Lrp52/2). Both the deep
and intermediate retinal vascular plexuses (DRVP, IRVP)
are absent in mice with deficient Wnt signaling components
(Ndpy/2, Fzd42/2, Lrp52/2 and Tspan122/2) and in
Ang2LZ/LZ mice, but not in Notch signaling deficient mice
(Dll4+/2 or Jag1iDEC). The intermediate plexus is absent in
HIF1aDPax6 mice, while the deep plexus is present
(Table 1). We hypothesized that the canonical Wnt target
gene Jag1 might link Norrin-Wnt and Notch signaling
during development of the SRVP, since knocking out Ndp or
Jag1 leads to aberrant SRVP development. However, we
found significant differences in morphometric parameters
between Ndpy/2 and Jag1iDEC retinas, which are in conflict
with this hypothesis. The number of filopodia was increased
in Ndpy/2 and reduced Jag1iDEC mice. Jag1iDEC retinas also
do not display defects in deep vascular development (22)
which is a characteristic feature in Ndpy/2 retinas. All these
phenotypic differences suggest that there is no direct link
between Norrin-Wnt and Notch signaling via Jag1.
Inhibiting Notch signaling through systemic DAPT admin-
istration led to an increased vascular density in Ndpy/2 mice,
but it did not reduce the supernumerary filopodia. Further-
more, vascular density increased similarly in wild-type and
Ndpy/2 retinas after DAPT treatment, excluding a synergistic
effect (Fig. 2E). Accordingly, interaction effects were rejected
by univariate analysis of variance (data not shown). Although
the peripheral vascular network at the front is denser in DAPT-
treated Ndpy/2 mice (Fig. 2D), it still seems disorganized,
three-dimensional and not planar. This implies that Notch in-
hibition can induce a peripheral hyper angiogenic response in
Ndpy/2 mice but not re-establish normal vascular develop-
ment. The diameter of the peripheral blood vessels increased,
which might be due to involvement of Dll4-Notch signaling in
A/V differentiation, leading to a more pronounced venous
phenotype after DAPT injection and to an increase in vessel
diameter (Fig. 2A–D). The number of filopodia significantly
Figure 3. Decreased proliferation rate of ECs in Norrin knockout mice and
reduced cell cycle progression due to a mutation (p.C95R) in human Norrin.
Overall proliferation is reduced in Ndpy/2 mice at P6. Representative retinal
whole-mounts of wild-type (WT) (A and B) and Ndpy/2 mice (KO) (C and
D) were stained for blood vessels with IB4 (red) and for proliferating cells
after BrdU incorporation (green). (D) Local hotspots of proliferation within
thickened areas of the vascular front are occasionally seen in Ndpy/2 mice
and were excluded from quantification of proliferation. (E) Quantification of
proliferating vascular ECs after BrdU-incorporation revealed a reduced
proliferation rate (238%) in Ndpy/2 mice. (F) Expression of wild-type
Norrin (WT) leads to 5.6-fold increase in the proliferation rate in HEK293T
cells compared with cells expressing a mutant (p.C95R) human Norrin.
Average and confidence intervals are shown. P-values below a ¼ 0.05 were
considered statistically significant. Scale bars ¼ 100 mm.
Figure 4. Massive vessel regression at the bulky vascular front in Ndpy/2 mice
at P7. IB4 (green) and ColIV (red) co-stained retinal whole-mounts from wild-
type (WT) (A and B) and Ndpy/2 mice (KO) (C and D). ColIV+,
IB4-stainings represent empty membrane sleeves, where blood vessels have
regressed (white dots). Regression was increased at the bulky vascular front
in Ndpy/2 retinas (D). Scale bars ¼ 100 mm.
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increased in wild-type mice, but was unaltered in Ndpy/2
retinas upon DAPT administration (Fig. 2G, I, J).
Vascular remodeling in Norrin-deficient mice
We found enhanced vascular proliferation (Fig. 3) and also
enhanced vascular regression/remodeling (Fig. 4) at the
vascular bulky front in Ndpy/2 mice after BrdU injection
and by co-staining of ColIV and IB4. We interpret the
vessel regression of Ndpy/2 retinas as secondary effect
which ensures a planar vascular plexus at positions where
bulky vascular fronts were present before moving towards
the periphery. Disorganized vascular fronts are also present
in Fzd42/2, Lrp52/2 and Tspan122/2 retinas (12,13,34).
Figure 5. Blood vessel crossing in Norrin knockout mice. Arteries and veins often cross each other in Ndpy/2 retinas. Retinal whole-mounts of wild-type (WT)
(A–C) and Ndpy/2 mice (KO) (D–H) were stained with IB4 to label blood vessels (green A–F, or grey G + H). We noticed abundant A/V crossings at the
center (E, arrowheads) and periphery (F, arrowheads) of the SRVP from Ndpy/2 retinas. Note, that (E) represents the box indicated in (D). (G) and (H) are
confocal images from the blood vessels marked in (E), focused on the upper artery (G), and on the lower vein (H). The distance between both vessels is
3.58 mm. (I) Ectopic expression of wild-type Norrin (WT) leads to 1.9-fold increase in MAPK signaling in HEK293T cells compared with cells expressing
a mutant (p.C95R), disease-associated human Norrin. a, artery; ac, arterial character; v, vein; vc, venous character. Scale bars ¼ 100 mm.
Figure 6. Large central filopodia in Ndpy/2 mice at P9. Retinal whole-mounts from wild-type (WT) (A–C) and Ndpy/2 mice (KO) (D–F) were co-stained with
IB4 (green) to label blood vessels and with endomucin (red) which preferentially stains veins, venous vessels and central filopodia. (B) represents box in (A) and
(E) represents box in (D). Endomucin staining revealed that vessels with a venous character (vc) but not with an arterial character (ac) are laced with super-
numerary central filopodia. a, artery; v, vein. Scale bars ¼ 100 mm.
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Further, we observed extensive crossing of arteries and veins
(A/V) in Ndpy/2 retinas and we excluded an altered astrocytic
scaffold to be the reason for these observations (Supplemen-
tary Material, Fig. S2).
Loss of Norrin signaling might alter MAPK signaling
A/V crossing is a feature of all Norrin-Wnt signaling deficient
mice and also (12,13,16,24,25) the lack of the cytoplasmatic
Figure 7. Retinal veins and capillaries are abundantly covered by mural cells (MCs) in Ndpy/2 mice at P12. Retinal whole-mounts were co-stained with IB4 to
label blood vessels (green) and against SMA to label arteries covered by MCs (red). Only arteries were covered by MCs in wild-type (WT) retinas. In contrast,
arteries, veins and capillaries were covered by MCs in Ndpy/2 retinas (KO). a, artery; ac, arterial character; v, vein; vc, venous character. Scale bars ¼ 100 mm.
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domain of Nrp1 (Nrp1cytoD/D) or dosage-dependent reduction
in neuronal VEGF-A paracrine signaling (VEGF-ANES-CRE)
lead to A/V crossing (24,25). The receptor pair consisting of
VEGFR2 and Nrp1 triggers VEGF-mediated downstream
MAPK signaling. Thus, the existence of A/V crossing in
Ndpy/2 retinas and in retinas from VEGF-ANES-CRE and
Nrp1cytoD/D mice suggests that both pathways influence each
other. Supporting this, Norrin-stimulated cells have elevated
MAPK signaling activity compared with cells stimulated
with mutant Norrin (Fig. 5I). Similarly, we previously reported
MAPK signaling to be the major pathway influenced by
Norrin signaling according to transcriptome analyses using
microarray data from Ndpy/2 retinas (18). Therefore, it will
be intriguing to investigate the putative link between
Norrin-Wnt and VEGF/Nrp1/MAPK signaling.
Norrin stimulates mitogenic activity in retinal ECs
Since the loss of Norrin leads to delayed and incomplete out-
growth of the SRVP, we analyzed the mitogenic activity of
Norrin in mouse retinas and in cell culture using systemic
BrdU injection and reporter assays, respectively. The
reduced proliferation of IB4-positive ECs from the SRVP in
Ndpy/2 retinas, as revealed after BrdU injection, indicates
that Norrin might act as a mitogenic stimulus (Fig. 3). Add-
itionally, we monitored cell cycle progression by using the
pE2F luciferase reporter construct. As expected, HEK293T
cells, which endogenously express FZD4, LRP5 and
TSPAN12 but not Norrin, and ectopically express human
wild-type Norrin had an increased cell cycle progression com-
pared with ectopically p.C95R mutant Norrin expressing cells
(Fig. 3F). Consistently, Ohlmann et al. (35) observed, by using
a BrdU ELISA, that Norrin efficiently stimulates proliferation
of human retinal microvascular ECs in vitro in a
Wnt-dependent manner. Our findings together with the BrdU
ELISA suggest that Norrin might act as a mitogenic stimulus
on microvascular/capillary ECs of the SRVP (Fig. 3C). This
also can explain the delayed outgrowth of the SRVP. A key
to understand the complexity of the retinal vascular phenotype
in Ndpy/2 mice could be the differentiated view of events at
the angiogenic front and within the central plexus. Transient
peripheral phenomena like local hotspots of proliferation and
remodeling, thickening of the vasculature and supernumerary
filopodia could be interpreted as inability of vascular sprouts
to escape the existing plexus. Hence, filopodia-projecting tip
cells could be overrun by stalk cells, cluster and form the
observed bulky areas. The supposed explanation for the
Ndpy/2 superficial plexus phenotype is also supported by in
silico models of vascular network formation. Travasso et al.
(36) recently found, utilizing a mathematical model of sprout-
ing angiogenesis, that low tip cell motility leads to a sparsely
ramified plexus and increased stalk cell proliferation. Due to
the lack of long tip cell protrusions projecting into the avascu-
lar space ahead of the vascular front, also characteristic for
Ndpy/2 mice, stalk cells spend more angiogenic factors
which decrease its concentrations and inhibits branching.
The same study highlights that low overall EC proliferation
also leads to reduced vessel ramification, corroborating our
observations.
Veins and capillaries of Ndpy/2 retinas possess
supernumerary central filopodia
To investigate the properties of ACs and VCs, we stained
retinal whole-mounts against endomucin and SMA.
The surface of veins and capillaries in Ndpy/2 retinas was
laced with endomucin-positive filopodia instead of being
smooth and covered with none or very few filopodia as in
control mice. The abundance of central filopodia peaks
around P9, exactly when deep vascular sprouting in wild-type
mice occurs. Interestingly, deep sprouting exclusively origi-
nates from venous vessels and capillaries but not from arteries.
Therefore, it seems that veins and capillaries of the SRVP
from Ndpy/2 retinas are able to create misaligned central filo-
podia. However, these filopodia might not be functional, since
Ndpy/2 mice lack deep sprouting. It is also unclear which mo-
lecular mechanisms lead to those central supernumerary filo-
podia since published data focuses exclusively on the
regulation of tip cell filopodia.
Veins and capillaries of Ndpy/2 retinas are excessively
covered by MCs
Staining of retinal blood vessels for SMA revealed extensive
MC coverage of veins and capillaries from P9 onwards. This
coverage persists at least till P21. We previously reported
upregulation of PDGFb and PDGFRb within the same time-
frame (14). Interaction of all these genes regulates MC recruit-
ment. Here, overexpression of PDGFb and its receptor
(PDGFRb) could stimulate MC recruitment and the missing
upregulation of Ang1 on MCs might prevent restriction of
MC recruitment. Considering this as the likely mechanism
of the excessive MC recruitment, we believe that this might
be a response to vessel leakiness caused by upregulation of
VEGF-A and PLVAP (14,18) due to hypoxia. Currently, it is
unclear if this extensive MC recruitment goes along with a
gain of AC in the affected veins and venules. If so, the gain
in arterial or loss of VC could explain the disability to form
the DRVP out of the SRVP from Ndpy/2 retinas, since deep
sprouts emerge exclusively from venous vessels and capillar-
ies of the SRVP (37). The fact that we still can morphologic-
ally distinguish ACs and VCs and that we detected
supernumerary endomucin-positive central filopodia on
veins, venules and capillaries, but not on arteries, argues
against a complete loss of the VC. However, the formation
of uncoordinated central endomucin-positive filopodia at P9
and the excessive MC recruitment of venous vessels may indi-
cate at least a partial loss of venous identity of the respective
ECs with the consequence that central tip cells might develop,
but being unable to induce proper deep sprouting.
The morphometric analysis together with results from the
DAPT injections does not suggest a direct link between
Norrin-Wnt and Notch signaling via Jag1. Our results
suggest that Norrin is a mitogenic stimulus for IB4-positive
ECs of the SRVP which explains its delayed outgrowth in
Ndpy/2 mice. The A/V crossing occurs unlikely due to a dis-
turbed astrocyte–EC interaction and it is unclear if the
altered basal membrane of the SRVP contributes to this
effect. We found that Norrin is able to stimulate MAPK sig-
naling and also previously reported that MAPK signaling
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might be the primarily altered pathway in Norrin KO retinas.
All this together with the A/V crossing phenotype suggests
that MAPK signaling might be significantly altered in Norrin
KO retinas. We also found excessive MC coverage of veins,
venules and capillaries in Ndpy/2 retinas which might indicate
a partial loss of venous identity but also contribute to the ap-
pearance of the altered basal lamina and possibly to the ap-
pearance of the thorn-like supernumerary central filopodia.
Postnatal stages after P7 in mice mimic developmental
stages from patients when hypoxia increases and leads to
pathologic alterations of various retinal angiogenic maturation
processes. These data are crucial for the investigation of
related diseases, like familial exudative vitreoretinopathy or
Coats’ disease, with a less severe phenotype than Norrie
disease, which have a realistic chance for the development
of treatment regimens.
MATERIALS AND METHODS
Animals
Generation of the Ndpy/2 mouse line has been described else-
where (4). The research was performed in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research and was approved by the Veterinary Office
of the State of Zurich (Switzerland).
Immunohistochemical staining
Retinas for whole-mount immunohistochemistry were fixed in
4% paraformaldehyde for 2 h or overnight at 48C. After fix-
ation, retinas were blocked using 1–10% normal goat or
rabbit serum (VectorLabs) in PBST and subsequently incu-
bated overnight with biotinylated IB4 (1:200; VectorLabs).
The following primary antibodies were diluted in 1–5%
serum in PBST and incubated over night: aSMA-CY3
(1:500; Sigma), ColIV (AbD serotec, 1:200), PDGFRa
(R&D Systems, 1:500) and Endomucin (R&D Systems,
1:100). For secondary detection, Alexa Fluor streptavidin con-
jugates (Molecular Probes, 1:100) or anti-goat/rabbit Alexa
Fluor-coupled secondary antibodies (Invitrogen, 1:500) were
used. Retinas were washed five times with PBS, flat
mounted and analyzed under bright-light illumination with a
microscope (Axioplan 2, AxioCam HRc; Carl Zeiss) equipped
with ApoTome (Carl Zeiss) or by confocal imaging using the
CLSM Leica SP2 inverse microscope (Leica). The protocol
from Pitulescu et al. (46) was used to stain for proliferating
ECs (BrdU staining).
Image processing
Image J 1.44p (NIH) and Photoshop CS5 (Adobe) software
were used for image processing. Overall image brightness
was adjusted in a linear fashion on whole images if it was ne-
cessary to improve picture quality for prints. These adjust-
ments did not influence interpretation and are in concert
with suggestions for image processing in reference (38).
Results shown were obtained by performing at least two dif-
ferent independent experiments including at least four
mutant or control animals per stage.
Morphometric analysis of retinal flatmounts
Each morphometric parameter was determined by averaging
over four non-overlapping images per retina (one retina used
per animal) with a minimum of four animals per group. Vas-
cular density was determined by measuring the endothelial
coverage per 300 × 300 mm field at the vascular front. The
number of branch points was determined by counting vessel
branch points within 300 × 300 mm fields. The number of filo-
podia at the vascular front within 68 × 51 mm fields was
counted and normalized to 100 mm length of vasculature.
BrdU-positive endothelial nuclei were counted in 424 ×
317 mm fields at the vascular front and normalized to endothe-
lial coverage within the same field (21).
In vivo Notch inhibition
Notch signaling was inhibited by subcutaneous injection
of 0.3 mg/g body weight N-[N-(3,5-Difluorophenacetyl-
L-alanyl)]-S-phenylglycine t-butylester (DAPT, Merck)
dissolved in 10% ethanol and 90% peanut oil. DAPT solution
was injected twice at P5 and P6. Retinas were collected at P7.
Control litters were injected with vehicle only. Seven litters
were DAPT injected. Quantification of vascular density and
number of filopodia in DAPT-treated versus untreated KO
and WT mice were performed as described above (23).
Quantification of Norrin-dependent proliferation and
MAPK signaling in vitro
Stably wild-type or mutant p.C95R Norrin expressing
HEK293T cells were used in these assays. Equal expression
levels of wild-type and mutant Norrin were determined by
western blot analysis (data not shown). To examine the prolif-
eration rate or MAPK signaling activity, 8 × 104 cells/well of
a 24-well plate were seeded and incubated at 378C/5% CO2
overnight. Cells were transiently co-transfected with pE2F or
pSRF firefly luciferase reporter and pRenilla constructs
(SABiosciences) using the calcium precipitation method
(39,40). Luciferase activity was measured using DualGlo-
LuciferaseReporterAssaySystem (Promega). Firefly luciferase
activity was normalized to co-transfected Renilla luciferase.
Statistical analysis
Statistical analysis was performed in SPSS 18.0 (IBM) using
two-tailed unpaired Student’s t-test.
Quantitative data from DAPT-injection experiments were
processed with univariate analysis of variance with two inde-
pendent variables. Avoiding bias due to unequal sample sizes,
the estimated marginal means were calculated instead of arith-
metically means. P-values below a ¼ 0.05 were considered
significant.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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Supplementary data 
 
 
 
Supplementary Fig 1 HEK293T cells endogenously express Norrin receptors but no Norrin and the 
quantity of ectopic expression of wildtype and p.C95R Norrin in HEK293T cells is the same in both cell 
lines. (a) HEK293T cells used for this assay endogenously express FZD4, LRP5, TSPAN12 but no NDP. 
(b) Western blot analysis from protein extracts of HEK293T cells that express either wildtype (WT) or 
p.C95R (p.C95R) mutant Norrin or Mock (HEK293T). The arrow indicates the respective Norrin which 
appear slightly above 17 kDa.   
 Supplementary Fig 2 Alignment of endothelial cells and astrocytes. Astrocyte/endothelial cell alignment 
is not altered in Ndphy/- mice at P7. Blood vessels of wildtype (WT) (a-f) and Ndphy/- retinas (KO) (g-l) 
were stained with isolectin B4 (IB4) to label blood vessels (green) and against PDGFRα to label 
astrocytes (red). Astrocytes align around the covering blood vessels in WT and KO mice. The density of 
the retinal astrocytic network at the avascular front is similar in Ndphy/- and wildtype retinas (m,n). Scale 
bar = 100 μm. 
 Supplementary Fig 3 Vessel crossing in norrin knockout mice. Arteries and veins often cross each other 
in Ndphy/- retinas between P7 and P21. Retinal wholemounts of wildtype (WT) (a-l) and Ndphy/- mice 
(KO) (m-w) were stained with isolectin B4 (IB4) to label blood vessels (green). We noticed abundant 
artery/vein crossing at the center (q, s, t) and in the periphery (u, v, w) of the superficial retinal vascular 
plexus from Ndphy/- retinas. a = artery, ac = arterial character, v = vein, vc = venous character. Scale bars 
= 100 µm 
 Supplementary Fig 4 Ndphy/- mice display small central filopodia at P12 and P21. Retinal flatmounts 
from wildtype (WT) (a-h) and Ndphy/- mice (KO) (i-r) were co-stained with isolectin B4 (IB4, green) to 
label blood vessels and with endomucin (red), which preferentially stained veins, venous vessels and 
central filopodia. (q) represents box in (l), (r) represents the box in (p). Endomucin staining revealed that 
vessels with venous character (vc) but no vessels with an arterial character (ac) are laced with small 
supernumerary central filopodia at P12 and P21 but not at P7. At P21, vessels grew above the superficial 
retinal vascular plexus resembling fibrosis. Fibrous vessels with vc but not ac were also laced with small 
filopodia (l, p, q, r). a = artery, v = vein. Scale bars = 100 µm. 
 
 Supplementary Fig 5 Increased smooth muscle cell coverage of retinal veins and capillaries in norrin 
knockout mice. Retinal veins and capillaries are abundantly covered by vascular smooth muscle cells 
(vSMCs) in Ndphy/- mice at P9 and P21. Retinal flatmounts were co-stained with isolectin B4 (IB4) to 
label blood vessels (green) and against smooth muscle actin (SMA) to label arteries covered by vSMCs 
(red). Arteries were covered by vSMCs in wildtype (WT) retinas at P7 and P9 and arteries and veins at 
P21. In contrast, arteries, veins and capillaries were covered by vSMCs in Ndphy/- retinas (KO) between 
P9 and P21. At P21, some areas of the superficial retinal vascular plexus (SRVP) are abundantly 
overgrown with blood vessels resembling fibrosis (m, r). Overgrowth with blood vessels is prevented in 
other areas of the SRVP (l, q). These areas display drum stick like elongations that are entirely covered by 
vSMCs (arrowhead). a = artery, ac = arterial character, v = vein, vc = venous character. Scale bars = 100 
µm. 
Supplementary Table 1  Morphometric data from wildtype and NDPhy/- retinas 
 wildtype retinas NDPhy/- retinas 
P5 
Number of filopodia 23 ± 2 (n=5) 32 ± 5 (n=6; p-value = 0.001) 
Vascular density 42 ± 5 (n=5) 30 ± 4 (n=5; p-value = 0.002) 
Number of branchpoints 30 ± 1 (n=5) 14 ± 3 (n=5; p-value <0.0001) 
P7 
Number of filopodia 21 ± 3 (n=4) 29 ± 2 (n=7, p-value <0.0001) 
Vascular density 48 ± 4 (n=5) 32 ± 3 (n=7; p-value = 0.0006) 
Number of branchpoints 89 ± 7 (n=5) 47 ± 8 (n=7; p-value <0.0001) 
average ± standard deviation are reported; n= number of retinas; 
Supplementary Table 2 Filopodia angle 
 wildtype retinas  NDPhy/- retinas 
Filopodia angle in ° 62.6 ± 29.0 (n=109) 51.0 ± 24.7 (n=109; p-value=0.002) 
average ± standard deviation are reported; n= number of filopodia;  
Supplementary Table 3 Quantification of morphometric parameters from wildtype and NDPhy/- mice 
after DAPT injection 
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+DAPT 
WT -DAPT KO +DAPT KO -DAPT 
WT 
+DAPT 
36 ± 7 
(n=6) 
p-value = 0.012 p-value =0.022  
WT -DAPT  21 ± 3 (n=4)  p-value = 0.025 
KO 
+DAPT 
  27 ± 5 (n=6) p-value = 0.279 
(N.S.) 
KO -DAPT    30 ± 4 (n=4) 
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WT -DAPT KO +DAPT KO -DAPT 
WT 
+DAPT 
72 ± 6 
(n=6) 
p-value = 0.00005 p-value = 0.149 
(N.S.) 
 
WT -DAPT  46 ± 5 (n=4)  p-value = 0.323 
(N.S.) 
KO 
+DAPT 
  66 ± 8 (n=6) p-value = 0.00067 
KO -DAPT    42 ± 5 (n=4) 
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WT -DAPT KO +DAPT KO -DAPT 
WT 
+DAPT 
87 ± 3 
(n=6) 
p-value = 0.075 
(N.S.) 
p-value = 0.00002  
WT -DAPT  83 ± 1 (n=4)  p-value = 0.00003 
KO 
+DAPT 
  70 ± 5 (n=6) p-value = 0.022 
KO -DAPT    62 ± 2 (n=4) 
average ± standard deviation are reported; n= number of retinas;  
Supplementary Table 4 Cell cycle progression 
 WT norrin  p.C95R norrin 
Cell cycle progression 5.60 ± 0.61 (n=3) 0.99 ± 0.07 (n=3; p-value=0.00021) 
average ± standard deviation are reported; n= number of technical replicas;  
 
 
Supplementary Table 5 MAPK activity 
 WT norrin  p.C95R norrin 
MAPK activity 1.00 ± 0.040 (n=3) 0.53 ± 0.052 (n=3; p-value=0.00023) 
average ± standard deviation are reported; n= number of technical replicas;  
 
 
3.2  Establishing calcium phosphate precipitation transfection method 
Before starting animal experiments, we investigated the interaction between Norrin-Wnt and 
Norrin-Notch signaling in HEK293T cells. The HEK293T cells used did not endogenously express NDP 
but FZD4, LRP5 and TSPAN12 (Master Thesis of Jurian Zuercher, 2007). The following section 
describes results obtained while establishing the pathway reporter assays and obtained from Norrin 
interaction assays. First, transfection parameters for the calcium phosphate precipitation method 
were established.  
A prerequisite to perform luciferase assays is an efficient transfection. A widely used transfection 
method for HEK293T cells is the calcium phosphate precipitation (Jordan et al., 1996; Jordan et al., 
2004). To establish a protocol for 24-well plates, a constitutive enhanced green fluorescent protein 
(GFP) expressing vector was applied in amounts ranging from 300 to 1500 ng/well according to 
conditions described under Methods (Figure 18). The achieved transfection efficiency was visually 
estimated to be 90% to 95% if 1500 ng eGFP vector were transfected per well (Figure 18). 
 
Figure 1: High transfection efficiency in HEK293T cells is achieved using the calcium phosphate precipitation 
method. a - d) 5*104 cells were incubated at 37°C/ 5%CO2 for 24 h and transfected with 1500 ng pGFP 
construct. Pictures of the same well were taken 48h (a, b) and 72h (c, d) post transfection. Transfection 
efficiency was visually estimated to be 90% to 95%. GFP = green fluorescent protein; DIC = differential 
interference contrast. 
 
3.3 Establishing Wnt reporter assay 
We used the pTopflash reporter construct to analyze Norrin-Wnt activity. The pTopflash harbors six 
TCF/LEF binding sites in front of a firefly luciferase gene. Therefore expression of firefly luciferase is 
Wnt activity dependent in pTopflash. Renilla luciferase was constitutively expressed and served as 
internal standard. Wnt activity was expressed as ratio of firefly/renilla luciferase activity. Additionally 
we co-expressed FZD4 and LRP5 during assay (Smallwood et al., 2007; Xu et al., 2004). Wnt reporter 
assays were optimized for transiently and stably Norrin expressing HEK293T cells. Mouse Wnt3A and 
lithium chloride (LiCl) served as positive controls, sodium chloride (NaCl) was used as negative 
control. 
3.3.1 Wnt-reporter assay for transiently Norrin expressing HEK293T cells 
Lithium chloride (LiCl) is an inhibitor of the canonical Wnt signaling inhibitor GSK3 and therefore 
activates Wnt signaling by disinhibition. First, 5, 10, 15 and 25 mM LiCl per well were applied to 
HEK293T cells transfected with pTopflash and pRenilla to monitor LiCl dependend activation of the 
pTopflash. Natrium chloride (NaCl) served as a negative control and was applied at the highest 
concentration tested. Readout was performed after 24 h of incubation (Figure 19a). LiCl activated 
pTopflash concentration dependent, but NaCl did not trigger Wnt activity.  
Next we wanted to monitor the Wnt activity of wildtype and mutant Norrin constructs from our lab. 
Therefore, Norrin constructs, pTopflash, pRenilla, pFZD4 and pLRP5 were co-transfected and 
analyzed 72 hours later. Wildtype Norrin activity was arbitrary set to 1 (Figure 19b). We found that 
only wildtype Norrin (Norrin) but none of the mutant Norrin variants (p.C95R, p.C96W, p.R121W, 
p.R121L) was able to trigger canonical Wnt signaling. 
Heparin might enhance binding of Norrin to its receptor FZD4 (Smallwood et al., 2007). We tested if 
addition of heparin to the assay would ameliorate Wnt reporter assay performance (Figure 19c). 
Wnt3A expression served as positive control. We compared Wnt signaling activity between wildtype 
and p.C95R mutant Norrin and detected significant differences with or without addition of heparin. 
Nonetheless, addition of heparin led to enlarged confidence intervals, rendering the assay less 
robust. Therefore we relinquished to add heparin for future assays. 
Tspan-12 was identified as a novel co-receptor for Norrin (Junge et al., 2009) and therefore we 
wanted to investigate if co-expression of TSPAN12 would ameliorate the readout of our Wnt 
reporter assay. For that, we co-expressed the indicated receptors together with pTopflash and 
pRenilla in wildtype or p.C95R Norrin expressing HEK293T cells (Figure 19d). We saw that FZD4 and 
LRP5 expression are crucial for the Wnt reporter assay, but additional expression of TSPAN12 has no 
influence on its performance. 
 
Figure 2: Establishing Wnt reporter assay for transiently Norrin expressing HEK293T cells. a) LiCl is able to 
activate the Wnt reporter in a dose dependent manner. NaCl did not activate Wnt reporter. b) Only 
transient expression of wildtype Norrin (Norrin) but none of the mutant Norrin variants (p.C95R, p.C96W, 
p.R121W, p.R121L) was able to activate the Wnt reporter. c) Wildtype Norrin without or with 5µl 
heparin/well was able to significantly trigger Wnt signaling compared to mutated Norrin (p.C95R). But 
robustness of the assay decreased upon addition of heparin visible by enlarged confidence intervals. Wnt3A 
was used as a positive control. d) Co-expression of TSPAN12 does not ameliorate the readout of the Wnt 
reporter assay. Average and confidence intervals are displayed. P-values below α=0.05 were considered 
statistically significant (*). 
 3.3.2 Wnt-Reporter assay for stably Norrin expressing HEK293T cells 
HEK293T cells with stable expression of wildtype Norrin and a mutant variant (p.C95R)(Master 
Thesis, Lucas Mohn, 2007), which is associated wit Norrie disease as well as non-Norrin expressing 
HEK293T cells (MOCK, generated by Stephan Labs by stable transfection of empty pBUD CE4.1 
vector) were co-transfected with pTopflash, pRenilla, pFZD4 and pLRP5 and analyzed 48 hours later. 
LiCl and NaCl served as positive and negative controls, respectively (data not shown)(Figure 20). Wnt 
activity of MOCK cells was arbitrary set to 1. Wnt signaling activity was induced in wildtype but 
reduced in p.C95R Norrin expressing HEK293T cells. 
 
Figure 3: Activation of canonical Wnt signaling in HEK293T cells with stable expression of wildtype or mutant 
Norrin. Values were normalized on MOCK samples. Wildtype Norrin expressing cells (Norrin) showed an 
increased, mutant Norrin (p.C95R) expressing cells showed a decreased Wnt signaling activity compared to 
MOCK cells. Average and confidence intervals are displayed. P-values below α=0.05 were considered 
statistically significant (p-value < 10-5). 
HEK293T cells stably expressing Norrin isoforms showed an improved performance of the Wnt 
reporter assay compared to those with transient expression, as reflected by reduced incubation time 
and higher firefly/renilla ratios in the raw data (data not shown). Therefore we only used stable 
Norrin isoform expressing HEK293T cells for further experiments. 
3.4 Analysis of Norrin-Wnt and Norrin-Notch signaling interactions in 
HEK293T cells 
We wanted to monitor the effect of Norrin on Notch1 mediated signaling and additionally elucidate 
the effect of the interaction between disheveled 1, 2 and 3 and notch1 intracellular domain (N1ICD) 
on Notch and Wnt signaling (Figure 21). Overexpression of N1ICD did not trigger Notch signaling in 
stable wildtype Norrin (Norrin) expressing HEK293T cells, in contrast, Notch signaling was triggered 
in p.C95R Norrin (p.C95R) expressing and MOCK cells (Figure 21a). Activation of Notch activity was 
impeded if Dvl1, Dvl2 or Dvl3 were co-expressed with N1ICD (Figure 21b). N1ICD was able to 
downregulate Dvl1, Dvl2 or Dvl3 mediated Wnt signaling (Figure 21c, d, e). 
 
Figure 4: Wildtype Norrin is able to downregulate Notch1 mediated signaling in HEK293T cells. (a) 
Overexpression of N1ICD did not trigger Notch activity in wildtype Norrin expressing HEK293T cells. In 
contrast, Notch activity was triggered by N1ICD overexpression in p.C95R or non-Norrin (MOCK) expressing 
HEK293T cells. (b) Dvl1, Dvl2 and Dvl3 were able to downregulate N1ICD mediated Notch signaling in 
HEK293T cells. (c, d, e) N1ICD is able to downregulate Dvl1, Dvl2 or Dvl3 mediated Wnt signaling. Average 
and confidence intervals are displayed. P-values below α=0.05 were considered statistically significant.  
 
3.5 Analysis of Norrin-Notch signaling interaction in mouse retina 
Ndphy/- mice were crossed with Notch reporter mice (Tg(Cp-EGFP)25Gaia/J, TNR1 mice, (Hellstrom 
et al., 2007a; Hellstrom et al., 2007b) to monitor Notch activity in Ndphy/- retinas. The Notch activity 
pattern in wildtype males looked random (Figure 22). Therefore no comparison between wildtype 
and Ndphy/- retinas was done and the breeding of mice was stopped. 
 
Figure 5 : Notch pathway analysis of Ndph+/+ x TNR1 wildtype (WT) mice at P7. Blood vessels were stained 
using isolectin B4 (IB4, red) and Notch activity was detected using an anti green fluorescent (GFP) antibody 
(green). Central (a-c) and peripheral (d-f) sections of a retinal wholemount from a wildtype male mouse are 
shown. The activation pattern looks random and unspecific. Scale bar = 100 µm. 
 3.6 Influence of Norrin on TGFβ signaling, ER stress and Estrogen 
response 
We replaced the pTopflash by different reporter constructs to investigate influence of Norrin on 
other pathways (Figure 23). We used pSMAD to monitor TGFβ signaling and found reduced TGFβ 
activity in cells expressing wildtype Norrin. ER stress was elevated in cells expressing the mutated 
p.C95R Norrin isoform, as monitored by using the pERSE reporter construct. Estrogen response was 
reduced in cells expressing the mutated p.C95R Norrin isoform, monitored by pERE reporter 
construct. 
 
Figure 6: Wildtype Norrin reduces TGFβ and enhances estrogen response, while mutated p.C95R Norrin 
enhances ER stress. An independent samples T-test was used to analyze the data. Average and confidence 
intervals are shown. P-values below α=0.05 were considered statistically significant. P-values are: TGFβ = 
0.001, ER stress = 0.002 and estrogen response = 0.00003. 
3.7 Quantification of Notch target genes after Norrin expression in 
HEK293T cells 
We checked if Norrin expression would alter expression of Notch target genes Hes1, Hes2, Hes5, 
Hey1 or Hey2 in HEK293T cells. Therefore we transiently expressed wildtype Norrin during 72 hours 
in HEK293T cells (Norrin). Empty vector transfected cells served as control (MOCK) (Figure 24). Only 
Hey1 expression was significantly increased upon Norrin expression. 
  
Figure 7: Expression of Norrin leads to an increase of Hey1 expression in HEK293T cells. Hes1, Hes5 and Hey2 
expression was not altered and Hes2 was not expressed nor induced after Norrin expression in HEK293T 
cells. Hey1 expression was doubled upon Norrin expression. Average and confidence intervals are shown. P-
values lower than α=0.05 were considered statistically significant (*). P-value of Hey1 is 0.0023. 
The focus of the next section is on experiments using the Ndphy/- mouse. Some of the results were 
discussed in the publication (see 3.1). Only results that were not included in the manuscript are 
reported below. 
3.8 Analysis of the retinal vascular phenotype in Ndphy/- mice 
3.8.1 Establishing weight control table for Ndphy/- and wildtype littermates 
Vascular defects affect normal development in mice. Consequences can be dwarfish appearance and 
reduced body weight of mice pups. Therefore, we quantified body weight of all mice pups and 
subsequently analyzed data using SPSS (IBM, New York, USA). For that, eight mice litters per stages 
at P5, P7, P9, P12 and P21 were weighted and statistically analyzed. Mice weights were plotted in 
following groups (Figure 25): 
• Weight differences depending on sex and postnatal age (Figure 25a) 
• Weight difference depending on genotype and postnatal age (Figure 25b) 
• Weight differences between different mice litters of a certain postnatal age (Figure 
25c) 
• Average body weight of mice dependent on postnatal age (Figure 25d) 
 
 
Figure 8: Sex or genotype of mice have no influence on their weight between P5 and P21, but litter 
affiliation matters. (a) Sex of mice has no influence on their weight during development from P5 to P21. (b) 
The genotype of mice has no influence on their weight during development from P5 to P21. (c) Eight litters 
per stage were analyzed. The average weight between mouse litters of the same postnatal age can differ 
significantly from each other. (d) The average weight of mice per postnatal age was calculated averaging 
eight randomly selected mice litters (see c). Average and confidence intervals are displayed. P-values (not 
shown) lower than α=0.05 were considered statistically significant. 
Sex or genotype at the Ndph locus of the C57BL/6J mice did not influence body weight during 
postnatal development between day 5 to 21 (Figure 25a, b). In contrast, the average weight of mice 
significantly differed between litters of the same stage (Figure 25c). Nevertheless, we calculated the 
average weight of mice depending on the stage pooling weights from all males, females and 
genotypes (Figure 25d). Exact statistical values are given in Appendix 3. 
3.8.2 Inhibition of Notch signaling partially rescues delayed outgrowth of the SRVP 
Comparison of vascular length between DAPT and non treated wildtype and Ndphy/- littermates 
revealed a significant increase in vascular length in Ndphy/- but not in wildtype mice at postnatal day 
6 (Figure 26).  
 
Figure 9: Inhibition of Notch signaling by administration of DAPT at P6increases vascular length in Ndphy/- 
(KO) but not in wildtype (WT) retinas. (a-d) Retinal whole-mounts stained with isolectin B4 to visualize blood 
vessels. Vascular length between untreated (a) and DAPT treated (b) wildtype animals did not increase 
significantly (e). In contrast, vascular length between untreated (c) and DAPT treated (d) Ndphy/- animals 
increased significantly (e). P-values below α=0.05 were considered to be statistically significant. Scale bar = 
100 µm. 
3.8.3 The bulky front of the SRVP from Ndphy/- mice shows enhanced Dll4 expression 
We continued staining of SRVP from Ndphy/- and wildtype littermates against the Notch1 ligand Dll4 
(Figure 27) and found elevated Dll4 expression levels at bulky vascular fronts in the SRVP of Ndphy/- 
retinas. 
 
Figure 10: The vascular plexus and the bulky front of Ndphy/- mice show enhanced Dll4 protein expression. 
Wildtype (WT) and Ndphy/- (KO) retinas were co-stained at P7 (a, b, e, f, i, j, m, n) and P9 (c, d, g, h, k, l, o, p) 
with isolectin B4 (IB4, green) and an anti-Dll4 antibody (Dll4, red). Arteries (b, j; arrowheads) and the 
vascular front were Dll4 positive in wildtype and Ndphy/- retinas at P7. At P9, no Dll4 staining was detectable 
on arteries or on the vascular plexus from wildtype retinas (d, h), but in contrast, Dll4 was still expressed on 
arteries (k, l; arrowheads) and at the vascular front on Ndphy/- mice. Scale bars = 50 µm.  
  
3.8.4 The number of hyaloid vessel-associated macrophages persists between P7 and 
P12 in Ndphy/- retinas 
Next we wanted to quantify the number of macrophages which are associated with hyaloid vessels. 
Therefore retinal whole-mounts were prepared without removing the hyaloid vessels. The whole-
mounts were co-stained against induction of brown adipocytes 1 (Iba1) and IB4 to visualize 
macrophages and blood vessels, respectively (Figure 28). We saw that hyaloid vessels regressed in 
both phenotypes, but that regression was dramatically delayed in Ndphy/- mice (Figure 28 a, b, c, j, k, 
l). The number of macrophages decreased with progressing regression in wildtype retinas (Figure 28 
d-i, s) but was not reduced  in Ndphy/- mice between P7 and P12 (Figure 28 g-i vs. m-r, s). 
 
Figure 11: Hyaloid regression is delayed in Ndphy/- mice and the number of hyaloid vasculature associated 
macrophages persists between P7 and P12. Retinal whole-mounts of wildtype (WT, a-i) and Ndphy/- (KO) 
mice (j-r) were double-stained with an antibody against IBA1 (red) and with IB4 (green) to label 
macrophages and blood vessels at P7, P9 and P12. The number of macrophages decreased in wildtype 
retinas from P7 to P12 but not in knockout retinas (s). Average and confidence intervals are shown. P-values 
below α=0.05 were considered statistically significant. Scale bar = 100 µm. 
 
3.8.5 LiCl administration does not rescue deep vascular sprouting in Ndphy/- mice 
We wanted to see if injection of LiCl, an activator of canonical Wnt signaling, might restore proper 
DRVP formation and deep sprouting in Ndphy/- mice. For that, LiCl was injected into mouse litters 
subcutaneously from P5 for five subsequent days with increasing doses of LiCl dissolved in PBS (see 
methods). Doses were weight adjusted and always 25% of lethal doses for adult C57BL/6J mice 
(Smith1978). Two litters were injected (Table 2). Litter 1 pups were above average weight at P5. 
Therefore higher doses of LiCl were injected at P6 and P7. Litter 2 pups were at average weight, 
therefore standard doses were injected each stage. One mouse in litter 1 lost weight at P7 and died 
at P8. A second mouse of the same litter died at P10. Because of that, injections were stopped at P8. 
Mice of litter 2 only moderately gained weight and many started to die at P8. 
Table 1: Monitoring of gain in body weight of  LiCl injected pups 
 Weight of animals [g] 
 P5 P6 P7 P8 P9 P10 
Litter 1 4 4.4 5.1 5.6 5.7 n.a. 
 4.1 5.4 5.2 5.7 5.3 n.a. 
 3.7 4.4 5.2 5.3 5.5 n.a. 
 3.7 4.7 5.1 5.7 4.1 dead 
 3.8 4.1 3.8 dead dead dead 
Average weight [g] 3.86 4.6 4.9 5.7 5.2 n.a. 
Dose injected P5 P8 P8 - - - 
       
 Weight of animals [g] 
 P5 P6 P7 P8 P9 P10 
Litter 2 2.3 2.5 3.7 dead dead dead 
 2.3 3.0 2.8 dead dead dead 
 2.3 2.6 3.6 dead dead dead 
 2.4 2.7 3 dead dead dead 
 2.4 3.0 3.1 dead dead dead 
 2.1 2.3 3.1 n.a. dead dead 
 2.5 2.9 3.1 n.a. dead dead 
 2.4 3.0 3.2 n.a. dead dead 
 2.3 2.4 3.2 n.a. dead dead 
 2.3 2.7 2.2 n.a. n.a. dead 
 2.1 2.8 2.1 n.a. n.a. dead 
 2.4 3.1 1.9 n.a. n.a. n.a. 
Average weight [g] 2.3 2.8 2.9 n.a. n.a. n.a. 
Dose injected P5 P6 P7 - - - 
n.a.= not available 
We took the eyes of the mice that survived and prepared retinal whole-mounts (Figure 29). Two 
were knockout males, three were wildtype females and one was a heterozygous female. 
 
Figure 12: Retinal whole-mounts at P12 from wildtype (WT) and Ndphy/- (KO) mice injected with LiCl form P5 
to P8. Retinal whole-mount of an Ndphy/- male (a), and of a wildtype female (b) mouse retina. Blood vessels 
were stained with isloectin B4 (IB4, red). The heterozygous female plexus was identical to the ones from 
wildtype males (not shown). Scale bar = 1000 µm.  
We did not see any gross difference of blood vessels of the SRVP in LiCl injected retinas from 
knockout males (Figure 29a) or wildtype females (Figure 29b) compared to uninjected animals (data 
not shown). No initiation of deep vascular sprouting was visible in LiCl treated Ndphy/- retinas. 
4. Discussion 
This thesis primarily aimed in investigating a putative role of Norrin as a Notch signaling inhibitor.  
For that we measured Dvl-N1ICD interaction and quantified the differential expression of Notch 
target genes Hes1, Hes2, Hes5, Hey1 and Hey2 in vitro. In mice, we conducted IHC of Dll4, Jag1 and 
a-SMA on retinas and systemically inhibited Notch signaling by DAPT injection. Finally we compared 
morphometric data from Ndphy/- with Jag1iΔEC and Dll4-/- mice. Considering all the results, we 
concluded that Norrin signaling does not interact with Notch signaling during the formation of the 
SRVP in mice. 
We found artery/vein crossing, which, together with results from a Norrin-MAPK luciferase reporter 
assay suggests that MAPK signaling might be significantely altered during the development of the 
SRVP in Ndphy/- mice. We could show that the lack of Norrin leads to decreased proliferation of ECs 
from the SRVP which could explain the delayed outgrowth of the SRVP observed in Ndphy/- mice. 
We also found excessive mural cell coverage of veins, venules and capillaries in Ndphy/- retinas which 
might indicate a partial loss of venous identity. Further, we identified endomucin as a marker for 
thorn-like aligned central filopodia in Ndphy/- mice. 
In contrast to wildtype retinas, we found a constant number of hyaloid associated macrophages 
between P7 and P12 in Ndphy/- mice. This may suggests that the hyaloid vessel might fail to regress 
despite a sufficient number of macrophages present. 
4.1 Establishing the luciferase assay 
The Calcium phosphate precipitation transfection method in HEK293T cells has proven to be efficient 
to perform luciferase based reporter assays. This method was also found to be very efficient for the 
transfection of COS7 cells (data not shown).  
LiCl has been shown to be a reliable and cheap positive control for Wnt luciferase assays (Figure 
19a). It should be applied at concentrations of 15 or 25 mM 24 hours before measurement. The 
negative control, NaCl, is applied in similar concentrations for the same period of time. pWnt3A is a 
second, also very reliable positive control and can be co-transfected between 24 and 72 hours 
during the assay (Figure 19c). Commercially available Wnt3A protein (R&D Systems, Minneapolis, 
USA) is also suitable as positive control and can be applied with 300 ng/well 24 hours prior to 
measurement (data not shown). 
The plasmids which were used by Lucas Mohn to generate stably Norrin or mutant Norrin isoform 
expressing HEK293T cells were tested for their ability to activate canonical Wnt signaling in the Wnt 
reporter assay by transiently expressing them for 72 hours in HEK293T cells (Figure 19b). As 
expected, only wildtype Norrin was able to trigger canonical Wnt signaling but none of the mutant 
Norrin isoforms. Addition of heparin rendered the assay less robust, indicated by enlarged 
confidence intervals (Figure 19c). Therefore addition of heparin during Norrin-Wnt reporter assays is 
not recommended.  
It was known from literature (Smallwood et al., 2007; Xu et al., 2004) that FZD4 and LRP5 essentially 
need to be co-expressed with pTopflash and pRenilla while conducting the Norrin-Wnt reporter 
assay. We tested if expression of the recently discovered co-receptor Tspan-12 would ameliorate the 
assays, but it did not (Figure 19d). Therefore it is sufficient but essential to co-express FZD4 and LRP5 
while performing Norrin-Wnt reporter assay. Tspan-12 might be essential to specify the Norrin-Wnt 
signal but not necessary to convey the canonical Wnt signal. 
We tested if the use of stable Norrin isoforms expressing HEK293T cells would ameliorate the 
readout and lead to stronger signal intensity (Figure 20). We used stably wildtype and mutant 
(p.C95R) Norrin expressing HEK293T cells since they have been shown to express similar amounts of 
the respective proteins (Zuercher et al., 2012). Indeed, using stably Norrin isoforms expressing 
HEK293T cells led to stronger signal intensity without amplification of background noise (Figure 20 
and data not shown). Therefore we decided to use this cell lines for Norrin-Notch interaction studies. 
4.2 Establishing quality control for mice litters 
We established body weight based quality control for mice litters, since vascular defects affect 
normal development in vertebrates. For that we measured body weight of all mice used in our 
experiments and plotted data to enlighten the following correlations: 
• Weight differences depending on sex and postnatal age (Figure 25a) 
• Weight difference depending on genotype and postnatal age (Figure 25b) 
• Weight differences between different mice litters of a certain postnatal age (Figure 
25c) 
• Average body weight of mice dependent on postnatal age (Figure 25d) 
Only mouse litter affiliation influenced body weight, but not sex and genotype at the Ndph locus 
(Figure 25a - c). The average body weights from different litters of the same age often differ 
significantly. We noticed that mice of small litters were often heavier than mice of the same age 
belonging to a bigger litter (data not shown). We also noticed significant differences in body weight 
of mice from equal membered litters of different breeding pairs (data not shown). We cannot 
deduce if the cause is genetic or if parent animals influence the frequency of food intake of their 
pups. Based on this data, we excluded from experiments mice that differed two or more standard 
deviations from the average weight of their litter. The average body weights of mice per stage 
(Figure 25d) served only as landmarks for body weight of the respective postnatal age.  
4.3 Molecular mechanisms of sprouting angiogenesis in the retina: 
crosstalk between Notch and Norrin signaling. 
One goal was to investigate a possible crosstalk between Norrin-Wnt and Notch signaling. For this 
purpose, we established Wnt and Notch reporter assays in cell culture using luciferase constructs, 
crossed Ndphy/- with Notch reporter mice (Ndphy/- x TNR1), quantified morphometric parameters of 
the retina (number of filopodia, number of branch points and vascular density), monitored 
proliferation by BrdU staining and reporter assays, applied immunohistochemistry for Jag1, Dll4, 
endomucin, SMA and IBA1 on retinal whole-mounts, inhibited Notch signaling in Ndphy/- mice by 
injecting DAPT and tried to rescue deep vascular sprouting from the SRVP by injection of LiCl.  
4.3.1 Norrin-Wnt signaling is unlikely to interact with Notch signaling in stalk cells 
Our initial hypothesis suggested that Norrin-Wnt signaling might impede Notch1 signaling in stalk 
cells. We suggested disheveled or GSK3 mediated inhibition of N1ICD or Jagged1 mediated lateral 
inhibition of tip cell sprouting (Figure 15) as possible modes of interaction. We tested the ability of 
Norrin to downregulate N1ICD mediated Notch signaling in HEK293T cells. For that we expressed the 
Notch reporter construct pJH23a either in wildtype, mutant (p.C95R) and none-Norrin expressing 
HEK293T cells (Figure 21a). We found that wildtype Norrin was able to downregulate N1ICD 
mediated Notch signaling during the first 24 hours. This effect was lost if the reporter assay was 
incubated for more than 24 hours (data not shown), possibly because luciferase expression reached 
saturation levels. GSK3 unlikely inhibits Notch1 signaling in tip cells. GSK3 exists in two isoforms 
(GSK3α and GSK3β), both of which are repressors of Wnt-signaling and thus are expected to be 
inactive during canonical Wnt-signaling. Inactivation of GSK3α/β enhances Notch1 activity in vitro, 
ruling out GSK3 to be part of the Norrin-mediated Notch1 inhibition (Jin et al., 2009). Therefore we 
focused on Dvl-N1ICD interactions (Figure 21b, c, d, e). We found that Dvl1, 2 and 3 are capable of 
impeding N1ICD mediated Notch signaling, but the presence of N1ICD also downregulated Dvl1, 2 or 
3 mediated Wnt signaling. It is noteworthy that N1ICD was transfected in moderate concentrations 
of 20 ng/well but any of the Dvls at 500 ng/well. This implies that N1ICD has a stronger influence on 
Dvls and Wnt signaling than vice versa. This might indicate that Dvl-N1ICD interactions unlikely link 
Norrin-Wnt and Notch signaling within stalk cells. This does not explain our previous findings, where 
Norrin was able to decrease N1ICD mediated Notch signaling (Figure 21). A disadvantage of the 
reporter assay might be that it was performed in HEK293T cells instead of primary human ECs (e.g. 
HUVECs). It is not clear to what extent HEK293T cells mimic interactions between pathways in 
human ECs. However, it is unlikely that Dvl-N1ICD interaction mainly links Norrin-Wnt and Notch 
signaling in endothelial cells. 
Additionally, we found supernumerary filopodia in Ndphy/- retinas which suggests enhanced Dll4 
mediated Notch1 signaling in stalk cells. Indeed, we found enhanced Dll4 expression in bulky 
vascular fronts of Ndphy/- retinas (Figure 27). Notch inhibition, by DAPT administration, did not 
diminish the number of filopodia at the vascular front, but it rescued vascular outgrowth in Ndphy/- 
retinas (Figure 26). Thus, Notch signaling might be slightly out of balance in Ndphy/- mice, but it 
might not be the main cause for the severe vascular phenotype. Additionally, we tried to monitor 
Notch signaling in Ndphy/- retinas by crossing Ndphy/- with Notch reporter mice (TNR1) (Figure 22). 
Unfortunately, we found random activation of the Notch reporter in wildtype retinas and therefore 
could not assess if Notch signaling was elevated in stalk cells from Ndphy/- retinas using the Notch 
reporter mice. All together, the data suggested that Notch signaling might be slightly altered in 
Ndphy/- mice, but the observed effects were too small and inconsistent to suggest a direct 
interaction of both pathways. 
4.3.2 TaqMan analysis of Notch target genes in vitro 
TaqMan analysis was performed in wildtype and none-Norrin expressing HEK293T cells to measure 
Notch target gene expression of Hes1, Hes2, Hes5, Hey1 and Hey2. Hey1 was higher expressed after 
Norrin expression (Figure 24). Hey1 encodes a bHLH transcription factor which is an important 
modulator of A/V specification (De et al., 2009; Fischer et al., 2004; Roca et al., 2007).  Hey1-/- mice 
are fertile, viable and do not develop defects in all organs of prominent Hey1 expression such as 
somites, kidney, heart atria and nervous tissue. An explanation might be the redundancy with Hey2. 
Fischer et al., 2004 therefore analyzed Hey1/2 double knockout mice (DKO). DKO mice died between 
E9.5 and E11.5 due to a global lack of vascular remodeling and massive hemorrhage. Initial 
vasculogenesis was unaffected but subsequent development of major vessels in the yolk sac and 
embryo was perturbed (Fischer et al., 2004). Similarly, the same authors found reduced Hey1 and 
Hey2 expression in Notch1 knockout mice together with failure of arterial marker expression (CD44, 
neuropilin1 and ephrinB2). Expression of Norrin enhanced Hey1 expression in our assay and thus we 
would expect that Hey1 would be downregulated in Ndphy/- mice. We were not able to assess the 
Hey1 expression profile in the SRVP from Ndphy/- retinas since Hey1 is abundantly expressed in 
neural tissue which would interfere with qPCR measurements in whole retinas. But we found 
elevated SMC coverage of veins and capillaries from Ndphy/- retinas which might indicate a gain in 
arterial character. This suggests that Hey1 expression might be elevated in retinal Ndphy/- ECs. This is 
in contradiction with results from our cell culture assay. It might be worth to repeat the TaqMan 
experiment in Norrin-stimulated primary endothelial cells (e.g. HUVECs, HMEC-1 or HMECS) since 
HEK293T cells are derived from human kidney and are not of endothelial nature. 
4.3.3 Extended pathway analysis of Norrin in vitro  
We extended our pathway analysis on other signaling cascades than Notch, starting with MAPK 
signaling (Zuercher et al., 2012). We previously performed a pathway interaction analysis based on 
730 differentially expressed genes in Ndphy/- compared to wildtype retinas. MAPK signaling ranked at 
the top position, Wnt signaling was ranked at position five (Schafer et al., 2009). Expression of Norrin 
in HEK293T cells indeed triggered MAPK signaling by downstream activation of the SRF transcription 
factor (Figure 23). Furtermore mice that lack the intracellular Nrp1 domain or VEGFNES-CRE knockout 
mice, representing mice with altered MAPK signaling, display artery/vein crossing of the SRVP, 
similarly as Ndphy/- mice do (Fantin et al., 2011; Haigh et al., 2003). A recent paper describes 
artery/vein crossing in apelin receptor deficient mice (McKenzie et al., 2012) and apelin has been 
shown to be a MAPK target gene in cells different than ECs. Apelin could therefore also be a MAPK 
target gene in ECs and its expression pattern might also be altered in the SRVP from Ndphy/- retinas. 
A striking difference between Ndphy/- and Apln-/- retinas is that the DRVP and IRVP do both develop 
in Apln-/- mice. However, the findings of Schaefer et al., 2008 and my data indicate a possible link 
between Norrin-Wnt and MAPK signaling via SRF activation. Interestingly, SRF has a well known 
history of mediating sprouting angiogenesis. In sprouting angiogenesis, SRF mediates VEGF-A 
signaling via VEGFR2-MAPK-RhoA signaling (Franco et al., 2009). VEGF-A induces SRF expression and 
SRF is mandatory for VEGF-A-mediated angiogenesis (Chai et al., 2004). SRF is also involved in the 
recruitment of SMCs (Franco et al., 2009; Miano et al., 2004). Inactivation of SRF in mice leads to a 
decrease in the number of branch points, altered tip cell morphology and disruption of EC junctions 
with vessel leakiness, hemorrhage and aneurisms leading to death at E14.5 (Franco et al., 2008). 
These experiments highlight the importance of MAPK signaling and SRF during angiogenesis in mice. 
It should therefore be assessed if MAPK signaling is altered in Ndphy/- mice and if SRF plays a role in 
Norrie disease or related disorders. 
Next, we assessed estrogen response. We previously published that Ndph-/- mice are viable but 
mostly infertile due defective vascular differentiation during decidualisation together with reduced 
decidualisation itself (Luhmann et al., 2005b). In rat, Norrin regulates decidual reaction and the 
placental angiogenesis along with the survival and differentiation of luminal and glandular epithelial 
and decidual cells. It also plays indirect roles controlling trophoblastic invasion and programmed cell 
death (Kaloglu et al., 2011). During pregnancy, estrogen promotes blood perfusion of the 
endometrium, initiates opening of the cervix and renders the cervical secret permeable for sperm. 
Estrogen was found to be 3.5-fold downregulated in placenta of Ndp-/- mice (U.F. Luhmann, personal 
communication). Here, we monitored estrogen response in wildtype and p.C95R mutant Norrin 
expressing HEK293T cells using a pERE (estrogen response element) luciferase reporter construct 
(Figure 23) and found an elevated estrogen response in wildtype Norrin expressing cells, which is in 
concert with previous observations. It is not clear whether the reduced estrogen response is the 
cause for the effects or whether if it is the consequence of failed decidualisation. It is also not clear if 
this effect of Norrin also occurrs in human females since no reports exist. Therefore I suggest not to 
focus on that. It is also not clear how transferable data from mouse to humans are. The hemichorial 
placenta in mice consists of three trophoblastic layers including the giant cells, glycogen trophoblast 
cells and spongiotrophoblast. In humans, first trimester placenta is hemodichorial consisting of an 
outer layer of syncitiotrophoblast and an inner layer of cytotrophoblast. At term, the human 
placenta is hemomonochorial with only the syncitiotrophoblast present (Herr et al., 2010; Rossant et 
al., 2001). Our lab has currently no expertise in analysis of the placenta, therefore it makes sense to 
keep the focus on eye research. Furtermore FZD4-/- females were reported to be infertile due to 
defective corpora lutea formation causing the failure of implantation in contrast to decidualisation 
defects of Ndp-/- mice (Hsieh et al., 2005). 
TGFβ signaling is known to be involved in SMC differentiation (Bertolino et al., 2005) and we found 
elevated smooth muscle cell (SMC) coverage in Ndphy/- retinas (Zuercher et al., 2012). Therefore we 
assessed the influence of Norrin on TGFβ signaling. Norrin expression reduced TGFβ signaling in 
HEK293T cells (Figure 23) which is in contradiction with the observed elevated SMC coverage found 
in Ndphy/- retinas. Thus, Norrin deficiency might indirectly cause smooth muscle cell recruitment to 
the SRVP, which is in concert with the relatively late apperance of this effect. First, it might be worth 
to repeat this measurement in primary endothelial cells. The design of the assay is crucial since it is 
known that TGFβ exerts bifunctional effects on endothelial cells in vitro. The choice of the primary 
cell line for the assay is also crucial (Bertolino et al., 2005; Goumans et al., 2003). Goals of these 
investigations should be to determine if the downstream TGFβ signaling of Alk1-Smad1/5 or Alk5-
Smad2/3 is altered. Blood vessels of Smad5 knockout mouse embryos are less covered by SMCs 
(Goumans et al., 2003) but Alk5-Smad2/3 pathway activity promotes binding of δEF1, Smad3 and 
SRF to the SMA promoter enhancing SMA expression (Nishimura et al., 2006). Additionally, TGFβ 
induced under the involvement of Smad2 and Smad3 general smooth muscle markers in Monc-1 
cells while epithelial markers were downregulated (Chen et al., 2004). In vitro stimulation of primary 
endothelial cells with recombinant Norrin and subsequent analysis of the phosphorylation pattern of 
the respective proteins could reveal alterations in the affected pathway. It might also be that Norrin 
indirectly activates ALK1-Smad1/5 signaling leading to the upregulation of endoglin, an accessory 
receptor for TGFβ (Ota et al., 2002). Endoglin was found to counteract the inhibitory effect of 
TGFβ/Alk5 signaling on cellular proliferation in HUVECS (Li et al., 2000) and we found reduced 
proliferation of vascular endothelial cells is in Ndphy/- retinas. It might be important to investigate a 
dose dependent effect of Norrin, since effects of TGFβ on angiogenesis are essentially dose 
dependent (Bertolino et al., 2005; Goumans et al., 2003). Furthermore it is possible to assess 
influence of Norrin on SMC differentiation. For that, SM precursor cells (VEGFR2+, PDGFRβ+) 
(Bergers et al., 2005) can be isolated from Ndphy/- retinas and stimulated with recombinant TGFβ to 
differentiate into SMCs. Analysis of epithelial/endothelial markers of these SMCs and their 
contractile behavior after carbachol (a muscarinic agonist that can induce contraction of cultured 
SMCs) administration can be used for monitoring the state of SMC differentiation (Chen et al., 2004). 
Interestingly, a recent publication has shown that maternal derived Norrin is a TGFβ antagonist and 
that it controls early neuroectoderm specification in Xenopus laevis. The authors suggested a model 
of specification in Xenopus where dorsal active Norrin counteracts the BMP4 signal from the ventral 
side and the Nodal-related signal from the vegetal half of the blastula. They could also show that 
p.R40K xNorrin lost its ability to trigger Wnt signaling but not its ability to inhibit TGFβ signaling. In 
contrast, p.K57N xNorrin had moderately increased Wnt signaling activity but it lost its ability to 
inhibit TGFβ signaling (Xu et al., 2012). This study is interesting in two regards, first it is in concert 
with the findings from our TGFβ luciferase reporter assay, showing reduced TGFβ signaling activity 
upon Norrin expression. Second, this study shows for the first time a differential analysis of mutant 
Norrin isoforms with different effects on different pathways. Xu et al., 2004, Smallwood et al., 2005 
and we (data not shown) analyzed already human pathogenic mutant Norrin isoforms that did not 
display a loss of canonical Wnt signaling activity in luciferase reporter assays. It will now be 
important to test those Norrin mutations using our TGFβ and possibly also using our MAPK luciferase 
reporter assays – even though it is currently not clear if Norrin influences TGFβ signaling in ECs. It is 
likely that some mutations that do not show altered Wnt signaling have lost their ability either to 
inhibit TGFβ signaling or that they have lost their ability to stimulate MAPK signaling or both. It will 
also be intriguing to correlate the gained data from these reporter assays with the reported human 
phenotypes of the respective Norrin mutations. This may yield in a genotype-phenotype correlation 
for EVR spectrum diseases for the first time. 
Finally, we found slightly elevated endoplasmatic reticulum (ER) stress in HEK293T cells that express 
mutant Norrin (p.C95R) compared to wildtype Norrin expressing cells (Figure 23). ER stress is a term 
that describes disturbance of cellular homeostasis due to accumulation of unfolded protein in the ER 
lumen. ER stress is transduced by three different mechanisms which are summarized as unfolded 
protein response (UPR). Details of the UPR pathways are nicely reviewed in the literature (Bernales 
et al., 2006; Ron et al., 2007; Schroder2006). Heavy ER stress can lead to cell death, but no increased 
numbers of dead cells were observed while performing the assay (data not shown). Therefore it 
might be possible that the p.C95R mutation leads to accumulation of an un- or misfolded Norrin 
protein within the lumen of the ER which is sensed by ATF6. The cystein at position 95, which is 
suspected to be involved in Norrin dimerisation, is exchanged by an arginine in p.C95R Norrin and 
this may putatively lead to misfolding of Norrin or to failure in Norrin dimerisation. Thus, monitoring 
ER stress may provide a first-impression to evaluate if mutations lead to ER stress, but subsequent 
analysis of ER stress should be performed to consolidate this result. Possible experiments include 
monitoring of expression of UPR target genes, including such from the other two cascades (e.g. 
XBP1s, XBP1u and ATF4 and CHOP target genes). The degree of phosphorylation from UPR cascade 
proteins and/or proteins involved in apoptosis might also be assessed. 
4.3.4 The number of hyaloid vasculature associated macrophages persists between P7 
and P12 in Ndphy/- retinas 
Ndphy/- retinas have a reduced vascular density in the SRVP compared to retinas from wildtype 
littermates, a reduced angle of the brush of filopodia extending from each retinal tip cell and 
delayed and incomplete regression of the hyaloid vessels. These features are also seen in PU.1 null 
mice which lack monocyte derived retinal microglia cells, csf-1op/op mice that lack retinal microglial 
cells (Kubota et al., 2009b; McKercher et al., 1996) as well as in FZD4+/-, LRP5-/- and TSPAN12-/- mice 
(Junge et al., 2009; Luhmann et al., 2005a; Xia et al., 2008; Xia et al., 2010; Xu et al., 2004). Altered 
macrophage function can contribute to the narrower angle of filopodia, reduced vascular density 
and delayed hyaloid regression (Kubota et al., 2009b; Lobov et al., 2005; Rymo et al., 2011). Hyaloid 
regression is strongest between P7 and P12 and therefore we decided to quantify hyaloid regression 
during that period (Figure 28). Hyaloid regression progressed fast in wildtype mice but was 
dramatically delayed in Ndphy/- retinas. Quantification of IBA1 positive hyaloids vasculature 
associated macrophages revealed a persistent number of macrophages between P7 and P12 in 
Ndphy/- retinas but a decreasing number of macrophages in wildtype retinas (Figure 28s). The similar 
number of macrophages at P7 indicates that similar numbers of macrophages had migrated towards 
the hyaloid vessels. In wildtype mice, the number of macrophages decreased with hyaloid 
regression. In mice, pericytes express Ang2 which induces Wnt7b expression in macrophages (Rao et 
al., 2007). This Wnt7b is a paracrine ligand that binds Fz-4 and LRP-5 on hyaloid vessels and triggers 
canonical Wnt-signaling mediating hyaloid regression (Lobov et al., 2005). Why hyaloid regression in 
Ndphy/- retinas fails, despite a sufficient number of macrophages, remains an open question. It might 
be necessary that Wnt7b/Norrin heterodimers are needed to activate canonical Wnt signaling in 
hyaloid vessel associated macrophages. This combination could be a feedback loop signalizing the 
ability for deep sprouting of the SRVP through the presence of Norrin and macrophages. If this holds 
true, hyaloid vessels would start to regress at P7, when deep sprouting starts but hyaloid regression 
would fail if any compound required for deep sprouting like Norrin, Fz-4, LRP-5, Tspan-12 or 
macrophages are missing. In that case, deep sprouting would not occur and instead hyaloid vessels 
would persist and nourish the retina. This suggests that macrophages are equally important as 
Norrin, Fz-4, LRP-5 and Tspan-12 for deep sprouting. Supporting this, several recent publications 
highlight the importance of macrophages in superficial and deep vascular sprouting. Rymo et al., 
2011 found that microglia are present at sites of endothelial tip cell anastomosis and that ablation of 
microglia causes a sparser retinal vascular network together with a reduced number of filopodia 
bearing sprouts (Rymo et al., 2011). Microglia are attracted by vascular endothelial cells to localize at 
places of sprouting and anastomosis (Outtz et al., 2011) and in turn, macrophages secrete 
proangiogenic factors distinct from VEGF-A to stimulate endothelial outgrowth of the SRVP (Rymo et 
al., 2011). Interestingly, retinal myeloid cells (RMCs), have recently been shown to balance deep 
vascular sprouting by non-canonical Wnt signaling (Stefater et al., 2011). RMCs that are associated to 
deep retinal vascular sprouts express Wnt5a and Wnt11, which act in an autocrine fashion via a FZD 
receptor leading to the expression of sVEGFR1 which in turn reduces deep vascular sprouting. 
Expression of the canonical Wnt pathway co-receptor LRP-5 in RMCs supresses this non-canonical 
Wnt response by acting as a sink for Wnt5a/11. Interestingly, RMC-specific deletion of LRP5 leads to 
a hypovascular deep retinal plexus, but systemic deletion of LRP5 prevents development of the deep 
vascular plexuses entirely (Xia et al., 2008). The latter effect might be caused by the absence of LRP5 
on vascular ECs. There are a few emerging questions about the role of Norrin and macrophages 
during sprouting angiogenesis: Do Norrin and Wnt7b act as heterodimers via FZD4/LRP5 on 
macrophages during hyaloid vessel regression? Is the number of macrophages within or at avascular 
areas of the SRVP altered in Ndphy/- compared to wildtype retinas? Are macrophages differentially 
aligned at the sprouting front of the developing SRVP or at deeper layers within the plexus between 
Ndphy/- and wildtype retinas? Is Norrin also expressed in macrophages? Does Norrin trigger Wnt7b 
expression in macrophages? Is Norrin involved in the regulation of migration of macrophages e.g. 
together with VEGF-A? Can Norrin influence non-canonical Wnt signaling in macrophages? These 
questions can be addressed by several experiments. Heterodimerisation of Norrin and Wnt7b could 
be investigated by immunoprecipitation or using a BRET2 assay. The alignment of Iba1 or F4/80 
positive macrophages with endothelial tip cells could be quantified on whole-mounts from wildtype 
and Ndphy/- retinas to detect any misalignment or reduced numbers of EC associated macrophages. 
Superficial (CD11b+, F4/80+, CD240+) and deep (CD11b+, F4/80+, CD240-) macrophages (Stefater et 
al., 2011) isolated from wildtype and Ndphy/- retinas can be used in aortic ring assays to figure out if 
migration of macrophages or their release of angiogenic cues are altered. By applying sVEGFR1 
protein while conducting the assays one can figure out if those macrophages release VEGF-A (Rymo 
et al., 2011). One might also check if the different macrophages express Norrin and Wnt7b by qPCR 
(Lobov et al., 2005). One could also check if Norrin is able to alter non-canonical Wnt signaling in 
deep retinal macrophages by Fura-2 analysis in vitro (Stefater et al., 2011). 
4.3.5 Lithium chloride is toxic for mice pups 
Our goal was to rescue the deep retinal vascular sprouting in Ndphy/- mice by reactivation of 
canonical Wnt-signaling. A rescue of the ocular phenotype in our mice was already achieved by 
overexpressing Norrin in the lens (Ohlmann et al., 2005), but we wanted to see if stimulation of 
canonical Wnt signaling with lithium chloride (LiCl) would be sufficient to rescue blood vessel 
defects. For that we subcutaneously injected low doses of LiCl into mice pups between P5 and P12. 
Injections were aborted at P8 due to the unexpected high toxicity of low LiCl doses in mice pups 
(Table 2). Deep vascular sprouting was not rescued in surviving Ndphy/- mice despite the almost 
lethal dose of LiCl in surviving pups (Figure 29). Therefore, systemic administration of LiCl is not 
recommended to rescue the vascular phenotype of Ndphy/- mice. LiCl administration is also not the 
treatment of choice for human patients. Firstly, we did not find any efficacy. Secondly, we estimated 
the lethal dose (LD50) to be more than three times lower for mice pups than for adult mice. The LD50 
might be even lower for developing mouse embryos. This is likely to be similar in humans. The 
vascular plexuses in humans develops prenatally and hence, pregnant women would have to take 
LiCl which would put mother and child at risk. A more promising approach to rescue deep vascular 
sprouting in mice could be intravitreal injection of Norrin or intravitreal or subretinal injection of 
Norrin encoding adeno-associated viral (AAV) particles. Injection of Norrin protein has the 
disadvantage that it might be necessary to inject Norrin repeatedly and that the purification of 
Norrin might be difficult. AAV injection has the disadvantage that virus particles need to be purified 
prior to injection and that integrated viral DNA might alter function of endogenously encoded genes. 
Advantages are that many different serotypes recombinant AAVs are available for desired cell 
tropism (Petrs-Silva et al., 2009) and that the expression specificity can be enhanced by using the 
endogenous Norrin promoter. Since the viral DNA integrates stably into the host DNA, persistent 
expression of the gene of interest is achieved. In addition, AAV was proven as a vector for gene 
therapy in the human retina (RPE65) (Bainbridge et al., 2008). To rescue the ocular phenotype in 
Ndphy/- mice, the AAV serotype 8 Y773F shuttle could be used, since this virus transduces also Müller 
cells after subretinal injection (Petrs-Silva et al., 2009). The most exciting experiments using AAVs 
might be to express putative downstream components or target genes of Norrin-Wnt signaling in 
vascular endothelial cells or macrophages of Ndphy/- retinas. Such experiments could give more 
insight into the mechanism of deep retinal vascular sprouting. 
4.3.6 Outlook and future experiments 
This section covers suggestions concerning the investigation of the role of Norrin. The suggestions 
are partially based on data from literature. 
Establishing ISH on retinal whole-mounts is mandatory for this lab, since reliable working antibodies 
are not commercially available for all the proteins of interest. Initially, ISH should be performed for 
arterial and venous markers (e.g. ephrinB2, EphB4, APJ).  
Norrin is expressed in Müller cells and acts on endothelial cells that express Fz-4, LRP-5 and Tspan-
12. Therefore it is essential to get a Fzd4 or Lrp5 or Tspan12 knockout mouse as a source for primary 
endothelial cells for cell culture experiments. A Fzd4 knockout mouse is available from Jackson Lab 
(stock number: 012823). These homozygous Fzd4 knockout mice have a congenital retinal 
hypovascularization, a progressive inner ear vascular atrophy, a defect in the blood brain barrier in 
the cerebellum, and a progressive cerebellar degeneration associated with severe ataxia. These mice 
also show an absence of a skeletal muscle sheath around the lower esophagus associated with 
progressive esophageal distension (http://jaxmice.jax.org/strain/012823.html). I suggest to use this 
mouse as a source for primary endothelial cells. Additionally, different commercially available 
primary endothelial cells should be purchased and tested (e.g. HUVECs, MAE, HMECs, BCE). I 
recommend to conduct RT-PCRs from all of the endothelial cell lines to test the following markers: 
EphB4, ephrinB2, Vegf-Axxx, Vegf-XXXb, Vegfr2, Vegfr1, Fgf, Plgf, sVEGFR1, Nrp1, Pcam1, Fzd4, Lrp5, 
Tspan12, Ndph. This helps to characterize the endothelial cells and facilitates interpretation of the 
outcome from the assays. For the same reason, macrophages should be isolated and tested for the 
expression of Wnt7b, Fzd4, Lrp5, Tspan12, Ndph, Iba1, F4/80, CD11b, CD240.  
We previously reported upregulation of Vegf-A in Ndphy/- mice during the hypoxic stage of Norrie 
disease (Luhmann et al., 2005a). For that, TaqMan probes binding in exon 2 and exon 3 were used. 
These primers recognize all VEGF-A splice variants including the anti-angiogenic b-variants 
(Ladomery et al., 2007). However, the detailed expression profile of the respective Vegf-A-a- and –b 
variants is crucial, since all splice isoforms exert specific effects on vascular development. Therefore I 
recommend to perform an extensive analysis monitoring the up- and downregulation of the known 
Vegf-A splice variants in Ndphy/- retinas at P5, P7 and P12. This work may help to explain reduction in 
vascular density and it may also provide a primer for the angiogenesis community of how to proper 
analyze VEGF-A in mice retinas. 
The endothelial cell alignment of Ndphy/- and their Ndphy/+ littermates should be analyzed by 
electron microscopy with the goal to reveal if the phalanx structure, tight junctions, SMC coverage or 
vascular fenestrations are altered. An altered phalanx structure of ECs in Ndphy/- mice could be 
caused by altered PHD2 expression (Mazzone et al., 2009). Regarding thight or adherens junctions 
and vascular fenestrations, we previously reported downregulation of cldn5 (claudin-5) in vessels of 
Ndphy/- retinas (Schafer et al., 2009) together with elevated vascular permeability (Luhmann et al., 
2005a). This strongly indicates a loss of blood-retinal barrier. Therefore it would be interesting to 
focus on zonula occludens and zonula adherens forming molecules (e.g. claudin5, ZO-1, ZO-2, VE-
cadherin, N-cadherin, cingulin, 7H6, rab13 and occludin) (Barber et al., 2003; Kevil et al., 1998; Wong 
et al., 1997). Misalignment of these compounds may also cause loss of phalanx structure of retinal 
endothelial cells and vascular permeability. It has been shown that alterations in the axin 
cytoskeleton also lead to vascular leakage. Therefore altered axin alignment within the cell or 
altered localization of any of the axin-associated proteins may also contribute to vascular 
permeability. MAPK signaling also influences axin-cytoskelleton formation via SRF. Apart from SRF, 
axin, integrin linked kinase (ILK) and Rho kinase (ROCK) are good candidates (Kogata et al., 2009) to 
investiagte. Amot might play a controlling permeability of cell-cell junctions or to establish polarity 
of ECs (Bratt et al., 2005) (see below).  
We found extensive smooth muscle cell coverage of the SRVP in Ndphy/- mice after P9, which likely 
involves altered PDGFB/PDGFRβ and Ang1/Tie-2 signaling (Zuercher et al., 2012). Preventing 
extensive SMC coverage after P9 by injection of antibodies against these proteins would be a strong 
argument for that (Falcon et al., 2009; Uemura et al., 2002). Additionally, the influence of Norrin on 
the differentiation of SMCs can be analyzed in cell culture. For that, C3H10T1/2 cells could be 
stimulated to differentiate into SMCs in presence or absence of Norrin. This work requires NG2 and 
SMA IHC, application of Wnt inhibitors and constructs to label the cells in co-culture (e.g. 
GFP/Cherry) (Darland et al., 2001). During this work IHC for the pericyte markers Desmin, NG2 and 
PDGFRβ should be established. A mouse anti-Desmin antibody is available in this lab, but unspecific 
binding of the secondary anti-mouse antibody limited reliability of the histological stainings. Specific 
blocking of retinal whole-mounts with a mouse on mouse (M.O.M.) kit could help to avoid this 
problem. PDGFRβ staining is described in Falcon et al., 2009. Finally, the influence of Norrin on SMC 
recruitment could be monitored. This could involve downstream activity of SRF (Miano et al., 2004). 
We noticed extensive central sprouting peaking at P9 in Ndphy/- mice (Zuercher et al., 2012). The 
etiology of this pathogenic central sprouting is not clear, because the current literature exclusively 
deals with peripheral sprouting. VEGFR3 (Tammela et al., 2008; Tammela et al., 2011) is a known tip 
cell marker and therefore it might be interesting to co-stain retinas at P9 for VEGFR3 and endomucin 
or isolectinB4. The polarity of the endothelial cells or their responsiveness to growth factors might 
be lost. Thus, analyzing Angiomotin (Amot) expression profiles might be interesting in this regard. 
Amot is a receptor for the angiogenesis inhibitor angiostatin and Amot is expressed in ECs during 
normal physiological angiogenesis of the mouse retina (Bratt et al., 2005). It has been shown in a 
Boyden chamber assay that EC migration towards sources of VEGF, bFGF is reduced in Amot 
deficient or knockdown ECs. Amot is not required for tight junction formation, but for the 
organization of actin and focal adhesions. The interaction partner of Amot is Syx, a synectin-binding 
guanine exchange factor that is specifically expressed in blood vessels (Aase et al., 2007; Ernkvist et 
al., 2009; Garnaas et al., 2008). Otherwise, a partial loss the venous character could account for 
extensive central sprouting. Venous insufficiency has also been reported in a Norrie disease family 
from Costa Rica (Rehm et al., 1997). To assess that, ephrinB2-lacZ or EphB4-lacZ mice could be 
crossed with Ndphy/- mice and expression of the pan-arterial parker ephrinB2 could be described 
(Stalmans et al., 2002; Wang et al., 1998). ECs of these mice could be used in cell culture to monitor 
the effect of Norrin on A/V specification. Another promising work could be to investigate the ratio 
between Nrp1 and Nrp2 which are arterial and venous markers, respectively. The distribution of 
these markers on arteries and veins could be addressed by ISH or IHC, depending on the availability 
of working antibodies. It might be likely that Nrp1 expression is altered, since Nrp1 knockout mice 
display also A/V crossing (Fantin et al., 2011), a phenotypic feature I also described in Ndphy/- mice. 
ColIV stainings in Ndphy/- mice show broader and thickened basement membrane sleeves on retinal 
whole-mounts and on cryosections. Therefore it would be interesting to analyze the basement 
membrane extensively (Baluk et al., 2003). Several stainings (e.g. fibronectin, laminin, SMA) could be 
done on cryosections which might help to answer whether the basement membrane is enlarged or 
just fails to be degraded during deep sprouting. MT1-MMP or similar metalloproteinases could be 
involved in this process (van Hinsbergh et al., 2008; Yana et al., 2007).  
EGFL7 expression or deposition next to vascular sprouts could be monitored (Schmidt et al., 2007). 
EGFL7-/- mice display a delayed outgrowth of the SRVP and an increased number of stalk cells 
following the tip cell. The retinal vascular front is bulky, similar to Ndphy/- mice (Schmidt et al., 2007, 
supplementary data). A locally altered expression of EGFL7 could explain the occurrence of the bulky 
vascular front in Ndphy/- mice. The defects reported for EGFL7 might alternatively be caused by 
altered levels of the EGFL7 intronic aligned miRNA-126 (Nikolic et al., 2010). Therefore it might be 
worth to investigate the abundance of miRNA-126 or its localization in blood vessels from Ndphy/- 
retinas. 
Different pathway inhibitors or activators might be injected into Ndphy/- mice and their littermates 
and their influence on the vasculature might be described. Possible candidate targets of these 
inhibitors or activating drugs are Rho kinase, MAPK or TGFβ inhibitors and activators. 
It is still not clear if or how Angpt2 and Norrin-Wnt signaling are linked. Overexpression of Angpt2 in 
Ndphy/- retinas and overexpression of Norrin in Angpt2-/- retinas after transduction might help to 
determine if one of the mentioned proteins acts ectopic to the other. Angpt2 might also be worth to 
be investigated regarding its role in hyaloid regression. Angpt2 seems, like Wnt7a, Norrin, Fz-4, LRP-
5 and Tspan12, to be mandatory for hyaloid regression. Regarding the screening of patients, it might 
be worth to consider Angpt2 mutations and Dickkopf1 (Dkk1) gain-of-function mutations as 
candidate genes for EVR phenotypes. The interpretation of Dkk1 mutations might be difficult, 
especially if they occur in promoter or silencer regions.  
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Appendix 1 
Large Deletions including the NDP locus 
Exon(s)  Mutation on DNA Level  Phenotype  References*  
1-3 entire NDP deletion, as well as part of 
MAOB, 150 kb 
ND Berger, 1992 
1-3 entire NDP deletion, as well as MAOA and 
MAOB; 2-2.5 Mb 
ND Suarez-Merino, 
2001 
2-3 partial NDP deletion, deletion of MAOA and 
MAOB, 340 kb 
ND Berger, 1992 
2-3 partial NDP deletion, 15-20 kb ND Berger, 1992 
2-3 partial NDP deletion ND Schuback, 1995 
1 partial NDP deletion, 8-15 kb ND Berger, 1992 
2 partial NDP deletion, 2-4 kb ND Berger, 1992 
2 partial NDP deletion, 4kb ND Chen, 1993 
2 partial NDP deletion, 5kb ND Chen, 1993 
2 partial NDP deletion, 2-10kb ND Chen, 1993 
2 partial NDP deletion ND Schuback, 1995 
3 partial NDP deletion; MAOA and MAOB del 
>20kb 
ND Chen, 1993 
3 partial NDP deletion; part of exon 3; 7 kb ND Chen, 1993 
3 partial NDP deletion ND Schuback, 1995 
3 partial NDP deletion ND Schuback, 1995 
3 partial NDP deletion; 3'-UTR of exon 3 
inclusive PAS 
ND Rivera-Vega, 2005 
 4 different deletions (complete, partial, 4bp 
and single) 
ND Zhu, 1994  
 Xp11.4invq22 ND Pettenati, 1993 
 
NDP mutations in Exons 1 to 3 and introns 1 and 2 
Exon / Intron DNA Level** Protein Level** Phenotype References* 
Exon 1 c.-
391_380delinsGTCTCTC 
- (5´-UTR) ROP (4 & 5) Talks, 2001 
Exon 1 c.-386_310del - (5´-UTR) ROP (3/5) Talks, 2001 
Exon 1 ins 12 bp (CT repeat) - (5´-UTR) ND, ROP (4B & 5) Hiraoka, 2001; 
Wu, 2007 
Exon 1 ins 10 bp (CT repeat) - (5´-UTR) ND Schuback, 1995 
Exon 1 del 14 bp (CT repeat) - (5-´UTR) ROP, RS Hiraoka, 2001; 
Dickinson, 2006; 
Wu, 2007 
Intron 1 c.-208+1G>A - (splicing) ND Fuchs, 1996 
Intron 1 c.-208+2T>G - (splicing) ND Nikopoulos, 2010 
Intron 1 c.-208+5G>A - (splicing) ND Nikopoulos, 2010 
Exon 2 c.1A>G p.M1? ND Isashiki, 1995; Gal, 
1996; Berger 
unpublished 
Exon 2 c.2_3del p.0? ND Caballero, 1996 
Exon 2 c.2T>G p.M1R ND Schuback, 1995 
Exon 2 c.11_12del p.H4RfsX21 ND Nikopoulos, 2010 
Exon 2 c.24_27dup p.F10IfsX17 ND Berger, 1992 
Exon 2 c.25_40del p.S9PfsX4 ND Nikopoulos, 2010 
Exon 2 c.38T>G p.L13R ND Fuchs, 1994 
Exon 2 c.44T>G p.L15R ND Berger 
unpublished 
Exon 2 c.47T>C p.L16P ND Yamada, 2001 
Exon 2 c.49delG p.V17fsX1 ND Waryah, 2011 
Exon 2 c.50dup p.I18DfsX8 ND Gal, 1996 
Exon 2 c.53T>A p.I18K ND, FEVR Kondo, 2007; 
Shima, 2009 
Exon 2 c.65del p.T22KfsX10 ND Schuback, 1995 
Exon 2 c.86C>G p.S29X ND Meindl, 1992 
Exon 2 c.103del p.D35TfsX6 ND Chynn, 1996 
Exon 2 c.109C>T p.R37X ND Ott, 2000 
Exon 2 c.112C>T p.R38C ND, FEVR, PHPV Royer 2003; 
Riveiro-Alvarez, 
2005 
Exon 2 c.115T>C p.C39R ND Joos, 1994; Wu, 
2007 
Exon 2 c.122G>A p.R41K EVR, sporadic Shastry, 1997 
Exon 2 c.123G>C p.R41S PFV Wu, 2007 
Exon 2 c.123G>? p.R41T ND Pelcastre, 2010 
Exon 2 c.123G>T p.R41S PFV Dhingra, 2006 
Exon 2 c.125A>G p.H42R FEVR, EVR 
(sporadic) 
Shastry, 1997; 
Wu, 2007 
Exon 2 c.128dup p.H43QfsX14 ND Caballero, 1996 
Exon 2 c.128A>G p.H43R ND Dickinson, 2006 
Exon 2 c.129C>G p.H43Q ND Royer, 2003 
Exon 2 c.129delC p.Y44MfsX60 ND Nikopoulos, 2010 
Exon 2 c.131A>G p.Y44C ND Meindl, 1992 
Exon 2 c.131dup p.Y44X ND, PHPV, 
sporadic 
Hatsukawa, 2002 
Exon 2 c.133G>A p.V45M ND Royer, 2003 
Exon 2 c.134T>A p.V45E ND, MR Lev, 2007 
Exon 2 c.136del p.D46IfsX58 ND Schuback, 1995 
Exon 2 c.142_145del p.I48VfsX55 ND Zhu, 1994 
Exon 2 c.162G>C p.K54N ND, FEVR Hoefsloot, 2000; 
Kondo, 2007; 
Boonstra, 2009 
Exon 2 c.163T>C p.C55R ND Nikopoulos, 2010 
Exon 2 c.170C>G p.S57X ND Berger, 1992 
Exon 2 c.174G>T p.K58N ND, EVR 
(sporadic) 
Fuentes, 1993; 
Shastry, 1997 
Intron 2 c.174+1G>T - (splicing) ND Berger 
unpublished 
Intron 2 c.174+1G>C - (splicing) ND Fuchs, 1996 
Intron 2 c.174+5G>C - (splicing) ND Berger, 1992; 
Fuchs, 1996 
Intron 2 c.175-1G>C - (splicing) ND Royer, 2003 
Intron 2 c.175-1G>A - (splicing) ND, FEVR Kondo, 2007 
Exon 3 c.179T>A p.V60E ND Meindl, 1992 
Exon 3 c.181C>T p.L61F ND, VI Berger, 1992; 
Rehm, 1997 
Exon 3 c.181C>A p.L61I FEVR Wu, 2007 
Exon 3 c.182T>C p.L61P ND Schuback, 1995 
Exon 3 c.185T>C p.L62P ND Zhu, 1994 
Exon 3 c.187G>T p.A63S ND Novelli, 1999 
Exon 3 c.188C>A p.A63D ND Schuback, 1995 
Exon 3 c.194G>A p.C65Y ND Strasberg, 1995; 
Wu, 2007 
Exon 3 c.195C>G p.C65W ND Schuback, 1995 
Exon 3 c.196G>A p.E66K PFV (unilateral) Aponte, 2009 
Exon 3 c.199G>A p.G67R ND Nikopoulos, 2010 
Exon 3 c.200G>A p.G67E ND Nikopoulos, 2010 
Exon 3 c.205del p.C69AfsX35 ND Schuback, 1995 
Exon 3 c.206G>C p.C69S ND Chen, 1993 
Exon 3 c.218C>A p.S73X ND Walker, 1997 
Exon 3 c.220C>T p.R74C ND, FEVR Berger, 1992; 
Fuchs, 1996; 
Allen, 2006 
Exon 3 c.223T>C p.S75P ND Yamada, 2001 
Exon 3 c.224C>G p.S75C ND Berger, 1992 
Exon 3 c.226G>T p.E76X ND Hutcheson, 2005 
Exon 3 c.236_240del p.S80QfsX67 ND Riveiro-Alvarez, 
2005 
Exon 3 c.267C>A p.F89L ND Nikopoulos, 2010 
Exon 3 c.267_268insCTC p.F89_R90insL ND Hutcheson, 2005 
Exon 3 c.268del p.R90VfsX14 ND Lin, 2010 
Exon 3 c.268C>T p.R90C ND Royer, 2003 
Exon 3 c.269G>C p.R90P ND Berger, 1992 
Exon 3 c.274T>C p.S92P ND Nikopoulos, 2010 
Exon 3 c.282_283ins8 p.C95MfsX12 ND Schuback, 1995 
Exon 3 c.283T>C p.P.C95R ND (severe) Isashiki, 1995 
Exon 3 c.284G>T p.C95F ND (severe) Khan, 2004 
Exon 3 c.285C>A p.C95X ND (severe) Wu, 2007 
Exon 3 c.287G>A p.C96Y ND, EVR 
(sporadic) 
Berger, 1992; 
Meindl, 1992; 
Shastry, 1999 
Exon 3 c.288C>G p.C96W CD Black, 1999 
Exon 3 c.290G>C p.R97P ND Rivera-Vega, 
2005; Kondo, 
2007 
Exon 3 c.291del p.Q99RfsX5 ND Berger, 1992 
Exon 3 c.293C>T p.P98L ND Nikopoulos, 2010 
Exon 3 c.302C>T p.S101F ND, PHPV (mild) Walker, 1997 
Exon 3 c.307C>G p.L103V FEVR Dickinson, 2006 
Exon 3 c.310A>C p.K104Q ND (mild) Meindl, 1995 
Exon 3 c.312G>T p.K104N ND Riveiro-Alvarez, 
2006 
Exon 3 c.313G>A p.A105T ND Torrente, 1997 
Exon 3 c.323T>C p.L108P ROP (4B/5) Shastry, 1997 
Exon 3 c.325C>T p.R109X ND Schuback, 1995; 
Mintz-Hittner, 
1996 
Exon 3 c.328T>C p.C110R ND Zhu, 1993; Fuchs, 
1996 
Exon 3 c.328T>G p.C110G FEVR Torrente, 1997 
Exon 3 c.328T>A p.C110S ND Berger 
unpublished 
Exon 3 c.330C>A p.C110X ND Berger, 1992 
Exon 3 c.332C>A p.S111X ND Nikopoulos, 2010 
Exon 3 c.333del p.G113AfsX149 ND Hutcheson, 2005 
Exon 3 c.335G>A p.G112E FEVR (highly 
variable) 
Allen, 2006 
Exon 3 c.344G>T p.R115L FEVR Kondo, 2007 
Exon 3 c.343C>T p.R115X ND Liu, 2010 
Exon 3 c.353C>A p.A118D ND Shastry, 1999 
Exon 3 c.359A>G p.Y120C EVR (sporadic) Shastry, 1997 
Exon 3 c.360C>A p.Y120X ND Riveiro-Alvarez, 
2005 
Exon 3 c.360_368del p.R121_I123del ND Schuback, 1995 
Exon 3 c.361C>G p.R121G ND, PRDX Zhu, 1994 
Exon 3 c.361C>T p.R121W ND, ND (mild), 
FEVR, ROP 
Meindl, 1995; 
Shastry, 1995; 
Kellner, 1996; 
Shastry, 1997; 
Wu, 2007; 
Pelcastre, 2010 
Exon 3 c.362G>A p.R121Q ND, ND (mild), 
FEVR 
Fuentes, 1993; 
Meindl, 1995; 
Riveiro-Alvarez, 
2005; Boonstra, 
2009; Pelcastre, 
2010 
Exon 3 c.362G>T p.R121L FEVR (highly 
variable) 
Johnson, 1996; 
Mintz-Hittner, 
1996 
Exon 3 c.365A>T p.Y122W FEVR Lucas Mohn 
unpublished 
Exon 3 c.368T>A p.I123N ND Schuback, 1995 
Exon 3 c.370C>T p.L124F FEVR Chen, 1993 
Exon 3 c.377G>C p.C126S ND Gal, 1996 
Exon 3 c.378T>A p.C126X ND Fuchs, 1996; 
Keller, 1996 
Exon 3 c.382T>C p.C128R ND Royer, 2003 
Exon 3 c.383_384del p.C128X ND Wong, 1993; 
Hutcheson, 2005 
Exon 3 c.384C>A p.C128X ND Schuback, 1995 
Exon 3 c.397del p.S133PfsX129 ND Berger, 1992 
Exon 3 c.399del p.X134EfsX128 ND Riveiro-Alvarez, 
2008 
Exon 3 c.*716T>C p.? FEVR Wu, 2007 
* Most of the cited references have multiple authors. For lack of space, only the last name of the 
first author of the respective publication was included. 
** Nomenclature was edited according to recommendations of the Human Genome Variation 
Society (http://www.hgvs.org/). 
 
  
Appendix 2 
Summary of the most prominent features of the syndromes described above 
 ND EVR CD ROP OPPG PHPV 
affected gene NDP x x x x  x 
FZD4  x     
LRP5  x   x  
TSPAN12  x     
mode of inheritance X-linked recessive x      
autosomal dominant  x    x 
autosomal recessive  x   x x 
sporadic  x x    
affected organ ear x      
brain x    (x)  
eye x x x x x x 
bone     x  
occurrence unilateral   x   x 
bilateral x x (x) x x (x) 
clinical symptoms subretinal exudation x x x    
intraretinal exudation   x    
retinal detachment x x x x   
pseudoglioma x    x  
neovascularisation  x  x   
vitreus hemorrhage x x     
retinal folds x x  x   
leukokoria x x    x 
phthisis bulbi x      
massed fractures     x  
persistent tunica vasculosa 
lentis 
     x 
osteoporosis     x  
muscular hypotonia     x  
ligamentous lataxy     x  
hyperplasia of vitreous     x  
microphthalmos x     x 
nystagmus (x)     (x) 
corneal opacities x    x (x) 
cataract x     x 
secondary glaucoma x    x x 
clinical consequences impaired vision x x x x x x 
progressive blindness  x x x  x 
congenital blindness x x    (x) 
progressive deafness x      
mental retardation x    (x)  
CD = Coats’ Disease, ND = Norrie Disease, EVR = Exudative Vitreoretinopathy, PHPV = Persistent 
Hyperplastic Primary Vitreous; OPPG = Osteoporosis-pseudoglioma syndrome; x = common feature 
in affected individuals; (x) = rarely observed; for references consider the respective chapter about 
the disease; (adapted from Masterthesis Jurian Zürcher, 2008). 
 
 
  
Appendix 3 
Descriptive Statistics of investigated C56BL/6J mouse population 
  Frequency Percent 
all stages 
male 167 48.7 
female 176 51.3 
wildtype 154 44.9 
heterozygous 102 29.7 
knockout 87 25.4 
total 343 100 
P5 
male 32 47.7 
female 35 52.3 
wildtype 25 37.3 
heterozygous 24 35.8 
knockout 18 26.9 
total 67 100 
P7 
male 32 47.7 
female 35 52.3 
wildtype 28 41.8 
heterozygous 19 28.4 
knockout 20 29.8 
total 67 100 
P9 
male 40 55.5 
female 32 44.5 
wildtype 38 52.8 
heterozygous 19 26.4 
knockout 15 20.8 
total 72 100 
P12 
male 34 47.9 
female 37 52.1 
wildtype 37 52.1 
heterozygous 21 29.6 
knockout 13 18.3 
total 71 100 
P21 
male 29 43.9 
female 37 56.1 
wildtype 26 39.4 
heterozygous 19 28.7 
knockout 21 31.9 
total 66 100 
 
  
Weight differences depending on sex and stage 
  
male 
  
female 
  
 
AV STDEV CI AV STDEV CI p-value 
P5 3.1 0.4 0.1 3.0 0.4 0.1 0.594 
P7 4.0 0.6 0.2 3.9 0.6 0.2 0.546 
P9 4.8 0.8 0.3 5.0 0.9 0.3 0.297 
P12 6.2 1.0 0.3 5.8 0.9 0.3 0.12 
P21 9.0 1.0 0.4 9.1 0.9 0.3 0.529 
PX = Postnatal day X; AV = average; STDEV = standard deviation; CI = confidence interval (α=0.05) 
Weight difference depending on genotype per stage 
 
wt het ko 
 
p-values 
 
 
AV STDEV CI AV STDEV CI AV STDEV CI wt - het wt - ko het - ko 
P5 3.1 0.3 0.1 3.0 0.5 0.2 3.0 0.4 0.2 0.587 0.454 0.866 
P7 4.0 0.7 0.3 3.9 0.2 0.2 3.9 0.6 0.3 0.692 0.775 0.907 
P9 4.8 0.7 0.2 5.0 1.0 0.4 5.0 1.0 0.6 0.313 0.458 0.859 
P12 6.0 1.0 0.3 5.9 0.8 0.3 6.3 1.0 0.6 0.586 0.309 0.212 
P21 8.8 0.9 0.4 9.1 0.9 0.4 9.2 1.0 0.4 0.340 0.136 0.613 
PX = Postnatal day X; AV = average; STDEV = standard deviation; CI = confidence interval (α=0.05); wt 
= wildtype; het = heterozygous; ko = knockout 
  
Weight differences between different mice litters 
 
litter AV STDEV CI litter AV STDEV CI 
1 3.1 0.4 0.3 21 6.7 0.6 0.5 
2 3.0 0.2 0.1 22 4.1 0.4 0.4 
3 3.6 0.3 0.3 23 4.2 0.2 0.2 
4 3.4 0.4 0.4 24 5.3 0.3 0.2 
5 3.1 0.1 0.1 25 7.3 0.5 0.7 
6 2.6 0.2 0.2 26 4.3 0.5 0.5 
7 3.1 0.1 0.1 27 6.6 0.8 0.6 
8 2.6 0.2 0.2 28 6.3 0.3 0.2 
9 4.3 0.3 0.3 29 6.6 0.8 0.6 
10 4.4 0.1 0.1 30 6.3 0.3 0.2 
11 3.1 0.2 0.2 31 5.3 0.5 0.4 
12 3.4 0.3 0.2 32 5.3 0.4 0.3 
13 4.1 0.4 0.3 33 8.5 0.4 0.3 
14 4.8 0.2 0.2 34 10.0 0.5 0.4 
15 3.4 0.3 0.2 35 8.5 0.6 0.4 
16 4.2 0.4 0.3 36 9.7 0.3 0.4 
17 4.9 0.2 0.2 37 9.9 0.5 0.5 
18 4.4 0.8 0.6 38 9.8 0.6 0.6 
19 4.9 0.4 0.2 39 8.9 1.0 0.8 
20 4.5 0.3 0.2 40 8.1 0.7 0.6 
AV = average; STDEV = standard deviation; CI = confidence interval (α=0.05);  
 
Average weight of mice dependent on stage 
 AV STDEV CI 
P5 3.1 0.4 0.1 
P7 4.0 0.6 0.1 
P9 4.9 0.9 0.2 
P12 6.0 0.9 0.2 
P21 9.0 0.9 0.2 
PX = Postnatal day X; AV = average; STDEV = standard deviation; CI = confidence interval (α=0.05); 
  
Appendix 4 
 
Quantification by independent samples t-test of morphometric data from wildtype and NDPhy/- 
retinas 
 wildtype retinas NDPhy/- retinas 
P5 
Number of filopodia 23 ± 2 (n=5) 32 ± 5 (n=6; p-value = 0.001) 
Vascular density 42 ± 5 (n=5) 30 ± 4 (n=5; p-value = 0.002) 
Number of branchpoints 30 ± 1 (n=5) 14 ± 3 (n=5; p-value =0.0001) 
P7 
Number of filopodia 21 ± 3 (n=4) 29 ± 2 (n=7, p-value =0.0001) 
Vascular density 48 ± 4 (n=5) 32 ± 3 (n=7; p-value = 0.0006) 
Number of branchpoints 89 ± 7 (n=5) 47 ± 8 (n=7; p-value =0.0001) 
average ± standard deviation are reported; n= number of retinas; P-values below α=0.05 are 
considered to be statistically significant. 
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